Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,A1BG,Alpha-1B-glycoprotein,22968,36,12.69 [2.05-78.64],0.0063228454973897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AAMDC,Mth938 domain-containing protein,22310,34,1.23 [0.68-2.22],0.4871636779329371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,26305,39,0.84 [0.51-1.38],0.4824898521249992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABCA2,ATP-binding cassette sub-family A member 2,22213,35,2.21 [1.13-4.31],0.0200111463992024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABHD14B,Protein ABHD14B,26157,40,0.56 [0.34-0.93],0.0255168643301893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABL1,Tyrosine-protein kinase ABL1,26305,39,1.01 [0.68-1.51],0.9577284648689336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABO,Histo-blood group ABO system transferase,22963,37,1.05 [0.84-1.31],0.6784391807729466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABRAXAS2,BRISC complex subunit Abraxas 2,22213,35,1.41 [0.93-2.14],0.1067009193975321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",25789,40,1.29 [0.94-1.77],0.1185995618860386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",22529,37,1.42 [1.06-1.92],0.019824444209342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",22945,37,1.05 [0.76-1.43],0.7733567255727418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAN,Aggrecan core protein,26177,40,0.75 [0.48-1.17],0.2047932272793265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE,Angiotensin-converting enzyme,22963,37,2.60 [0.85-7.96],0.0938362859270503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE2,Angiotensin-converting enzyme 2,25946,40,1.67 [1.10-2.53],0.0169394754122599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACHE,Acetylcholinesterase,22429,37,0.82 [0.34-1.96],0.6576179129459381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOT13,Acyl-coenzyme A thioesterase 13,22858,36,1.10 [0.85-1.42],0.4678684313354184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,26416,40,1.48 [0.92-2.37],0.1024682156875856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,22293,36,0.63 [0.30-1.34],0.2313373054981135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,26503,40,3.95 [2.43-6.42],2.92701043109888e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP6,Lysophosphatidic acid phosphatase type 6,26621,42,1.13 [0.73-1.73],0.5857603634771243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRBP,Acrosin-binding protein,22835,37,1.13 [0.57-2.23],0.7233976121168298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRV1,Acrosomal protein SP-10,22293,36,0.99 [0.68-1.43],0.9628994858451824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,22213,35,0.80 [0.28-2.30],0.6763959735929037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",25946,40,1.56 [1.01-2.42],0.0463842897967802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN2,Alpha-actinin-2,22213,35,1.29 [0.82-2.05],0.2720809684841389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN4,Alpha-actinin-4,25930,40,0.70 [0.25-1.96],0.5030723256949284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,26202,40,5.40 [2.47-11.80],2.3206468284263062e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,26416,40,1.89 [1.28-2.79],0.0012707648184849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,22213,35,2.38 [1.44-3.93],0.000742069446539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACYP1,Acylphosphatase-1,22345,36,1.12 [0.71-1.76],0.6179138405900515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA,Adenosine deaminase,26732,42,0.64 [0.30-1.36],0.2451913983877862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,26236,40,6.11 [3.95-9.45],4.604762662586903e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,22293,36,2.24 [1.46-3.46],0.0002537737500221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,25946,40,1.58 [0.62-4.00],0.3350160153851417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,26246,40,1.30 [0.60-2.83],0.5047197084816453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,26732,42,1.30 [0.62-2.74],0.483954749977303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,26638,41,2.32 [0.88-6.07],0.0876930230044675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,22858,36,4.04 [2.31-7.08],1.018018064854539e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,22293,36,2.41 [1.34-4.31],0.0031320403018144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,26739,40,4.96 [1.60-15.38],0.0055988053152567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,26305,39,2.90 [1.45-5.83],0.0027044910209488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,25946,40,0.94 [0.36-2.42],0.896279989940629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,22293,36,1.82 [0.96-3.45],0.0668109419289339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,26490,42,0.57 [0.32-1.02],0.0587273092721026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,22926,36,5.64 [3.17-10.02],3.760949051159727e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL4,ADAMTS-like protein 4,22310,34,1.33 [0.36-4.88],0.6684771883590143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL5,ADAMTS-like protein 5,22945,37,1.08 [0.48-2.43],0.8588397625591548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,25789,40,0.69 [0.23-2.04],0.4999183253305294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADD1,Alpha-adducin,22429,37,0.88 [0.58-1.33],0.5327153707629918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRB3,Adhesion G protein-coupled receptor B3,26202,40,1.96 [0.87-4.44],0.1056025122375721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRD1,Adhesion G-protein coupled receptor D1,22429,37,1.80 [0.90-3.59],0.0968347646498865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,22858,36,2.72 [1.66-4.47],7.57202605931802e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,26539,40,8.91 [4.20-18.91],1.1865448066145241e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,26587,39,4.51 [2.41-8.42],2.294139023705655e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRF5,Adhesion G protein-coupled receptor F5,22945,37,3.89 [1.43-10.59],0.0077817985161494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,26305,39,2.34 [1.89-2.90],1.0042504427847556e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,26416,40,0.43 [0.29-0.64],2.352683365543012e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRV1,Adhesion G-protein coupled receptor V1,22212,34,1.09 [0.71-1.66],0.7030354593146797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH1B,All-trans-retinol dehydrogenase,22429,37,1.09 [0.74-1.60],0.6751969558474561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,25946,40,1.09 [0.77-1.54],0.6349775367432018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADIPOQ,Adiponectin,22968,36,0.67 [0.42-1.09],0.109018037234014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,26655,42,25.24 [8.84-72.10],1.6551197272410299e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADRA2A,Alpha-2A adrenergic receptor,22213,35,0.54 [0.27-1.07],0.07564492638231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFAP1,Actin filament-associated protein 1,22429,37,1.19 [0.86-1.66],0.2908525326994243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFM,Afamin,22968,36,5.82 [1.25-27.09],0.0247424732542436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFP,Alpha-fetoprotein,26163,40,0.77 [0.48-1.24],0.2839515515528768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGBL2,Cytosolic carboxypeptidase 2,22212,34,0.91 [0.63-1.30],0.6043187781694707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGER,Advanced glycosylation end product-specific receptor,26352,39,0.54 [0.26-1.11],0.0941461663294325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,25602,41,2.05 [1.63-2.59],1.5530205494744755e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,25754,40,1.66 [1.19-2.32],0.0026885786464336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,26539,40,3.88 [2.49-6.07],2.5853454647475903e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,26732,42,2.44 [1.44-4.13],0.0009311079929383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGT,Angiotensinogen,22963,37,0.46 [0.08-2.50],0.3673646993350071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGXT,Serine--pyruvate aminotransferase,26416,40,1.24 [0.86-1.79],0.2419621324518359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHCY,Adenosylhomocysteinase,26416,40,0.94 [0.62-1.42],0.7688315817609225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,22310,34,1.03 [0.39-2.72],0.9461992120808144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK2,Protein AHNAK2,22310,34,0.75 [0.23-2.43],0.6351706016767231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,22835,37,0.69 [0.39-1.23],0.2106196844037809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSG,Alpha-2-HS-glycoprotein,22963,37,1.53 [0.47-4.99],0.4831861457819549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSP,Alpha-hemoglobin-stabilizing protein,26367,41,0.91 [0.66-1.25],0.5512373903291917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIDA,"Axin interactor, dorsalization-associated protein",22304,36,0.87 [0.59-1.30],0.5072076140884143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1,Allograft inflammatory factor 1,25789,40,0.95 [0.57-1.60],0.8587699028324296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1L,Allograft inflammatory factor 1-like,22310,34,1.50 [0.97-2.33],0.0687193928640194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",26258,39,1.17 [0.91-1.50],0.2127212658343119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK1,Adenylate kinase isoenzyme 1,26416,40,0.63 [0.40-0.99],0.0434898704303504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK2,"Adenylate kinase 2, mitochondrial",22882,35,1.04 [0.78-1.39],0.7664558159760482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKAP12,A-kinase anchor protein 12,22429,37,0.38 [0.07-1.94],0.2428497586358409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B1,Aldo-keto reductase family 1 member B1,25789,40,1.28 [0.91-1.81],0.154092879747771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B10,Aldo-keto reductase family 1 member B10,22304,36,1.40 [0.96-2.06],0.0831484783591821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1C4,Aldo-keto reductase family 1 member C4,25946,40,1.05 [0.62-1.78],0.864403058646588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,22293,36,1.28 [0.84-1.94],0.2445586145544649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT1S1,Proline-rich AKT1 substrate 1,25812,41,0.97 [0.64-1.47],0.8940317997878828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT2,RAC-beta serine/threonine-protein kinase,22907,37,1.04 [0.82-1.31],0.7394046805935511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT3,RAC-gamma serine/threonine-protein kinase,25662,40,1.12 [0.71-1.76],0.6295138359419792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,26739,40,5.05 [1.50-16.93],0.0087706609024141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH1A1,Retinal dehydrogenase 1,26404,41,1.04 [0.64-1.68],0.8759671665405062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",22835,37,0.80 [0.39-1.65],0.5480467182986875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",26368,41,1.24 [0.88-1.74],0.2129120960901105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",22907,37,0.89 [0.46-1.74],0.742107881766848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALMS1,Alstrom syndrome protein 1,22529,37,1.26 [0.66-2.41],0.4852583082748372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPI,Intestinal-type alkaline phosphatase,22293,36,1.12 [0.86-1.46],0.3872058379938241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPP,"Alkaline phosphatase, placental type",26305,39,1.45 [1.14-1.85],0.0027873318888143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBN,Ameloblastin,25930,40,0.31 [0.09-1.10],0.0707481574293347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,26622,42,25.46 [8.54-75.92],6.3419718421117475e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,22926,36,0.75 [0.23-2.47],0.6378211096349471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMFR,E3 ubiquitin-protein ligase AMFR,25812,41,0.98 [0.67-1.43],0.9206212301915246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO1,Amphoterin-induced protein 1,22304,36,0.91 [0.46-1.80],0.7854906320619943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,26305,39,4.76 [1.65-13.75],0.0039582966481914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMN,Protein amnionless,25930,40,0.73 [0.40-1.32],0.2994120844529213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOT,Angiomotin,22429,37,1.42 [0.67-3.02],0.3606302692958607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOTL2,Angiomotin-like protein 2,22760,37,0.87 [0.43-1.76],0.7003927232444952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMPD3,AMP deaminase 3,22882,35,0.82 [0.52-1.28],0.3774090763523583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,21531,35,0.88 [0.44-1.74],0.7115734721627252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2A,Pancreatic alpha-amylase,25423,37,1.17 [0.66-2.09],0.5926529916127491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2B,Alpha-amylase 2B,24631,34,1.08 [0.59-1.99],0.7974013514207164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,26314,40,2.46 [1.33-4.56],0.0041638407636589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT1,Angiopoietin-1,26343,40,1.51 [1.07-2.12],0.0191232872677722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,26655,42,6.30 [3.38-11.76],7.271175385919685e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,26023,40,1.93 [0.73-5.09],0.1848526526822066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL2,Angiopoietin-related protein 2,26453,40,2.23 [1.14-4.33],0.0183698104433088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL3,Angiopoietin-related protein 3,26412,40,0.61 [0.28-1.35],0.2247504586414094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,26498,40,4.20 [2.34-7.55],1.619107485382683e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,26655,42,3.33 [2.12-5.22],1.616403006462709e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANK2,Ankyrin-2,22213,35,0.51 [0.24-1.05],0.0665123471648008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,22293,36,1.08 [0.74-1.57],0.6855517833341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRA2,Ankyrin repeat family A protein 2,22139,37,0.94 [0.52-1.70],0.8488950820789962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRD54,Ankyrin repeat domain-containing protein 54,25789,40,0.80 [0.47-1.34],0.3939279171111142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,22310,34,0.93 [0.36-2.37],0.873260140620425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANPEP,Aminopeptidase N,26442,40,0.72 [0.25-2.10],0.5466289952654764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA1,Annexin A1,22300,37,1.17 [0.64-2.15],0.613994874046244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,25812,41,1.68 [1.31-2.16],5.287119401385218e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA11,Annexin A11,26354,41,0.75 [0.51-1.10],0.1409942478116486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA2,Annexin A2,21983,34,1.25 [0.84-1.84],0.2665893056613868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA3,Annexin A3,26638,41,0.89 [0.60-1.31],0.5528396268979232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA4,Annexin A4,26285,40,0.81 [0.56-1.18],0.2707910776877586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA5,Annexin A5,25723,40,2.17 [0.99-4.73],0.0522288220021505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],25930,40,0.64 [0.33-1.24],0.1849193471838152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,26487,40,5.04 [2.28-11.14],6.379157906994491e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP1G2,AP-1 complex subunit gamma-like 2,22835,37,1.23 [0.86-1.77],0.253021418824953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP2B1,AP-2 complex subunit beta,22304,36,1.16 [0.67-1.99],0.6009859557030465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3B1,AP-3 complex subunit beta-1,22858,36,1.27 [0.88-1.83],0.1936821853362288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3S2,AP-3 complex subunit sigma-2,22882,35,1.15 [0.67-1.97],0.6093942061602298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,26305,39,0.57 [0.28-1.20],0.1393467225819339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APCS,Serum amyloid P-component,22779,36,1.92 [0.68-5.41],0.219112782954431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,26583,42,0.82 [0.50-1.35],0.4402071544463686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,26416,40,0.43 [0.24-0.76],0.0033251334143201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA1,Apolipoprotein A-I,22968,36,0.40 [0.11-1.55],0.1859716247956329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA2,Apolipoprotein A-II,22963,37,0.83 [0.45-1.55],0.5590536529826051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,22968,36,3.38 [2.31-4.94],3.076688266040783e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOB,Apolipoprotein B-100,22963,37,1.08 [0.31-3.81],0.8997219484660887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOBR,Apolipoprotein B receptor,22310,34,0.50 [0.25-0.98],0.0430960200245382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOC1,Apolipoprotein C-I,22923,36,0.43 [0.19-1.00],0.0495617160225041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOD,Apolipoprotein D,21877,34,0.70 [0.48-1.02],0.0655584371456843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOE,Apolipoprotein E,22968,36,0.86 [0.53-1.39],0.5275830626537592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOF,Apolipoprotein F,22963,37,0.35 [0.15-0.85],0.0200502045346919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOH,Beta-2-glycoprotein 1,26404,41,0.66 [0.31-1.42],0.2879965301830954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOL1,Apolipoprotein L1,22963,37,0.64 [0.34-1.21],0.1707503079096654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOM,Apolipoprotein M,26454,40,0.58 [0.35-0.95],0.0295612857371653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APP,Amyloid-beta precursor protein,26354,41,1.34 [0.91-1.98],0.1437282317025484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APPL2,DCC-interacting protein 13-beta,22429,37,1.12 [0.85-1.47],0.4208413081004363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APRT,Adenine phosphoribosyltransferase,26214,40,0.77 [0.43-1.37],0.3694409923637027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARAF,Serine/threonine-protein kinase A-Raf,22529,37,1.33 [0.87-2.05],0.1858826968624909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,26305,39,4.04 [2.69-6.07],1.8243953637089203e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARF6,ADP-ribosylation factor 6,22858,36,1.09 [0.81-1.47],0.581622633048599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARFIP1,Arfaptin-1,22907,37,1.17 [0.78-1.73],0.4484384471174314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG1,Arginase-1,26282,42,0.49 [0.29-0.85],0.0110796350813959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG2,"Arginase-2, mitochondrial",22835,37,1.08 [0.52-2.24],0.8373093490288605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP1,Rho GTPase-activating protein 1,25789,40,0.48 [0.27-0.86],0.0126423592761708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP25,Rho GTPase-activating protein 25,25789,40,0.81 [0.51-1.31],0.395539859956563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP30,Rho GTPase-activating protein 30,22529,37,0.62 [0.23-1.69],0.3497843569939046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP45,Rho GTPase-activating protein 45,22429,37,1.17 [0.82-1.67],0.3998431427145574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP5,Rho GTPase-activating protein 5,22139,37,1.35 [0.95-1.92],0.0958861885717251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,22882,35,1.30 [0.92-1.84],0.1369974359497267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,22907,37,1.27 [0.94-1.72],0.121291556932391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,26402,41,1.07 [0.83-1.40],0.5931638739766821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,22212,34,1.51 [1.08-2.10],0.0158005412855306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID3A,AT-rich interactive domain-containing protein 3A,22212,34,0.92 [0.46-1.84],0.8167009342745193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID4B,AT-rich interactive domain-containing protein 4B,25812,41,0.43 [0.17-1.07],0.0687062581913542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL13B,ADP-ribosylation factor-like protein 13B,22213,35,0.95 [0.62-1.45],0.8190987711083938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,22213,35,0.71 [0.32-1.57],0.3947673175929759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,22212,34,1.27 [0.81-1.98],0.2955972223653252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,25930,40,1.10 [0.52-2.32],0.8077208673507761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,22213,35,0.97 [0.52-1.81],0.9200219142549132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSA,Arylsulfatase A,26404,41,1.40 [0.83-2.37],0.2124363239833878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSB,Arylsulfatase B,26305,39,0.96 [0.58-1.57],0.8597589052153036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART3,Ecto-ADP-ribosyltransferase 3,26487,40,0.96 [0.44-2.14],0.9284800421433654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART5,Ecto-ADP-ribosyltransferase 5,22212,34,1.47 [1.07-2.00],0.0160004389987875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARTN,Artemin,25930,40,0.97 [0.54-1.75],0.9314307503758604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH1,Acid ceramidase,22732,36,1.79 [1.14-2.79],0.0106444126343836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH2,Neutral ceramidase,26246,40,1.58 [0.87-2.88],0.1337407355012263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,26246,40,7.26 [4.24-12.42],5.060839357235406e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,22963,37,5.25 [1.76-15.69],0.0030021585882607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPN,Asporin,22945,37,1.95 [0.82-4.63],0.1285842765977374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPSCR1,Tether containing UBX domain for GLUT4,22907,37,1.08 [0.71-1.65],0.7216812244759707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,22310,34,0.94 [0.68-1.30],0.7002951762625449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASS1,Argininosuccinate synthase,22213,35,1.25 [0.83-1.90],0.2881115680786449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,25812,41,1.13 [0.78-1.64],0.5085138570494807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,22139,37,0.68 [0.23-1.97],0.4744265501861979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG16L1,Autophagy-related protein 16-1,22858,36,1.28 [0.91-1.80],0.1559278692287399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG4A,Cysteine protease ATG4A,25789,40,0.77 [0.48-1.23],0.2795116238001162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATOX1,Copper transport protein ATOX1,26490,42,1.26 [0.86-1.85],0.2432976893225979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,22213,35,1.41 [1.02-1.95],0.0352929740531445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,22213,35,0.73 [0.24-2.22],0.5825459091025207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,22213,35,0.58 [0.21-1.57],0.2834094954159136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B4,Protein ATP1B4,22139,37,0.83 [0.38-1.78],0.6254024839048515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,22213,35,0.51 [0.22-1.17],0.1127398930541579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",22213,35,0.50 [0.21-1.21],0.1258593386055419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5IF1,"ATPase inhibitor, mitochondrial",26539,40,1.25 [0.97-1.60],0.083793527970593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5PO,"ATP synthase subunit O, mitochondrial",25812,41,1.08 [0.55-2.12],0.8261230097207857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6AP2,Renin receptor,25789,40,1.76 [1.14-2.73],0.0112880547191328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1D,V-type proton ATPase subunit D,26305,39,1.02 [0.34-3.09],0.966804928055613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1F,V-type proton ATPase subunit F,25769,41,0.89 [0.59-1.35],0.5835109113757775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G1,V-type proton ATPase subunit G 1,22310,34,0.88 [0.56-1.36],0.5572777090978032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G2,V-type proton ATPase subunit G 2,22213,35,1.01 [0.72-1.42],0.941123173283515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,22858,36,1.14 [0.37-3.57],0.819316572206421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRN,"Attractin, Isoform 2",22968,36,17.58 [4.68-66.06],2.201953548929675e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN10,Ataxin-10,25812,41,0.79 [0.55-1.14],0.2033273604876015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2,Ataxin-2,22212,34,0.82 [0.55-1.22],0.3226732596425871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2L,Ataxin-2-like protein,22907,37,0.96 [0.51-1.78],0.8931707646747066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN3,Ataxin-3,22882,35,0.84 [0.52-1.36],0.4759531449844778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXIN1,Axin-1,26402,41,1.03 [0.77-1.37],0.8339488078947251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,26487,40,3.91 [1.56-9.80],0.0036736113268624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZI2,5-azacytidine-induced protein 2,22907,37,1.13 [0.68-1.87],0.6356729171604122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZU1,Azurocidin,25609,37,0.99 [0.67-1.45],0.9457358523504448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,22968,36,1.64 [1.18-2.26],0.0028399245094355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,22213,35,0.49 [0.09-2.53],0.3937333574474506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",22310,34,11.45 [6.34-20.69],6.473035655432643e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",26539,40,6.54 [2.68-15.99],3.764980779139412e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",26404,41,0.91 [0.30-2.75],0.8722682655406049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BABAM1,BRISC and BRCA1-A complex member 1,22293,36,1.13 [0.39-3.22],0.823278171038857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BACH1,Transcription regulator protein BACH1,26402,41,1.13 [0.79-1.62],0.4990009936175791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG3,BAG family molecular chaperone regulator 3,26202,40,1.07 [0.53-2.15],0.859389862453588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG4,BAG family molecular chaperone regulator 4,22293,36,1.48 [0.87-2.52],0.1488597833224178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG6,Large proline-rich protein BAG6,25946,40,0.60 [0.27-1.34],0.2125901304953024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,25789,40,1.65 [1.23-2.21],0.0008989352040653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,25789,40,2.94 [1.80-4.80],1.7353079491127424e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BANK1,B-cell scaffold protein with ankyrin repeats,26402,41,1.08 [0.83-1.42],0.5578826153714452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAP18,Chromatin complexes subunit BAP18,22882,35,1.12 [0.73-1.71],0.6064506957120088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BATF,Basic leucine zipper transcriptional factor ATF-like,22304,36,1.02 [0.70-1.50],0.9002275345682984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAX,Apoptosis regulator BAX,25763,41,1.11 [0.84-1.47],0.4673742656001433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAM,Basal cell adhesion molecule,26404,41,1.93 [0.65-5.77],0.2377010426482536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,26246,40,0.44 [0.30-0.64],1.9641052043984137e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",22945,37,0.89 [0.33-2.45],0.8284212888462421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",22212,34,0.84 [0.62-1.14],0.2557982934416383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCHE,Cholinesterase,22530,36,1.40 [0.41-4.81],0.5951657965935063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2,Apoptosis regulator Bcl-2,22858,36,1.46 [0.93-2.28],0.0980322582725023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L1,Bcl-2-like protein 1,22882,35,1.12 [0.82-1.52],0.469198215454646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",26402,41,3.42 [1.60-7.29],0.0014477442057716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L15,Bcl-2-like protein 15,22293,36,1.05 [0.62-1.76],0.8671559620488235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,22139,37,1.02 [0.61-1.71],0.9498024617129844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,22835,37,0.57 [0.24-1.35],0.2017652255644972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCR,Breakpoint cluster region protein,26402,41,1.13 [0.84-1.51],0.4271430499379628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BDNF,Brain-derived neurotrophic factor,22926,36,1.60 [1.07-2.39],0.0214385510041223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BECN1,Beclin-1,22310,34,1.11 [0.68-1.81],0.6773512988790431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BEX3,Protein BEX3,22139,37,0.69 [0.31-1.51],0.3517903997681582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGLAP,Osteocalcin,22926,36,0.60 [0.42-0.85],0.0045172379505746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGN,Biglycan,25754,40,0.97 [0.76-1.23],0.7869502111575736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHLHE40,Class E basic helix-loop-helix protein 40,22212,34,0.62 [0.36-1.06],0.0823817846195873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,22213,35,0.44 [0.14-1.46],0.1803297834405699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BID,BH3-interacting domain death agonist,26402,41,0.85 [0.55-1.29],0.4407049355753393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIN2,Bridging integrator 2,26404,41,0.97 [0.73-1.30],0.8543143726475669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIRC2,Baculoviral IAP repeat-containing protein 2,25789,40,0.96 [0.64-1.45],0.856034837857775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLMH,Bleomycin hydrolase,26739,40,0.44 [0.22-0.88],0.0194827964490613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLNK,B-cell linker protein,22293,36,0.67 [0.27-1.68],0.3926730571751217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,22212,34,0.82 [0.51-1.34],0.4330527647532403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,22882,35,1.47 [0.76-2.84],0.2498034510604059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLVRB,Flavin reductase,26404,41,0.80 [0.51-1.23],0.3055036075989836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP10,Bone morphogenetic protein 10,22429,37,1.74 [0.58-5.22],0.3261373467724669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP4,Bone morphogenetic protein 4,26202,40,1.00 [0.57-1.77],0.9989879061258204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP6,Bone morphogenetic protein 6,25896,40,1.20 [0.61-2.39],0.5973710899422474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,22429,37,6.61 [3.48-12.55],7.809942996844162e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,22945,37,0.91 [0.41-2.05],0.821796486929091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,22293,36,1.54 [0.85-2.78],0.152447763695129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOC,Brother of CDO,25946,40,2.31 [0.70-7.64],0.1717178846554198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA1,BolA-like protein 1,22212,34,1.21 [0.71-2.06],0.4895538688252482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA2_BOLA2B,BolA-like protein 2,22310,34,0.50 [0.27-0.92],0.0247247752492756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFA2,BPI fold-containing family A member 2,21494,33,0.84 [0.61-1.15],0.2694486482814117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB1,BPI fold-containing family B member 1,26359,37,0.94 [0.61-1.46],0.7847707618768086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB2,BPI fold-containing family B member 2,22907,37,1.56 [1.04-2.34],0.0332998649929427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRAP,BRCA1-associated protein,22641,35,1.16 [0.86-1.58],0.3303341006580552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD1,Bromodomain-containing protein 1,22529,37,0.93 [0.33-2.62],0.8834350756966723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD2,Bromodomain-containing protein 2,22212,34,0.41 [0.13-1.32],0.1335429352224144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD3,Bromodomain-containing protein 3,22213,35,0.57 [0.24-1.33],0.190085984507697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRDT,Bromodomain testis-specific protein,22213,35,1.26 [0.52-3.04],0.6092201809191118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRK1,Protein BRICK1,25812,41,0.79 [0.44-1.41],0.4205320754963612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRME1,Break repair meiotic recombinase recruitment factor 1,22212,34,1.47 [1.02-2.12],0.0395336393528118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRSK2,Serine/threonine-protein kinase BRSK2,22907,37,1.44 [0.76-2.71],0.2604222401673681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,26684,42,2.96 [0.84-10.46],0.0918448368177491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSND,Barttin,22139,37,0.95 [0.35-2.62],0.9273777247204948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,26677,41,2.82 [1.09-7.32],0.0326878136506786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST2,Bone marrow stromal antigen 2,26677,41,1.65 [1.09-2.49],0.0174751802981959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTC,Probetacellulin,25789,40,1.25 [0.90-1.75],0.1883471151749341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTD,Biotinidase,22968,36,7.38 [1.81-30.15],0.0053986966358111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTLA,B- and T-lymphocyte attenuator,22139,37,1.32 [1.06-1.64],0.0135022803367117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN1A1,Butyrophilin subfamily 1 member A1,22795,37,0.65 [0.23-1.84],0.4125261721338981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,26539,40,6.07 [3.01-12.25],4.801396231912366e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,26402,41,2.91 [1.80-4.72],1.4131932193451416e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTNL10,Butyrophilin-like protein 10,22139,37,1.17 [0.55-2.48],0.6869633750697481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C19orf12,Protein C19orf12,25812,41,1.18 [0.84-1.66],0.3287929653793582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1GALT1C1,C1GALT1-specific chaperone 1,22213,35,0.58 [0.19-1.75],0.3311884317017273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QA,Complement C1q subcomponent subunit A,26595,42,3.23 [1.04-10.07],0.0429372995244477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",22907,37,0.95 [0.55-1.63],0.8481570940917293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QL2,Complement C1q-like protein 2,22293,36,0.61 [0.29-1.29],0.1981602735709471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,26487,40,3.21 [2.14-4.81],1.5211141554821772e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,22429,37,1.74 [0.73-4.16],0.2106962778449978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,22907,37,1.14 [0.43-3.01],0.7860391962254503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,22389,37,1.38 [0.68-2.81],0.3683455582335121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1R,Complement C1r subcomponent,22968,36,1.83 [0.57-5.90],0.3105170733338022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1RL,Complement C1r subcomponent-like protein,22933,36,6.74 [1.30-34.84],0.0229084752863765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1S,Complement C1s subcomponent,22968,36,3.03 [0.79-11.65],0.1062096763547354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2,Complement C2,26454,40,20.24 [7.82-52.41],5.710787369289275e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2CD2L,Phospholipid transfer protein C2CD2L,25769,41,1.56 [0.97-2.52],0.0670331186964129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2orf69,UPF0565 protein C2orf69,22304,36,1.13 [0.65-1.98],0.6589815887594586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C3,Complement C3,21811,36,1.14 [0.57-2.29],0.719367780707038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C4BPB,C4b-binding protein beta chain,26490,42,1.00 [0.48-2.05],0.99222887089143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C5,Complement C5,22968,36,3.23 [0.63-16.55],0.1589842030803882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,22430,34,8.77 [4.55-16.88],8.24703748561028e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7orf50,Uncharacterized protein C7orf50,22882,35,1.04 [0.28-3.90],0.9565738054896202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C8B,Complement component C8 beta chain,22968,36,3.48 [1.24-9.80],0.0180981138492159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9,Complement component C9,22963,37,0.65 [0.40-1.07],0.0885658964418976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9orf40,Uncharacterized protein C9orf40,22858,36,0.81 [0.54-1.21],0.302149615997266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA1,Carbonic anhydrase 1,25796,39,0.64 [0.39-1.05],0.078145608348196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA11,Carbonic anhydrase-related protein 11,25789,40,2.12 [1.33-3.39],0.0015637152737289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,26305,39,3.52 [2.37-5.21],3.8919657177025903e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA13,Carbonic anhydrase 13,26105,38,1.04 [0.80-1.36],0.7757719954475646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA14,Carbonic anhydrase 14,26655,42,0.54 [0.25-1.17],0.1184565832151466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA2,Carbonic anhydrase 2,26330,41,0.82 [0.54-1.24],0.3495091621375368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA3,Carbonic anhydrase 3,26695,40,0.98 [0.62-1.55],0.9357683403161496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA4,Carbonic anhydrase 4,26739,40,1.21 [0.37-3.98],0.7566590879870801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",25946,40,1.29 [0.98-1.71],0.0705234218796962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,26321,41,0.32 [0.21-0.50],2.0631421272879321e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA7,Carbonic anhydrase 7,22529,37,0.76 [0.33-1.73],0.5081257301546172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA8,Carbonic anhydrase-related protein,22293,36,1.27 [0.43-3.72],0.6634014259785652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,26655,42,3.47 [2.37-5.07],1.3936507259018239e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CABP2,Calcium-binding protein 2,22304,36,1.07 [0.67-1.73],0.7661139374636732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,22212,34,0.82 [0.30-2.22],0.6917092826723721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,22213,35,1.07 [0.62-1.85],0.8163887214178951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,22212,34,0.73 [0.38-1.40],0.3384897942949199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,22907,37,1.23 [0.87-1.74],0.2319013991753018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACYBP,Calcyclin-binding protein,22382,36,1.18 [0.87-1.59],0.2889465023591875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CADPS,Calcium-dependent secretion activator 1,22304,36,0.77 [0.31-1.95],0.585224467783989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB1,Calbindin,26305,39,1.31 [0.68-2.55],0.417721982980062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB2,Calretinin,25812,41,2.39 [1.59-3.59],3.031529310509611e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,26203,40,2.02 [1.53-2.67],6.824824815462654e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCB,Calcitonin gene-related peptide 2,22882,35,0.78 [0.33-1.86],0.5812576436281882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,26581,42,1.03 [0.79-1.34],0.8238967614885414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,22310,34,1.21 [0.80-1.82],0.3623037825657313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALY,Neuron-specific vesicular protein calcyon,22213,35,0.48 [0.18-1.30],0.1505956648109883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,25789,40,1.16 [0.63-2.13],0.6325613884737988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,22304,36,0.96 [0.54-1.71],0.8905651155331059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,22907,37,1.05 [0.79-1.39],0.7369052042900869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,26350,40,6.95 [1.83-26.33],0.0043428847256494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPG,Macrophage-capping protein,26257,42,1.29 [0.84-1.98],0.2399396465222159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPN3,Calpain-3,22835,37,0.77 [0.32-1.86],0.5679319299889709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPS,Calcyphosin,22882,35,1.12 [0.82-1.52],0.4801270091919198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CARHSP1,Calcium-regulated heat-stable protein 1,25812,41,0.61 [0.34-1.09],0.0941384984655465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASC3,Protein CASC3,22304,36,1.31 [0.71-2.43],0.3858394391882764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP1,Caspase-1,25812,41,1.15 [0.80-1.64],0.4521131342134764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP10,Caspase-10,25812,41,1.05 [0.71-1.55],0.8043944971390827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP2,Caspase-2,26402,41,1.12 [0.77-1.62],0.55318453192143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP3,Caspase-3,26739,40,0.97 [0.71-1.32],0.8479877577702966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP4,Caspase-4,22529,37,0.99 [0.82-1.20],0.9431178861572188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP7,Caspase-7,22882,35,1.29 [0.90-1.83],0.1604945668152586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP8,Caspase-8,26588,42,0.60 [0.38-0.95],0.0288238322543755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP9,Caspase-9,22293,36,0.87 [0.51-1.48],0.6058173436747334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASQ2,Calsequestrin-2,22213,35,1.37 [0.82-2.28],0.2302706564958445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAT,Catalase,22611,36,0.70 [0.37-1.32],0.2723765097844295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLIF,Cobalamin binding intrinsic factor,26384,40,2.38 [1.71-3.30],2.578159952701944e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN1,Cerebellin-1,22212,34,0.96 [0.65-1.40],0.8163897625181904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN4,Cerebellin-4,26655,42,0.34 [0.14-0.78],0.0114880437551826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBS,Cystathionine beta-synthase,22310,34,0.87 [0.43-1.78],0.7076748183769015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBX2,Chromobox protein homolog 2,22213,35,0.83 [0.35-1.96],0.6726502079090371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,26246,40,1.02 [0.71-1.47],0.9199513725026032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCAR2,Cell cycle and apoptosis regulator protein 2,22882,35,0.94 [0.50-1.77],0.8462883606813261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC134,Coiled-coil domain-containing protein 134,22835,37,1.16 [0.66-2.05],0.5966018653968292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC28A,Coiled-coil domain-containing protein 28A,22304,36,1.93 [0.71-5.29],0.1985773409771581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC50,Coiled-coil domain-containing protein 50,22907,37,1.18 [0.82-1.72],0.3729533481573726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,26416,40,1.37 [0.61-3.09],0.450190453193026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,22310,34,0.98 [0.59-1.63],0.941240608297796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,26732,42,4.67 [2.31-9.46],1.8553217092453663e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL13,C-C motif chemokine 13,26690,42,1.21 [0.82-1.78],0.334791914187202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL14,C-C motif chemokine 14,26314,40,1.66 [1.04-2.63],0.0323592269329318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,26739,40,4.16 [2.53-6.85],2.0338977886519903e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,26739,40,2.54 [1.46-4.43],0.0010291597239587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL17,C-C motif chemokine 17,26351,39,1.20 [0.88-1.64],0.2422262799234701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL18,C-C motif chemokine 18,26028,40,1.10 [0.82-1.48],0.5147026084598979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL19,C-C motif chemokine 19,26677,41,1.18 [0.97-1.43],0.0994402148206588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL2,C-C motif chemokine 2,26202,40,1.03 [0.63-1.70],0.8959827858464632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,26732,42,1.63 [1.31-2.02],7.754150839239725e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,26539,40,2.17 [1.45-3.26],0.000185727124416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL22,C-C motif chemokine 22,26116,39,1.87 [1.17-2.98],0.0085486896597179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL23,C-C motif chemokine 23,26539,40,1.85 [0.96-3.56],0.0643691623023998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL24,C-C motif chemokine 24,26498,40,1.31 [0.95-1.80],0.0978831415651461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,26732,42,2.03 [1.17-3.54],0.0123664564335512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL26,C-C motif chemokine 26,26402,41,0.91 [0.64-1.28],0.5758032431718274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL27,C-C motif chemokine 27,26416,40,1.31 [0.83-2.06],0.2431757638293979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL28,C-C motif chemokine 28,26325,41,1.58 [1.04-2.40],0.0325996086889125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL3,C-C motif chemokine 3,26402,41,1.38 [1.08-1.76],0.0090189018871127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL4,C-C motif chemokine 4,26442,40,1.25 [0.86-1.81],0.2363598857226477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL5,C-C motif chemokine 5,26487,40,1.16 [0.90-1.48],0.2449972061820904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,26402,41,1.65 [1.24-2.19],0.0006045291352071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL8,C-C motif chemokine 8,26622,42,1.60 [1.03-2.47],0.0358312800546786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN1,CCN family member 1,26269,39,1.91 [1.23-2.96],0.003736753961591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN2,CCN family member 2,26425,40,1.35 [0.84-2.16],0.2089951269420886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,26700,40,1.97 [1.03-3.77],0.0402580550220414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,26655,42,2.57 [1.57-4.23],0.0001900020380748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,26404,41,1.50 [0.75-3.02],0.2529550029282411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCND2,G1/S-specific cyclin-D2,22529,37,0.81 [0.36-1.81],0.6022860130307548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCNE1,G1/S-specific cyclin-E1,22293,36,0.84 [0.53-1.31],0.4360184793158193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCS,Copper chaperone for superoxide dismutase,26246,40,0.35 [0.18-0.67],0.0015191789712731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCT5,T-complex protein 1 subunit epsilon,25789,40,0.53 [0.26-1.06],0.0730598488438461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD101,Immunoglobulin superfamily member 2,22858,36,1.94 [0.92-4.09],0.0826899258045436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,26404,41,2.98 [1.31-6.74],0.0088775463499797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,25824,40,2.62 [1.47-4.66],0.001060466630971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,26732,42,2.49 [1.59-3.89],6.543912999807174e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,26487,40,3.02 [1.73-5.25],9.41137084978889e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,26404,41,2.02 [1.40-2.94],0.0002020263202816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164L2,CD164 sialomucin-like 2 protein,22304,36,0.86 [0.34-2.17],0.7507195998757829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD177,CD177 antigen,26360,41,1.08 [0.87-1.35],0.4721594278792947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD1C,T-cell surface glycoprotein CD1c,26490,42,0.83 [0.27-2.55],0.7489079463560646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2,T-cell surface antigen CD2,22213,35,1.80 [1.20-2.71],0.0046848545668018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200,OX-2 membrane glycoprotein,26402,41,1.92 [0.74-5.01],0.1808568508426871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,26310,40,1.94 [0.90-4.16],0.089689653266531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,25861,38,5.06 [2.73-9.41],2.848193380797761e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD209,CD209 antigen,26472,38,1.09 [0.52-2.30],0.813893183105052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD22,B-cell receptor CD22,26732,42,1.80 [0.94-3.44],0.0738632349306298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD226,CD226 antigen,22293,36,2.30 [1.21-4.39],0.0111467624498963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,26732,42,4.21 [1.94-9.16],0.0002850549882883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD248,Endosialin,22926,36,0.50 [0.23-1.07],0.0756660456363534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,26490,42,4.41 [2.98-6.53],1.412698687790283e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,26246,40,3.37 [1.77-6.40],0.0002113861927242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,26400,39,7.92 [3.85-16.31],1.9449318602629385e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,25789,40,3.03 [1.77-5.20],5.423571094367459e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2AP,CD2-associated protein,26416,40,1.09 [0.73-1.63],0.6817084086966678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,22429,37,6.59 [2.67-16.22],4.1433497825586846e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,26677,41,3.40 [1.62-7.13],0.0011766460588872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,26572,42,3.25 [1.85-5.70],3.825405834127193e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LF,CMRF35-like molecule 1,26655,42,1.75 [1.04-2.95],0.0346666583845446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LG,CMRF35-like molecule 9,26404,41,0.62 [0.28-1.38],0.2432898871563836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,26305,39,3.48 [1.98-6.12],1.5149629522382948e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD33,Myeloid cell surface antigen CD33,26490,42,1.47 [0.99-2.18],0.0536419448827635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD34,Hematopoietic progenitor cell antigen CD34,26586,41,0.58 [0.34-1.01],0.0549046377504826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD36,Platelet glycoprotein 4,22293,36,1.93 [1.06-3.50],0.0316872424343065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,26305,39,2.34 [0.98-5.59],0.0565440004767745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3D,T-cell surface glycoprotein CD3 delta chain,22212,34,1.23 [0.48-3.15],0.6730005318605345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,22529,37,0.35 [0.10-1.22],0.1005198762609488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,22293,36,1.05 [0.77-1.45],0.7516550615802593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD4,T-cell surface glycoprotein CD4,26359,41,2.53 [1.65-3.87],1.9364842842707543e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,26401,40,2.17 [1.43-3.30],0.0002815139656086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40LG,CD40 ligand,26732,42,1.16 [0.84-1.62],0.36496128023922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,26230,40,3.31 [1.62-6.75],0.0010325064667864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,26498,40,9.66 [4.78-19.52],2.668414407423065e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,26622,42,4.46 [2.62-7.62],4.1426363425024586e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,25471,38,2.33 [0.99-5.49],0.0534245884112505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD58,Lymphocyte function-associated antigen 3,26350,39,0.41 [0.08-2.00],0.2703765837634235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,25416,37,5.02 [2.61-9.64],1.300319405326885e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5L,CD5 antigen-like,22845,36,1.52 [0.81-2.85],0.1898348000785032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD6,T-cell differentiation antigen CD6,26684,42,1.55 [0.91-2.65],0.1059119678956553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD63,CD63 antigen,26202,40,2.05 [1.15-3.65],0.0148033128278866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD69,Early activation antigen CD69,26269,40,1.09 [0.81-1.48],0.5579151613538493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,22260,35,1.81 [0.96-3.42],0.0687249763695421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,26402,41,1.80 [1.03-3.15],0.0385721253397424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,22429,37,2.35 [1.18-4.68],0.0146575782905095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,26677,41,6.41 [3.37-12.20],1.4850362891217076e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,26732,42,3.43 [2.21-5.33],3.7859291469716025e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,22945,37,5.82 [3.36-10.07],3.2183210181679583e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD82,CD82 antigen,22529,37,1.72 [1.12-2.65],0.0132979993342575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,26402,41,3.18 [1.91-5.30],8.60023235041395e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD84,SLAM family member 5,26402,41,0.93 [0.41-2.12],0.8621427688975865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD86,T-lymphocyte activation antigen CD86,22858,36,1.43 [0.47-4.42],0.5294713786312402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,26677,41,2.56 [1.51-4.32],0.0004753202239424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD93,Complement component C1q receptor,25380,38,1.59 [0.63-4.06],0.3278657393804461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,26404,41,0.96 [0.22-4.18],0.9538972351334593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99L2,CD99 antigen-like protein 2,26404,41,0.94 [0.29-2.99],0.9101055859623676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDA,Cytidine deaminase,22907,37,1.10 [0.59-2.07],0.7625479922786831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDAN1,Codanin-1,22882,35,0.54 [0.12-2.47],0.4248475856119216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC123,Cell division cycle protein 123 homolog,22139,37,1.29 [0.88-1.91],0.1937199988546135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC25A,M-phase inducer phosphatase 1,22139,37,1.38 [0.75-2.53],0.3003546693308518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC26,Anaphase-promoting complex subunit CDC26,22821,36,1.12 [0.73-1.73],0.6012520395908787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC27,Cell division cycle protein 27 homolog,25789,40,0.98 [0.64-1.50],0.9237464438557028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC37,Hsp90 co-chaperone Cdc37,26490,42,0.94 [0.70-1.28],0.7139621562003489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,22858,36,1.20 [0.91-1.59],0.1973049114866558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,26246,40,3.49 [2.45-4.98],4.869141921699944e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,25509,38,2.04 [1.48-2.80],1.2844901030041974e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,26634,41,1.55 [1.15-2.10],0.004580494172187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,26416,40,1.96 [1.35-2.84],0.0003776431054544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,26416,40,8.31 [4.02-17.17],1.0765374484016388e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH22,Cadherin-22,22529,37,1.04 [0.33-3.26],0.939659380768606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH23,Cadherin-23,22882,35,0.61 [0.17-2.19],0.4478350782859439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,26677,41,1.35 [0.64-2.86],0.4275447630766202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH4,Cadherin-4,22212,34,0.73 [0.33-1.62],0.4338507187172498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH5,Cadherin-5,26739,40,1.12 [0.43-2.91],0.8198604388695254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,26416,40,2.06 [1.02-4.16],0.0443942320171443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR1,Cadherin-related family member 1,25812,41,0.73 [0.36-1.50],0.3930615174435287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR2,Cadherin-related family member 2,26305,39,1.68 [1.07-2.64],0.0228482020834302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR5,Cadherin-related family member 5,26416,40,1.33 [0.62-2.84],0.4655937461233111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK1,Cyclin-dependent kinase 1,22139,37,0.95 [0.41-2.23],0.908068603601106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,22907,37,0.90 [0.57-1.42],0.6452050676396088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKL5,Cyclin-dependent kinase-like 5,22212,34,1.13 [0.60-2.12],0.7013777665955863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,26305,39,1.19 [0.92-1.54],0.1948366236146463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,26305,39,0.88 [0.66-1.17],0.3732541981712627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDNF,Cerebral dopamine neurotrophic factor,26305,39,0.85 [0.36-2.02],0.7120897808858461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,26448,39,0.69 [0.26-1.89],0.4767025301143949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDSN,Corneodesmosin,26649,42,1.37 [0.73-2.58],0.3254241483722863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,26450,42,4.99 [1.60-15.58],0.0056178843098195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,22858,36,0.81 [0.56-1.19],0.2866632913583557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,22529,37,1.23 [0.86-1.77],0.2583304958536925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,22858,36,1.63 [0.74-3.59],0.2220921905107206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,22529,37,1.01 [0.54-1.89],0.9798183094311328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,26402,41,1.32 [0.97-1.79],0.0786834757637717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,25789,40,0.99 [0.55-1.80],0.9787237074676052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,25434,40,2.06 [1.47-2.91],3.244257037714394e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,22926,36,2.15 [1.58-2.92],1.0913775503612262e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,25946,40,1.41 [0.84-2.36],0.1941871470865007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPA,CCAAT/enhancer-binding protein alpha,22293,36,1.03 [0.42-2.52],0.9431372581895766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPB,CCAAT/enhancer-binding protein beta,25946,40,0.70 [0.31-1.56],0.3779926218125602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA2A,Chymotrypsin-like elastase family member 2A,22926,36,1.51 [0.93-2.45],0.0975273075033709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA3A,Chymotrypsin-like elastase family member 3A,26691,40,1.34 [0.85-2.12],0.210974772210104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,22429,37,1.45 [0.47-4.49],0.5159554308310444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEMIP2,Cell surface hyaluronidase,22293,36,2.25 [1.48-3.42],0.0001413136144674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,22212,34,1.14 [0.72-1.80],0.5824031590657484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPF,Centromere protein F,22529,37,0.94 [0.54-1.64],0.8380401141965782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPJ,Centromere protein J,22529,37,1.17 [0.78-1.77],0.4518964595338781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP112,Centrosomal protein of 112 kDa,22213,35,1.31 [0.71-2.43],0.38288774542945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP152,Centrosomal protein of 152 kDa,22139,37,1.24 [0.66-2.31],0.505664439094125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP164,Centrosomal protein of 164 kDa,25930,40,1.19 [0.82-1.74],0.3524748089470232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP170,Centrosomal protein of 170 kDa,22310,34,1.19 [0.80-1.77],0.3783036660214225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP20,Centrosomal protein 20,25789,40,1.12 [0.79-1.60],0.5120134827823759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP290,Centrosomal protein of 290 kDa,22529,37,0.77 [0.38-1.58],0.4796638609444834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP350,Centrosome-associated protein 350,22139,37,1.77 [0.81-3.85],0.1513527319578422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP43,Centrosomal protein 43,25740,39,0.87 [0.57-1.32],0.5110637125459732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP85,Centrosomal protein of 85 kDa,25789,40,0.93 [0.60-1.43],0.7400598693764762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CERT,Ceramide transfer protein,25812,41,1.03 [0.67-1.59],0.8824785670111603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES1,Liver carboxylesterase 1,26462,37,1.45 [1.12-1.88],0.0049376037119441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES2,Cocaine esterase,26305,39,2.09 [1.39-3.14],0.0003914879366461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES3,Carboxylesterase 3,26305,39,0.93 [0.63-1.36],0.707130116308715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN2,Centrin-2,25812,41,1.07 [0.74-1.55],0.7304237295594506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN3,Centrin-3,22858,36,1.28 [0.90-1.83],0.1644543359542709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFB,Complement factor B,22541,36,6.36 [2.32-17.42],0.0003169928838244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,25789,40,1.91 [1.25-2.92],0.0029464216993497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,22968,36,2.15 [0.61-7.56],0.2331054758267393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFH,Complement factor H,21636,35,6.59 [2.18-19.91],0.0008273783587519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR2,Complement factor H-related protein 2,22803,35,1.64 [0.83-3.24],0.1507344421776478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR4,Complement factor H-related protein 4,22922,36,1.00 [0.64-1.56],0.996304255298086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR5,Complement factor H-related protein 5,22675,37,1.37 [0.61-3.06],0.4452478403937978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFI,Complement factor I,22968,36,9.55 [2.19-41.66],0.0026820099416586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFP,Properdin,22968,36,0.69 [0.15-3.16],0.6339308699398634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,26404,41,2.13 [1.54-2.94],4.292847033087764e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,22963,37,0.63 [0.28-1.42],0.2676279586049822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGN,Cingulin,22304,36,0.80 [0.32-1.97],0.6218928217748951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,26416,40,4.62 [2.59-8.22],1.985792816535461e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,25789,40,0.75 [0.45-1.24],0.2600796255456357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,22429,37,0.60 [0.44-0.81],0.0010259423526489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22882,35,3.34 [2.17-5.15],4.8873242807233134e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,22835,37,2.35 [1.27-4.36],0.0068367442304319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHEK2,Serine/threonine-protein kinase Chk2,25946,40,0.78 [0.32-1.90],0.5784466344379817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,22926,36,1.85 [1.47-2.34],1.9386495042859245e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,26589,41,1.64 [0.85-3.15],0.1391665351498022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,25800,39,1.76 [1.34-2.32],5.289797805279559e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHIT1,Chitotriosidase-1,26509,38,1.12 [0.88-1.42],0.3510338915991666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHL1,Neural cell adhesion molecule L1-like protein,26445,39,0.69 [0.25-1.88],0.4675792871721388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHM,Rab proteins geranylgeranyltransferase component A 1,22304,36,1.08 [0.66-1.78],0.7528126294431668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP1A,Charged multivesicular body protein 1a,26246,40,0.95 [0.67-1.34],0.7642204891823968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP6,Charged multivesicular body protein 6,22945,37,1.37 [0.83-2.27],0.2142823243270836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHP1,Calcineurin B homologous protein 1,22212,34,0.93 [0.56-1.53],0.7710507378429857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,26498,40,3.81 [1.69-8.57],0.0012136373131705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL2,Chordin-like protein 2,26416,40,1.25 [0.73-2.14],0.4229715075402483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRM1,Muscarinic acetylcholine receptor M1,22304,36,0.50 [0.17-1.45],0.2002631968637545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIAPIN1,Anamorsin,26490,42,0.92 [0.61-1.39],0.6987947812241788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,22926,36,2.63 [1.74-3.98],4.409685079718067e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CINP,Cyclin-dependent kinase 2-interacting protein,22529,37,0.69 [0.29-1.66],0.4106539144172806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIRBP,Cold-inducible RNA-binding protein,22858,36,1.08 [0.79-1.49],0.6160227482811113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIT,Citron Rho-interacting kinase,22304,36,1.01 [0.52-1.99],0.9698349226005958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,26587,42,4.18 [2.62-6.68],2.0911606951516288e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKB,Creatine kinase B-type,22926,36,0.86 [0.49-1.51],0.6058326396392204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",26303,40,1.66 [1.06-2.60],0.0255509282497689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLASP1,CLIP-associating protein 1,22139,37,1.13 [0.75-1.72],0.551601414435793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLC,Galectin-10,26382,40,0.62 [0.39-0.99],0.0436615541439035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,26246,40,3.09 [1.42-6.74],0.0044742070109598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC11A,C-type lectin domain family 11 member A,26361,41,0.78 [0.43-1.39],0.3909397468637023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC12A,C-type lectin domain family 12 member A,22293,36,1.92 [0.57-6.49],0.2951368847986662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,26404,41,2.25 [0.97-5.23],0.0580624901896454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,25946,40,1.79 [0.76-4.19],0.1798499406711132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1B,C-type lectin domain family 1 member B,26677,41,1.23 [0.94-1.60],0.1326115140722475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC2L,C-type lectin domain family 2 member L,22304,36,0.81 [0.40-1.61],0.5400941915190647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC3B,Tetranectin,22436,36,0.67 [0.32-1.37],0.2698765183167036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4A,C-type lectin domain family 4 member A,26402,41,0.52 [0.25-1.09],0.0835906580449096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4C,C-type lectin domain family 4 member C,26402,41,0.67 [0.37-1.19],0.16678017547281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,26402,41,2.09 [1.42-3.06],0.0001768397800599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4G,C-type lectin domain family 4 member G,26402,41,1.37 [0.59-3.18],0.4587972149068751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4M,C-type lectin domain family 4 member M,22887,36,1.00 [0.52-1.95],0.9945311589873572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,26317,40,3.61 [1.70-7.67],0.000858196614552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,25789,40,2.75 [1.71-4.42],2.764301099403825e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC7A,C-type lectin domain family 7 member A,26732,42,1.24 [0.72-2.14],0.4307464530244339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLGN,Calmegin,22304,36,1.85 [1.03-3.31],0.0395642420906321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIC5,Chloride intracellular channel protein 5,22304,36,1.03 [0.37-2.86],0.955446593563604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLINT1,Clathrin interactor 1,22139,37,0.81 [0.40-1.64],0.5512511060078504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIP2,CAP-Gly domain-containing linker protein 2,26402,41,1.09 [0.86-1.39],0.4785811965152596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,26655,42,4.53 [1.50-13.66],0.0073911323689306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLNS1A,Methylosome subunit pICln,22304,36,0.50 [0.17-1.45],0.2048700364981448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",26203,40,1.09 [0.83-1.44],0.526006111336865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPS,Colipase,26367,41,0.99 [0.66-1.48],0.9476579519692846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSPN,Claspin,25769,41,0.44 [0.15-1.31],0.1400230686809661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN1,Calsyntenin-1,25812,41,0.90 [0.48-1.67],0.7331270549424793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,26732,42,2.28 [1.42-3.64],0.0006078364952768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN3,Calsyntenin-3,22882,35,2.33 [0.97-5.57],0.0580613390309816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLTA,Clathrin light chain A,25946,40,0.64 [0.33-1.26],0.2003591076025545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLU,Clusterin,22968,36,1.11 [0.47-2.62],0.8060079889432674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,26374,40,0.32 [0.17-0.59],0.0003496997560488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMC1,COX assembly mitochondrial protein homolog,22945,37,1.16 [0.86-1.58],0.3268522235804385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMIP,C-Maf-inducing protein,22835,37,1.18 [0.84-1.66],0.3301285467136382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNDP1,Beta-Ala-His dipeptidase,26487,40,3.48 [1.70-7.12],0.0006687149990846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,22212,34,1.28 [0.77-2.13],0.3415627471051984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",22268,34,1.01 [0.68-1.51],0.9534256605618004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY2,Protein canopy homolog 2,25946,40,0.95 [0.58-1.57],0.8470403057768839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY4,Protein canopy homolog 4,26305,39,0.92 [0.64-1.33],0.6514280524818284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNST,Consortin,26416,40,1.17 [0.92-1.49],0.2007728774604085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTF,Ciliary neurotrophic factor,22212,34,0.54 [0.20-1.49],0.2352611354496679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN1,Contactin-1,26739,40,0.65 [0.22-1.87],0.4227430196929956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN2,Contactin-2,26655,42,1.83 [1.01-3.32],0.0467865748958476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN3,Contactin-3,26404,41,6.09 [2.42-15.31],0.0001256673467814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN4,Contactin-4,26404,41,2.21 [0.70-6.96],0.1768648154912418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN5,Contactin-5,26507,40,0.58 [0.41-0.83],0.002310003127254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP2,Contactin-associated protein-like 2,26402,41,1.85 [1.04-3.26],0.0350068911469629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP4,Contactin-associated protein-like 4,22304,36,0.82 [0.55-1.21],0.3146132750141998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COCH,Cochlin,22945,37,2.54 [1.47-4.42],0.000902451854429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL15A1,Collagen alpha-1(XV) chain,22926,36,0.33 [0.14-0.76],0.0090521634627364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,26499,39,15.38 [5.85-40.46],3.0138076201596825e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL1A1,Collagen alpha-1(I) chain,26739,40,0.78 [0.46-1.33],0.3625773883582656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL24A1,Collagen alpha-1(XXIV) chain,22858,36,1.45 [0.78-2.68],0.2411900868597341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL28A1,Collagen alpha-1(XXVIII) chain,22304,36,1.07 [0.73-1.55],0.7421808681643722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL2A1,Collagen alpha-1(II) chain,22310,34,1.11 [0.76-1.62],0.588002429962136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL3A1,Collagen alpha-1(III) chain,22926,36,1.96 [0.53-7.20],0.3099308209164093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,26416,40,2.17 [1.12-4.18],0.0211852479222656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A4,Collagen alpha-4(IV) chain,22495,37,0.67 [0.41-1.11],0.1166233307370934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,22429,37,2.74 [1.64-4.58],0.0001213859107012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,26739,40,3.26 [1.83-5.79],5.8237785109474345e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A1,Collagen alpha-1(IX) chain,26402,41,1.16 [0.64-2.08],0.6255471570835996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A2,Collagen alpha-2(IX) chain,22529,37,0.68 [0.29-1.62],0.3810591927571296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,26400,39,8.04 [3.87-16.69],2.218222661224282e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD1,COMM domain-containing protein 1,22310,34,0.86 [0.51-1.47],0.5903078145032963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD9,COMM domain-containing protein 9,22835,37,0.85 [0.38-1.89],0.6943431092119086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMP,Cartilage oligomeric matrix protein,26108,40,0.62 [0.27-1.43],0.2643521864550576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMT,Catechol O-methyltransferase,25657,39,0.89 [0.63-1.25],0.4848255461786414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPB2,Coatomer subunit beta',22213,35,1.27 [0.62-2.61],0.5088508953104507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPE,Coatomer subunit epsilon,25812,41,1.07 [0.58-1.95],0.832447183946823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",22310,34,0.80 [0.33-1.96],0.6315209120292131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO1A,Coronin-1A,25884,38,1.04 [0.78-1.39],0.7727276304414661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO6,Coronin-6,22212,34,1.14 [0.53-2.44],0.7417543099418693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",26305,39,0.97 [0.67-1.42],0.8784628452042076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX6B1,Cytochrome c oxidase subunit 6B1,22945,37,1.37 [0.61-3.07],0.450446007086097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA1,Carboxypeptidase A1,26739,40,1.14 [0.73-1.76],0.5702107272687104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,26583,41,2.03 [1.41-2.93],0.0001434716185027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA4,Carboxypeptidase A4,21983,35,0.44 [0.22-0.88],0.0207562252291892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB1,Carboxypeptidase B,26739,40,1.27 [0.82-1.96],0.2797445155404972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB2,Carboxypeptidase B2,22923,36,1.88 [0.49-7.27],0.3595899616286924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPE,Carboxypeptidase E,26467,42,0.54 [0.30-0.98],0.0442381307792703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPLX2,Complexin-2,22139,37,1.31 [0.55-3.08],0.5433334386290294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,26562,40,7.86 [3.98-15.52],2.825334158231426e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",22293,36,1.72 [0.55-5.31],0.3491803553731624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,26677,41,0.95 [0.63-1.42],0.798970233144723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPQ,Carboxypeptidase Q,22887,36,0.85 [0.39-1.87],0.6911257045431893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPTP,Ceramide-1-phosphate transfer protein,22213,35,0.61 [0.26-1.44],0.2576202698884127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPVL,Probable serine carboxypeptidase CPVL,26606,42,1.76 [0.90-3.43],0.0959887682607817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM1,Probable carboxypeptidase X1,26490,42,1.52 [1.05-2.19],0.0265140848037135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,22945,37,4.03 [1.58-10.30],0.0035845855834701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,22875,37,2.14 [1.01-4.52],0.0459802247588762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,26487,40,1.78 [0.97-3.26],0.0615683974617757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,25789,40,1.04 [0.76-1.42],0.8062447497937175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRADD,Death domain-containing protein CRADD,26203,40,0.86 [0.60-1.23],0.4098917991077558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREB3,Cyclic AMP-responsive element-binding protein 3,22139,37,0.93 [0.52-1.66],0.8145640325494596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREBZF,CREB/ATF bZIP transcription factor,22139,37,1.14 [0.36-3.57],0.8262830614544769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREG1,Protein CREG1,26062,42,0.61 [0.29-1.27],0.1862065095657609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,22429,37,5.88 [2.63-13.14],1.619774734998867e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,26498,40,2.12 [1.37-3.28],0.0008023246645798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRH,Corticoliberin,25747,39,0.68 [0.49-0.96],0.0270132717078023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,26400,39,9.15 [3.42-24.51],1.067314264952574e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHR1,Corticotropin-releasing factor receptor 1,25946,40,0.49 [0.28-0.85],0.0107095063167722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,26539,40,6.99 [2.14-22.79],0.0012749669053179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,26246,40,3.00 [1.79-5.04],3.148414707706641e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP2,Cysteine-rich secretory protein 2,26655,42,0.77 [0.49-1.22],0.2694323426261401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP3,Cysteine-rich secretory protein 3,22739,34,0.76 [0.23-2.53],0.6543313475615131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRKL,Crk-like protein,26448,40,1.02 [0.79-1.32],0.875016515989457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRLF1,Cytokine receptor-like factor 1,26539,40,3.03 [1.06-8.67],0.0386711641179516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRNN,Cornulin,25645,42,0.73 [0.49-1.10],0.1335146820704781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAC1,Cartilage acidic protein 1,26739,40,0.99 [0.39-2.50],0.988623036316905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAM,Cytotoxic and regulatory T-cell molecule,26246,40,1.28 [0.73-2.27],0.3905178647537184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAP,Cartilage-associated protein,22304,36,0.91 [0.48-1.70],0.7577682349460649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRX,Cone-rod homeobox protein,25946,40,0.99 [0.76-1.30],0.9567244802479612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB1,Beta-crystallin B1,22945,37,1.44 [0.94-2.20],0.093712320497748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB2,Beta-crystallin B2,22882,35,1.13 [0.67-1.90],0.6486490958476936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYGD,Gamma-crystallin D,22882,35,0.88 [0.64-1.21],0.4356729164559493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYM,Ketimine reductase mu-crystallin,22212,34,1.14 [0.78-1.66],0.4934944037323486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYZL1,Quinone oxidoreductase-like protein 1,22310,34,0.95 [0.67-1.34],0.7529200721236411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSDE1,Cold shock domain-containing protein E1,22213,35,0.97 [0.74-1.28],0.837117856080374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,26539,40,6.86 [2.94-15.97],8.099624349594477e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,22963,37,3.11 [1.89-5.14],8.781400280364873e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2,Granulocyte-macrophage colony-stimulating factor,22213,35,1.47 [0.67-3.23],0.3308009800068555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,26246,40,1.49 [1.00-2.22],0.0491345169215281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RB,Cytokine receptor common subunit beta,22293,36,0.67 [0.33-1.39],0.2866840872013303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3,Granulocyte colony-stimulating factor,25930,40,0.74 [0.40-1.37],0.3373791968816514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3R,Granulocyte colony-stimulating factor receptor,22293,36,2.01 [1.05-3.83],0.0342692952385627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSH1,Chorionic somatomammotropin hormone 1,22963,37,0.79 [0.50-1.25],0.309664996339247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK1D,Casein kinase I isoform delta,22293,36,1.01 [0.63-1.63],0.9553814887681332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK2A1,Casein kinase II subunit alpha,22907,37,0.73 [0.37-1.44],0.3698792304583087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG4,Chondroitin sulfate proteoglycan 4,22926,36,1.58 [0.58-4.27],0.3666655598529275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG5,Chondroitin sulfate proteoglycan 5,22212,34,0.76 [0.35-1.66],0.4950005120741031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSRP3,Cysteine and glycine-rich protein 3,22213,35,1.28 [0.97-1.69],0.0789912674217461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST1,Cystatin-SN,19867,32,0.91 [0.63-1.33],0.6286079552905659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,26447,40,4.67 [2.34-9.31],1.2215794238403757e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST5,Cystatin-D,25936,40,1.26 [0.75-2.14],0.3853523772528251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST6,Cystatin-M,25735,38,1.64 [0.91-2.95],0.0989840324389948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST7,Cystatin-F,26442,40,1.38 [1.12-1.70],0.0022106891837555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSTB,Cystatin-B,26039,37,1.85 [1.02-3.35],0.0435677565335606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,22483,37,0.81 [0.41-1.60],0.5505219547659981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTBS,Di-N-acetylchitobiase,22655,34,4.70 [1.35-16.34],0.0150748881186774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTF1,Cardiotrophin-1,25946,40,0.89 [0.64-1.22],0.4586337411441318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,22926,36,3.25 [1.26-8.42],0.0151438940697719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTLA4,Cytotoxic T-lymphocyte protein 4,22926,36,0.58 [0.18-1.85],0.3588277024877612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTNNA1,Catenin alpha-1,22212,34,0.66 [0.21-2.11],0.4863672716202165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRB1,Chymotrypsinogen B,26404,41,0.93 [0.56-1.54],0.7714230301651402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRC,Chymotrypsin-C,26403,39,0.72 [0.46-1.12],0.1468063769252386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRL,Chymotrypsin-like protease CTRL-1,22882,35,0.92 [0.57-1.47],0.71894411396216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSB,Cathepsin B,26411,39,0.97 [0.53-1.78],0.9337389051853406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSC,Dipeptidyl peptidase 1,26359,39,1.45 [0.79-2.67],0.2357558289200577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,24627,36,2.54 [1.69-3.81],7.295126573496568e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSE,Cathepsin E,22429,37,2.65 [1.52-4.61],0.0005660815470059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSF,Cathepsin F,26490,42,1.03 [0.53-2.03],0.92442459551395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSH,Pro-cathepsin H,25864,40,1.37 [0.93-2.04],0.1146167967657546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,26416,40,4.54 [1.60-12.91],0.0045582052356979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,26732,42,3.91 [1.88-8.15],0.0002708566183381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,20851,30,14.74 [4.16-52.15],3.010683641035286e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSV,Cathepsin L2,26570,42,0.62 [0.32-1.21],0.1628610045885307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,26388,40,5.22 [2.29-11.92],8.748331710523709e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,22304,36,1.44 [0.77-2.71],0.2549011926051853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CWC15,Spliceosome-associated protein CWC15 homolog,22737,35,0.78 [0.41-1.50],0.4619894629270742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CX3CL1,Fractalkine,26246,40,1.04 [0.44-2.46],0.9234832748879588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXADR,Coxsackievirus and adenovirus receptor,26402,41,1.45 [0.86-2.43],0.1628079735782576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL1,Growth-regulated alpha protein,26356,40,1.26 [0.96-1.65],0.0958548177963288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL10,C-X-C motif chemokine 10,26539,40,1.20 [0.84-1.72],0.3183734892044851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL11,C-X-C motif chemokine 11,26677,41,1.28 [0.93-1.74],0.1251888691623804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL12,Stromal cell-derived factor 1,25930,40,1.00 [0.50-2.00],0.995921355191716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,26677,41,1.43 [1.02-1.99],0.0365798768351126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL14,C-X-C motif chemokine 14,25930,40,1.28 [1.01-1.62],0.0446719681555498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,26686,40,6.69 [2.42-18.49],0.0002478638295793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL17,C-X-C motif chemokine 17,26732,42,1.93 [1.29-2.89],0.0013325323708274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL3,C-X-C motif chemokine 3,26401,40,1.00 [0.75-1.33],0.986751967564074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL5,C-X-C motif chemokine 5,26322,40,1.28 [1.01-1.63],0.0409100458552608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL6,C-X-C motif chemokine 6,26732,42,1.56 [1.12-2.19],0.0093351655835675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,26215,42,1.44 [1.13-1.84],0.0033985007738286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL9,C-X-C motif chemokine 9,26539,40,1.46 [0.99-2.14],0.0531011518702381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5A,Cytochrome b5,22139,37,0.78 [0.46-1.32],0.3550263215125735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5R2,NADH-cytochrome b5 reductase 2,22591,36,1.02 [0.59-1.76],0.9499458746719968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",22213,35,0.73 [0.44-1.23],0.24180473585387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTH3,Cytohesin-3,22139,37,0.84 [0.54-1.33],0.4637029037369395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTL1,Cytokine-like protein 1,22926,36,0.51 [0.13-2.01],0.3355051781465155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAAM1,Disheveled-associated activator of morphogenesis 1,22429,37,1.34 [0.96-1.87],0.0821678543368832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAB2,Disabled homolog 2,26655,42,0.95 [0.75-1.21],0.6864080429618598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAG1,Dystroglycan,26539,40,2.44 [1.45-4.10],0.0007732401426483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAND5,DAN domain family member 5,22293,36,0.71 [0.40-1.25],0.2373946632005395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPK2,Death-associated protein kinase 2,22293,36,0.96 [0.55-1.68],0.8862036573720129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,26402,41,0.93 [0.74-1.15],0.4860903089189019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",26203,40,0.84 [0.58-1.23],0.3724501437871008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBH,Dopamine beta-hydroxylase,22925,37,1.02 [0.78-1.35],0.8624903856559759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBI,Acyl-CoA-binding protein,26274,41,1.06 [0.75-1.52],0.728425408086006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBN1,Drebrin,22293,36,1.04 [0.57-1.90],0.8909627483981759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBNL,Drebrin-like protein,26539,40,1.06 [0.79-1.41],0.7064948375828666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",26490,42,3.92 [2.53-6.06],8.44042183876239e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCC,Netrin receptor DCC,22304,36,0.55 [0.11-2.86],0.4764716225257117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCDC2C,Doublecortin domain-containing protein 2C,22139,37,1.22 [0.80-1.86],0.3526711215120595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCLRE1C,Protein artemis,22139,37,1.70 [0.86-3.34],0.1244092547260483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,25946,40,4.65 [1.40-15.47],0.0121414509555804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTD,Deoxycytidylate deaminase,22429,37,1.07 [0.78-1.46],0.6892490463203664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN1,Dynactin subunit 1,26655,42,0.90 [0.59-1.35],0.6018882154399341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN2,Dynactin subunit 2,26305,39,0.89 [0.65-1.20],0.4367482234178953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN6,Dynactin subunit 6,25812,41,0.78 [0.52-1.18],0.2485959186583303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTPP1,dCTP pyrophosphatase 1,26416,40,0.37 [0.16-0.87],0.0224728278580737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D1,DCN1-like protein 1,22212,34,0.47 [0.23-0.98],0.0453608214563271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D2,DCN1-like protein 2,22139,37,1.33 [0.95-1.86],0.0922639929558475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCXR,L-xylulose reductase,26490,42,0.96 [0.58-1.60],0.8709937898869515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDA1,DET1- and DDB1-associated protein 1,22213,35,0.91 [0.41-2.03],0.8265133348815636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",26305,39,1.97 [1.17-3.33],0.0113490033860309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDC,Aromatic-L-amino-acid decarboxylase,26384,40,1.21 [0.68-2.14],0.5221323849312491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDHD2,Phospholipase DDHD2,22907,37,1.19 [0.76-1.85],0.4506328754301336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDI2,Protein DDI1 homolog 2,22429,37,0.82 [0.54-1.26],0.3604233261786885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,26677,41,4.95 [1.90-12.86],0.0010368725978702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDT,D-dopachrome decarboxylase,22926,36,0.94 [0.45-1.96],0.87760241914676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX1,ATP-dependent RNA helicase DDX1,22858,36,0.80 [0.42-1.52],0.4878499637904908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX25,ATP-dependent RNA helicase DDX25,22304,36,0.93 [0.36-2.43],0.8903519802931037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX39A,ATP-dependent RNA helicase DDX39A,22293,36,1.56 [0.43-5.66],0.4993565240078018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX4,Probable ATP-dependent RNA helicase DDX4,22293,36,0.64 [0.29-1.40],0.2638699413934867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX53,Probable ATP-dependent RNA helicase DDX53,22304,36,0.60 [0.23-1.56],0.2945590386016183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX58,Antiviral innate immune response receptor RIG-I,25789,40,0.87 [0.53-1.43],0.5821761966168398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",26402,41,1.11 [0.85-1.45],0.4540319465336165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,25854,39,1.63 [1.11-2.39],0.0126088300668648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,22134,36,2.67 [1.80-3.97],9.805969891103031e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB104A_DEFB104B,Beta-defensin 104,22212,34,0.84 [0.44-1.58],0.5866819869252218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB116,Beta-defensin 116,22212,34,1.03 [0.67-1.60],0.889154835445633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB118,Beta-defensin 118,22212,34,0.82 [0.39-1.70],0.5936500621906158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,26026,39,1.40 [1.16-1.70],0.0005997562508387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENND2B,DENN domain-containing protein 2B,22213,35,1.43 [0.90-2.27],0.1275377974357095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENR,Density-regulated protein,22293,36,1.01 [0.60-1.72],0.9571605084452018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DFFA,DNA fragmentation factor subunit alpha,26732,42,0.93 [0.63-1.38],0.7310538786415821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGCR6,Protein DGCR6,22212,34,0.97 [0.43-2.21],0.9443586965651324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKA,Diacylglycerol kinase alpha,22293,36,1.40 [0.84-2.34],0.2021634499664573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKZ,Diacylglycerol kinase zeta,25930,40,0.81 [0.36-1.80],0.6067997306070569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHODH,Dihydroorotate dehydrogenase,22213,35,0.91 [0.43-1.92],0.8071707924449262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHPS,Deoxyhypusine synthase,22835,37,1.43 [0.86-2.36],0.1670372834861684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,22882,35,1.57 [0.98-2.53],0.0600480186085448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIABLO,"Diablo homolog, mitochondrial",26317,40,1.01 [0.80-1.28],0.9241907003703252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK1C,Divergent protein kinase domain 1C,22304,36,0.93 [0.43-2.04],0.8612532830714561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK2B,Divergent protein kinase domain 2B,22429,37,0.44 [0.18-1.09],0.0752911397606705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK1,Dickkopf-related protein 1,26677,41,1.76 [1.14-2.71],0.0111356624379934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK3,Dickkopf-related protein 3,26739,40,3.40 [1.40-8.26],0.0070219895807264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,26197,40,2.77 [1.82-4.22],2.2076699971301377e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKKL1,Dickkopf-like protein 1,26305,39,1.17 [0.81-1.69],0.4153384969231822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLG4,Disks large homolog 4,22882,35,1.18 [0.79-1.77],0.4163087743637081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLGAP5,Disks large-associated protein 5,22907,37,0.88 [0.41-1.91],0.7473954321342168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLK1,Protein delta homolog 1,26739,40,1.36 [0.85-2.17],0.1948288941855348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,26490,42,6.64 [3.49-12.62],7.70712786993235e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL4,Delta-like protein 4,22310,34,0.74 [0.37-1.48],0.3902694344187019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMD,Dystrophin,22310,34,1.43 [0.89-2.31],0.140228199828981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,22310,34,0.41 [0.31-0.54],1.924039910723168e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA1,DnaJ homolog subfamily A member 1,22139,37,0.75 [0.34-1.67],0.4767181170629326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA2,DnaJ homolog subfamily A member 2,26635,42,0.94 [0.68-1.29],0.6862294498739783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA4,DnaJ homolog subfamily A member 4,22882,35,0.86 [0.54-1.37],0.523858621169752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB1,DnaJ homolog subfamily B member 1,26305,39,1.08 [0.78-1.50],0.641514883820628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB14,DnaJ homolog subfamily B member 14,22858,36,1.58 [1.07-2.33],0.0223112664298801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB2,DnaJ homolog subfamily B member 2,22429,37,0.92 [0.53-1.59],0.7574668880166594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB6,DnaJ homolog subfamily B member 6,22223,36,1.20 [0.85-1.71],0.2956183178035788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB8,DnaJ homolog subfamily B member 8,25946,40,0.92 [0.53-1.59],0.7623418916027955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC21,DnaJ homolog subfamily C member 21,22882,35,1.21 [0.56-2.60],0.6312326622907344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,22310,34,1.03 [0.72-1.48],0.8742690539668637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC9,DnaJ homolog subfamily C member 9,22858,36,0.79 [0.53-1.19],0.2632254099623798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,26369,39,0.68 [0.42-1.10],0.1179286773810849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNLZ,DNL-type zinc finger protein,22212,34,1.06 [0.72-1.56],0.7752995257837092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM1,Dynamin-1,22858,36,1.05 [0.82-1.36],0.6933903530084344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM3,Dynamin-3,22907,37,1.69 [1.08-2.63],0.0210765342264828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNMBP,Dynamin-binding protein,26246,40,1.10 [0.71-1.72],0.6590212458499809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPEP,Aspartyl aminopeptidase,22882,35,0.99 [0.57-1.71],0.9735309041938596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,26489,40,0.65 [0.38-1.12],0.1225189077368119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOC2B,Double C2-like domain-containing protein beta,22304,36,0.45 [0.13-1.53],0.2005758658077533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOCK9,Dedicator of cytokinesis protein 9,22212,34,0.92 [0.67-1.27],0.6201755987218733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK1,Docking protein 1,22882,35,1.08 [0.85-1.38],0.5087871928423908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK2,Docking protein 2,26416,40,1.07 [0.87-1.33],0.5238823605581266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP1,Dipeptidase 1,26203,40,0.58 [0.33-1.02],0.0585092676709215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP2,Dipeptidase 2,26305,39,1.14 [0.42-3.07],0.7934623047071152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP10,Inactive dipeptidyl peptidase 10,26402,41,2.47 [1.43-4.27],0.0011508472574033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP4,Dipeptidyl peptidase 4,25877,40,0.42 [0.17-1.05],0.0631317525958082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,26305,39,5.46 [2.71-11.03],2.124781477192683e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP7,Dipeptidyl peptidase 2,26193,40,1.36 [0.89-2.08],0.1527093046506271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,26739,40,6.42 [1.92-21.51],0.0025849994576544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,26583,42,1.72 [1.20-2.45],0.0028209838291567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,26246,40,1.88 [1.00-3.56],0.0512525369150581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRG2,Developmentally-regulated GTP-binding protein 2,26305,39,0.87 [0.53-1.42],0.5703638174334286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,26090,40,4.08 [2.21-7.53],6.804484248731178e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSCAM,Down syndrome cell adhesion molecule,22907,37,6.08 [2.80-13.21],5.065947084613817e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG2,Desmoglein-2,26404,41,1.09 [0.38-3.13],0.8685444452097083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG3,Desmoglein-3,26577,42,0.89 [0.41-1.96],0.7736809399666644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG4,Desmoglein-4,26221,39,0.57 [0.33-0.96],0.033912672468658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTD1,D-aminoacyl-tRNA deacylase 1,22429,37,1.06 [0.77-1.47],0.7287696428192216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,22798,37,2.22 [1.38-3.57],0.000966694597363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,22304,36,0.50 [0.25-1.01],0.0539412790243216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,26305,39,1.02 [0.31-3.30],0.9742111751481344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTYMK,Thymidylate kinase,22945,37,1.11 [0.73-1.70],0.6138453347326641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUOX2,Dual oxidase 2,25946,40,0.62 [0.34-1.10],0.1030370366163221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,22835,37,0.96 [0.46-2.03],0.9248753917649988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP29,Dual specificity phosphatase 29,22304,36,0.72 [0.39-1.31],0.2821472481603518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP3,Dual specificity protein phosphatase 3,25812,41,0.84 [0.59-1.21],0.3475495227331849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",22858,36,1.25 [0.96-1.63],0.0969699980168354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DXO,Decapping and exoribonuclease protein,22882,35,1.08 [0.57-2.06],0.813474675072444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,22835,37,0.87 [0.43-1.75],0.6972911718461738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT1,Dynein light chain Tctex-type 1,22304,36,1.31 [0.94-1.81],0.1100362207513014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT3,Dynein light chain Tctex-type 3,22835,37,1.03 [0.52-2.03],0.9344770299108154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,26246,40,0.99 [0.75-1.32],0.9572695250024124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,26621,42,4.18 [2.18-8.03],1.7267542623550997e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECE1,Endothelin-converting enzyme 1,25812,41,0.48 [0.22-1.05],0.0658922488097758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",22945,37,1.17 [0.80-1.73],0.412987902836291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",22310,34,1.19 [0.87-1.64],0.2830347155921725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECI2,Enoyl-CoA delta isomerase 2,22213,35,1.00 [0.62-1.62],0.9974533690727072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECM1,Extracellular matrix protein 1,22315,35,0.58 [0.26-1.29],0.1785101359725406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECSCR,Endothelial cell-specific chemotaxis regulator,22212,34,1.02 [0.51-2.05],0.9604441461327794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,26655,42,4.03 [2.57-6.32],1.201514318509316e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,26402,41,1.08 [0.81-1.45],0.6021710039019179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDDM3B,Epididymal secretory protein E3-beta,22835,37,0.78 [0.43-1.39],0.3899656784036887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,22213,35,0.40 [0.12-1.31],0.1297000578725118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDF1,Endothelial differentiation-related factor 1,22907,37,1.15 [0.76-1.74],0.4986813412809633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,25946,40,2.20 [1.19-4.04],0.0114763453867318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,22310,34,3.07 [1.16-8.09],0.0237646981433298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDNRB,Endothelin receptor type B,22293,36,0.66 [0.26-1.67],0.3749653763174758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EEF1D,Elongation factor 1-delta,22945,37,1.24 [0.90-1.70],0.1828093272549619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,22858,36,2.95 [1.79-4.85],2.199731701815125e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB2,Dynein regulatory complex protein 8,22529,37,1.47 [0.68-3.16],0.3278393444128716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,26435,40,4.01 [1.95-8.24],0.0001538558031668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFHD1,EF-hand domain-containing protein D1,22907,37,1.42 [0.65-3.13],0.3787904084463016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,26356,41,3.98 [2.03-7.79],5.51536335880292e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA4,Ephrin-A4,26202,40,7.09 [4.36-11.53],2.688618716291872e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNB2,Ephrin-B2,22304,36,1.11 [0.67-1.83],0.6902675021898572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGF,Pro-epidermal growth factor,26361,40,1.23 [0.95-1.60],0.1226217566888326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,25789,40,2.47 [1.38-4.41],0.002305061245026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFLAM,Pikachurin,22858,36,1.50 [0.59-3.86],0.3969411186364251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFR,Epidermal growth factor receptor,26739,40,1.72 [0.28-10.48],0.5545203872691987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGLN1,Egl nine homolog 1,26402,41,0.91 [0.54-1.55],0.7409951510133101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHBP1,EH domain-binding protein 1,22945,37,1.15 [0.79-1.69],0.4644936628751671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHD3,EH domain-containing protein 3,22310,34,1.11 [0.84-1.47],0.4787257705392894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",22882,35,0.86 [0.46-1.60],0.6267391503403803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",22786,36,1.17 [0.90-1.52],0.2296434459803233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,22213,35,1.06 [0.67-1.68],0.7964949465099207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,22310,34,0.53 [0.22-1.29],0.1634659802233551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4B,Eukaryotic translation initiation factor 4B,26246,40,0.79 [0.49-1.28],0.331040694712105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4E,Eukaryotic translation initiation factor 4E,22293,36,1.08 [0.78-1.51],0.6297036363111996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,26416,40,1.00 [0.67-1.50],0.9995697339761136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,26732,42,1.04 [0.79-1.38],0.7696655522578211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,22907,37,1.12 [0.74-1.67],0.599262287139934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5,Eukaryotic translation initiation factor 5,22213,35,1.02 [0.50-2.09],0.9481214028247524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5A,Eukaryotic translation initiation factor 5A-1,25930,40,0.36 [0.13-0.99],0.0481244643550073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,22907,37,1.15 [0.81-1.62],0.4466177356488803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAVL4,ELAV-like protein 4,22212,34,1.18 [0.83-1.67],0.361306999594894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELN,Elastin,22945,37,2.55 [1.00-6.50],0.0496800363106316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOA,Elongin-A,26305,39,1.00 [0.59-1.68],0.9931814353352466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOB,Elongin-B,22213,35,0.99 [0.43-2.23],0.971801364043302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENAH,Protein enabled homolog,25930,40,1.53 [0.92-2.55],0.1042172528203125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENDOU,Poly(U)-specific endoribonuclease,21202,35,1.31 [0.73-2.33],0.3635502697525914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENG,Endoglin,26739,40,1.09 [0.21-5.62],0.9219192473900082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO1,Alpha-enolase,26393,40,0.88 [0.63-1.25],0.480252495174697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO2,Gamma-enolase,26677,41,0.85 [0.57-1.26],0.4145660775011399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO3,Beta-enolase,22310,34,0.70 [0.40-1.23],0.2162068069385968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOPH1,Enolase-phosphatase E1,22835,37,0.85 [0.41-1.76],0.6652018203363756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,22213,35,1.64 [0.60-4.49],0.3328336130844245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPEP,Glutamyl aminopeptidase,22213,35,1.37 [0.83-2.27],0.222488197703647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,26739,40,2.02 [0.72-5.67],0.1825880198352546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,26539,40,0.77 [0.45-1.30],0.3239544620893946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,22310,34,0.98 [0.38-2.52],0.95929147701128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,25658,38,1.64 [1.17-2.30],0.0039458645191282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENSA,Alpha-endosulfine,22835,37,0.91 [0.50-1.66],0.7669879921871621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,25789,40,1.29 [0.72-2.30],0.3957867680222848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,25946,40,0.64 [0.34-1.20],0.1632483595943137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,25946,40,1.60 [0.49-5.22],0.4386364397181099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTR1,Endosome-associated-trafficking regulator 1,22310,34,0.90 [0.53-1.54],0.7142895701682916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EP300,Histone acetyltransferase p300,22293,36,1.67 [0.89-3.11],0.1092556934931472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPB41L5,Band 4.1-like protein 5,22304,36,0.95 [0.57-1.59],0.8511875677158951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPCAM,Epithelial cell adhesion molecule,26410,39,0.76 [0.55-1.04],0.0903176965048311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPGN,Epigen,22835,37,0.84 [0.39-1.81],0.6495036186919425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA1,Ephrin type-A receptor 1,26489,40,2.72 [1.11-6.64],0.0284174201897667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA10,Ephrin type-A receptor 10,25812,41,0.88 [0.52-1.47],0.6177796196903096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,25470,39,4.27 [2.55-7.14],3.297916241515713e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA4,Ephrin type-A receptor 4,22429,37,1.18 [0.38-3.64],0.7730335818440792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,26739,40,5.43 [2.56-11.50],9.986330852914009e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,26203,40,2.28 [0.93-5.63],0.0728063615912817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHX2,Bifunctional epoxide hydrolase 2,25946,40,1.10 [0.72-1.69],0.6608680127802347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPN1,Epsin-1,22529,37,0.62 [0.25-1.54],0.3028596343038454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPO,Erythropoietin,26402,41,1.21 [0.93-1.58],0.1479797124461326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPPK1,Epiplakin,22310,34,0.94 [0.58-1.51],0.799566325891624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,26617,42,2.79 [1.33-5.86],0.0068830175313346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,26490,42,2.28 [0.85-6.10],0.1014250828011616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,26301,39,9.91 [3.25-30.26],5.6320242402521866e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,26490,42,5.59 [2.08-15.03],0.0006541482954981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBIN,Erbin,26305,39,0.94 [0.72-1.23],0.6530645398534793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERC2,ERC protein 2,22304,36,0.97 [0.62-1.53],0.8924810302160421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERCC1,DNA excision repair protein ERCC-1,22139,37,0.92 [0.31-2.74],0.8827483000767968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EREG,Proepiregulin,26203,40,1.07 [0.77-1.47],0.6848218252735391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERI1,3'-5' exoribonuclease 1,22529,37,0.76 [0.31-1.91],0.5642932693972085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,22293,36,2.39 [1.24-4.63],0.009332111618084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,22835,37,1.60 [0.76-3.36],0.2131305707570387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP29,Endoplasmic reticulum resident protein 29,22429,37,1.12 [0.87-1.43],0.3835799164828783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP44,Endoplasmic reticulum resident protein 44,26269,39,1.06 [0.37-3.03],0.9173892393270612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,22213,35,1.08 [0.54-2.15],0.8364208657621887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,26739,40,3.59 [1.92-6.70],6.224854528721202e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESM1,Endothelial cell-specific molecule 1,26400,39,0.85 [0.37-2.00],0.7173429917145134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESPL1,Separin,22139,37,1.33 [0.84-2.11],0.2192532395086213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESR1,Estrogen receptor,22293,36,1.19 [0.73-1.94],0.4964854105863636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESYT2,Extended synaptotagmin-2,22882,35,1.40 [0.99-1.98],0.0576134725375486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI2B,Protein EVI2B,22139,37,1.21 [0.57-2.60],0.6172413745329562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI5,Ecotropic viral integration site 5 protein homolog,22293,36,1.20 [0.85-1.68],0.2955517237582018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVPL,Envoplakin,22529,37,0.73 [0.25-2.14],0.5650364610494762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXOSC10,Exosome component 10,22213,35,0.84 [0.65-1.10],0.2101122128048762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXTL1,Exostosin-like 1,22213,35,0.58 [0.24-1.38],0.2202471637223556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EZR,Ezrin,26677,41,1.70 [0.59-4.91],0.33002355555126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F10,Coagulation factor X,22963,37,1.26 [0.41-3.92],0.6888893271457268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11,Coagulation factor XI,22625,36,1.88 [1.26-2.79],0.0018458349352697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11R,Junctional adhesion molecule A,26404,41,1.65 [1.07-2.54],0.0224724241695449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F12,Coagulation factor XII,22968,36,1.46 [0.64-3.33],0.3683540303743438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F13B,Coagulation factor XIII B chain,22845,36,1.23 [0.35-4.28],0.7461983404490958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2,Prothrombin,22968,36,0.65 [0.09-4.78],0.6763764926881081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2R,Proteinase-activated receptor 1,26498,40,1.65 [1.05-2.60],0.030989383871573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F3,Tissue factor,26493,42,1.15 [0.43-3.07],0.7829458423523593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F7,Coagulation factor VII,26441,40,3.05 [1.16-8.07],0.0243331170090549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F9,Coagulation factor IX,26454,40,9.93 [2.47-39.95],0.0012260054509928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",26400,39,2.24 [1.76-2.87],1.0774440817052312e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP2,"Fatty acid-binding protein, intestinal",26416,40,1.63 [1.18-2.26],0.0029219995318872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP3,"Fatty acid-binding protein, heart",22945,37,2.37 [1.66-3.38],1.7808742371053288e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",26739,40,3.64 [2.48-5.36],5.383119620709273e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP5,Fatty acid-binding protein 5,26599,41,1.26 [0.85-1.86],0.2443601762754221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP6,Gastrotropin,25913,40,1.08 [0.67-1.74],0.751935481133678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP9,Fatty acid-binding protein 9,26402,41,1.28 [0.82-1.98],0.2753753080036428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FADD,FAS-associated death domain protein,26416,40,0.87 [0.61-1.24],0.4364362537175856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM13A,Protein FAM13A,22858,36,1.06 [0.68-1.65],0.7936068797502688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171A2,Protein FAM171A2,22907,37,0.85 [0.67-1.09],0.1993037940238399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171B,Protein FAM171B,22835,37,1.25 [0.40-3.84],0.7023815281495296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM172A,Cotranscriptional regulator FAM172A,22310,34,0.79 [0.47-1.31],0.3581202733622443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM20A,Pseudokinase FAM20A,22945,37,3.63 [1.33-9.89],0.011717557892984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,26305,39,5.91 [2.58-13.54],2.670665811945726e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,26384,40,10.77 [6.01-19.29],1.2965423341103196e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,22858,36,2.58 [1.74-3.85],2.8646189535912808e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAP,Prolyl endopeptidase FAP,26739,40,0.43 [0.16-1.13],0.0859514570391906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,22304,36,1.08 [0.71-1.63],0.7265602638841646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,26640,40,1.97 [1.30-2.99],0.0013231887418944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FASLG,Tumor necrosis factor ligand superfamily member 6,26732,42,0.41 [0.20-0.83],0.0127715577532376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,22926,36,1.53 [0.56-4.14],0.4058047817936192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBN2,Fibrillin-2,22304,36,1.00 [0.57-1.74],0.9861388544392536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBP1,"Fructose-1,6-bisphosphatase 1",26416,40,0.91 [0.62-1.33],0.6227992753073914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,22945,37,2.13 [1.44-3.13],0.0001367140547238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAR,Immunoglobulin alpha Fc receptor,26402,41,2.48 [1.40-4.37],0.0017383776537595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,22907,37,1.72 [0.49-6.01],0.3971377523109305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,26404,41,1.18 [0.67-2.07],0.5612946528354024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,26274,40,1.84 [1.07-3.19],0.0285887280945849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,25789,40,1.13 [0.70-1.84],0.6128459706088016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,26400,40,1.51 [0.85-2.68],0.1628830372369534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,22925,37,2.37 [1.23-4.55],0.009834024423918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN2,Ficolin-2,26278,40,0.90 [0.45-1.80],0.7711069585820858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL1,Fc receptor-like protein 1,26416,40,1.11 [0.58-2.12],0.7524736119198617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,26619,42,2.27 [1.47-3.52],0.0002458386808549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL3,Fc receptor-like protein 3,25930,40,1.16 [0.68-1.99],0.5878085847662357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL5,Fc receptor-like protein 5,26404,41,1.38 [0.87-2.19],0.1752071973797327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL6,Fc receptor-like protein 6,26402,41,2.04 [1.36-3.07],0.0006257584132583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,25789,40,1.93 [1.43-2.61],1.9818427265778705e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX1,"Adrenodoxin, mitochondrial",22213,35,1.22 [0.80-1.85],0.3497088480094847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX2,"Ferredoxin-2, mitochondrial",22213,35,1.27 [0.77-2.07],0.3466137146651286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FEN1,Flap endonuclease 1,25789,40,0.72 [0.42-1.24],0.2381246393875978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FES,Tyrosine-protein kinase Fes/Fps,25789,40,0.52 [0.26-1.03],0.0604085207578736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FETUB,Fetuin-B,26454,40,2.95 [1.16-7.51],0.0232421228859534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGA,Fibrinogen alpha chain,22420,36,2.16 [0.83-5.62],0.114115551840135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",22907,37,1.07 [0.75-1.52],0.7198852691957216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF12,Fibroblast growth factor 12,22293,36,0.97 [0.45-2.06],0.9272276737056432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF16,Fibroblast growth factor 16,22293,36,0.71 [0.33-1.54],0.3875629841729052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF19,Fibroblast growth factor 19,26539,40,1.19 [0.83-1.70],0.3402772673293034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF2,Fibroblast growth factor 2,26402,41,1.22 [0.84-1.77],0.3033623477988466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF20,Fibroblast growth factor 20,22293,36,0.99 [0.44-2.21],0.98170995711669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,26621,42,1.37 [1.13-1.67],0.0014743931198251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,26611,42,1.50 [1.11-2.02],0.007556833206786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF3,Fibroblast growth factor 3,22293,36,1.27 [0.57-2.84],0.5537387805432288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,25930,40,2.62 [1.62-4.22],7.669808388056892e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF6,Fibroblast growth factor 6,22293,36,1.13 [0.54-2.37],0.7506014226200056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF7,Fibroblast growth factor 7,22139,37,1.11 [0.80-1.55],0.5185843474884728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF9,Fibroblast growth factor 9,22095,37,0.47 [0.23-1.00],0.0494890274588484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,26490,42,0.47 [0.32-0.71],0.0002661953833263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP2,Fibroblast growth factor-binding protein 2,22926,36,0.70 [0.37-1.33],0.2755947143766683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP3,Fibroblast growth factor-binding protein 3,22882,35,0.69 [0.30-1.60],0.390245254280122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,26490,42,11.30 [5.34-23.90],2.3075323456101847e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR4,Fibroblast growth factor receptor 4,22429,37,1.36 [0.75-2.46],0.3074512808325087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,22963,37,1.76 [1.10-2.80],0.0174553141935612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGR,Tyrosine-protein kinase Fgr,25812,41,0.94 [0.58-1.52],0.7903388679635558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FH,"Fumarate hydratase, mitochondrial",22212,34,0.68 [0.38-1.21],0.1906488727179398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,22213,35,0.46 [0.20-1.05],0.0647669226311471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIT,Bis(5'-adenosyl)-triphosphatase,25812,41,0.82 [0.57-1.18],0.2869718028992456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FIS1,Mitochondrial fission 1 protein,26392,40,1.22 [0.89-1.66],0.2134988213869691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,22907,37,1.21 [0.89-1.63],0.2196953497161085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,26524,42,0.96 [0.76-1.22],0.7633599110457873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,26246,40,1.17 [0.61-2.25],0.6419537239968294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,26246,40,1.03 [0.76-1.38],0.8554856629699893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,25769,41,1.02 [0.59-1.78],0.9320740866626644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBPL,FK506-binding protein-like,22858,36,1.18 [0.73-1.91],0.4942346431379754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLI1,Friend leukemia integration 1 transcription factor,25789,40,0.98 [0.78-1.24],0.8926991602889255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,26246,40,2.47 [0.94-6.48],0.0656943540767918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT1,Vascular endothelial growth factor receptor 1,26260,39,0.76 [0.18-3.21],0.7082045465318355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,25789,40,1.09 [0.44-2.69],0.8500243035555353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,26732,42,0.99 [0.45-2.21],0.986707920467894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT4,Vascular endothelial growth factor receptor 3,26490,42,1.74 [0.78-3.92],0.1780852677940375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMNL1,Formin-like protein 1,25812,41,0.94 [0.59-1.49],0.780331318603676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMR1,Synaptic functional regulator FMR1,25789,40,0.70 [0.31-1.56],0.3810729791680192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FN1,Fibronectin,22968,36,0.75 [0.24-2.40],0.6304708494260233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNDC1,Fibronectin type III domain-containing protein 1,22882,35,1.05 [0.54-2.02],0.8923993967361099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,22835,37,1.30 [0.64-2.61],0.4690947470760693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLH1,Glutamate carboxypeptidase 2,22293,36,0.81 [0.53-1.23],0.3248103114975317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,26360,42,4.17 [2.17-8.03],1.9341464610718527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR2,Folate receptor beta,26677,41,1.21 [0.49-3.02],0.6812889433928737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR3,Folate receptor gamma,26402,42,1.15 [1.03-1.28],0.0149055020835988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOS,Proto-oncogene c-Fos,22095,37,1.60 [0.81-3.16],0.1777375258430136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOSB,Protein fosB,25812,41,1.64 [1.07-2.53],0.0243173881742358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXJ3,Forkhead box protein J3,22293,36,1.17 [0.62-2.20],0.6219940569711613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO1,Forkhead box protein O1,26402,41,0.95 [0.69-1.31],0.768539183506587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO3,Forkhead box protein O3,25789,40,0.96 [0.71-1.30],0.8040798470498232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD4B,FERM domain-containing protein 4B,22213,35,1.10 [0.72-1.68],0.6530974892519351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD7,FERM domain-containing protein 7,22304,36,0.62 [0.24-1.61],0.3264553156123849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRZB,Secreted frizzled-related protein 3,26157,40,1.32 [0.44-4.01],0.6214521845343004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSHB,Follitropin subunit beta,22310,34,1.99 [1.39-2.85],0.0001716355427285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FST,Follistatin,26498,40,1.50 [0.87-2.57],0.1462730077481618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,22310,34,3.24 [0.92-11.36],0.0664362867475937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,26362,39,6.99 [4.00-12.22],9.238004038427911e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FTCD,Formimidoyltransferase-cyclodeaminase,22845,35,1.49 [1.08-2.07],0.0164322423189386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUCA1,Tissue alpha-L-fucosidase,26553,40,0.89 [0.66-1.21],0.4634446363438188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUOM,Fucose mutarotase,22429,37,1.20 [0.75-1.93],0.4428724807105673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FURIN,Furin,26490,42,2.37 [1.06-5.29],0.0356805894924983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUS,RNA-binding protein FUS,25745,40,0.67 [0.31-1.46],0.3115784552899041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",22492,37,0.91 [0.52-1.60],0.7498911790812324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,26677,41,1.82 [0.99-3.35],0.0542614773075016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT8,"Alpha-(1,6)-fucosyltransferase",26246,40,1.02 [0.64-1.63],0.9291524532076504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXN,"Frataxin, mitochondrial",26655,42,0.97 [0.69-1.37],0.8693141925108088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXYD5,FXYD domain-containing ion transport regulator 5,25930,40,1.09 [0.72-1.63],0.686148898884186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FYB1,FYN-binding protein 1,26367,41,1.03 [0.77-1.37],0.8297462502674815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD10,Frizzled-10,22304,36,0.79 [0.40-1.56],0.5031218026612332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD8,Frizzled-8,22212,34,1.55 [0.90-2.68],0.1125819370800146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,22835,37,1.08 [0.58-2.01],0.8056255272478912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,22529,37,0.95 [0.58-1.57],0.8428989421094251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,22212,34,0.90 [0.57-1.44],0.6637914975889708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD1,Glutamate decarboxylase 1,22139,37,0.99 [0.29-3.31],0.9823461737957452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD2,Glutamate decarboxylase 2,22293,36,1.75 [1.15-2.65],0.0085109084159978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,22529,37,1.08 [0.57-2.07],0.8094865742168591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,22310,34,1.25 [0.76-2.06],0.3699410811695834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAGE2A,G antigen 2A,22139,37,1.16 [0.72-1.90],0.5411742009394387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAL,Galanin peptides,26539,40,0.90 [0.58-1.38],0.6206142244193324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,26305,39,4.71 [1.97-11.26],0.0004977118326787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,26655,42,0.56 [0.20-1.58],0.2722427009194208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,25930,40,2.15 [1.14-4.07],0.0187719106305555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,22945,37,0.66 [0.22-1.98],0.4585621114230117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT7,N-acetylgalactosaminyltransferase 7,26305,39,5.06 [1.58-16.19],0.0063414934814554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAMT,Guanidinoacetate N-methyltransferase,22213,35,0.78 [0.50-1.23],0.2814045693808688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,21955,35,4.01 [1.00-16.14],0.0504441275537909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GART,Trifunctional purine biosynthetic protein adenosine-3,22907,37,0.32 [0.07-1.42],0.1341053653852925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS2,Growth arrest-specific protein 2,22529,37,1.18 [0.69-2.03],0.544301674512622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS6,Growth arrest-specific protein 6,26543,39,1.94 [0.66-5.68],0.2265647434823872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GASK1A,Golgi-associated kinase 1A,22213,35,0.48 [0.23-1.00],0.048602377533095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,22882,35,1.43 [1.19-1.72],0.0001094470583117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,22139,37,1.52 [0.48-4.77],0.4736626326295824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",22310,34,0.99 [0.66-1.46],0.946278328353388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBA,Lysosomal acid glucosylceramidase,22304,36,1.13 [0.62-2.04],0.6958011130805486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP1,Guanylate-binding protein 1,22840,35,1.46 [0.92-2.34],0.1111757592770157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP2,Guanylate-binding protein 2,25930,40,1.33 [0.88-2.00],0.1763458761457342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP4,Guanylate-binding protein 4,25812,41,1.07 [0.62-1.84],0.808511594867338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP6,Guanylate-binding protein 6,22213,35,0.92 [0.41-2.09],0.8438899302557621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GC,Vitamin D-binding protein,22968,36,0.46 [0.13-1.69],0.2407673048971431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCC1,GRIP and coiled-coil domain-containing protein 1,22882,35,1.20 [0.91-1.58],0.2080367785674118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,25789,40,1.76 [1.39-2.24],3.2413844284144264e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,21877,35,1.09 [0.56-2.11],0.7994092350589276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCLM,Glutamate--cysteine ligase regulatory subunit,22213,35,0.86 [0.40-1.84],0.6960869706128887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",26305,39,4.13 [1.94-8.77],0.0002287447982991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,26739,40,2.77 [2.26-3.40],1.0397150043241316e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF2,Growth/differentiation factor 2,26416,40,1.79 [0.86-3.73],0.1202565482097137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,25812,41,1.89 [0.97-3.67],0.0605824651537105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GET3,ATPase GET3,22945,37,1.20 [0.70-2.05],0.5012340589630055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFAP,Glial fibrillary acidic protein,25749,40,1.16 [0.60-2.25],0.6546210281051739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFER,FAD-linked sulfhydryl oxidase ALR,25789,40,1.31 [0.88-1.97],0.1847565504788254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,25789,40,0.56 [0.35-0.90],0.0177347071588507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,26621,42,6.48 [3.32-12.66],4.461216954557216e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA2,GDNF family receptor alpha-2,26305,39,1.40 [0.34-5.83],0.6451627936362339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA3,GDNF family receptor alpha-3,26155,40,1.12 [0.41-3.07],0.8230572109254258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRAL,GDNF family receptor alpha-like,22209,34,0.84 [0.49-1.45],0.5355467730792125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGA1,ADP-ribosylation factor-binding protein GGA1,25812,41,0.95 [0.67-1.35],0.7909927946260877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGACT,Gamma-glutamylaminecyclotransferase,22945,37,0.98 [0.65-1.48],0.9325510128292784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGCT,Gamma-glutamylcyclotransferase,22905,37,0.85 [0.46-1.56],0.5990650462006177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGH,Gamma-glutamyl hydrolase,25917,39,1.53 [0.68-3.45],0.3087301801254671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT1,Glutathione hydrolase 1 proenzyme,26356,41,2.02 [1.35-3.02],0.0006340294235516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT5,Glutathione hydrolase 5 proenzyme,26246,40,4.74 [2.67-8.44],1.2062917414853192e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH1,Somatotropin,26384,40,0.99 [0.84-1.17],0.92378944073423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH2,Growth hormone variant,25789,40,0.86 [0.69-1.08],0.1947033341461548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHR,Growth hormone receptor,22429,37,0.90 [0.29-2.82],0.862809244193224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRHR,Growth hormone-releasing hormone receptor,25812,41,0.70 [0.36-1.37],0.298778083985618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRL,Appetite-regulating hormone,26416,40,0.86 [0.61-1.21],0.3907781534101785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GID8,Glucose-induced degradation protein 8 homolog,22907,37,0.82 [0.27-2.51],0.7285515385317558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIGYF2,GRB10-interacting GYF protein 2,22907,37,1.21 [0.83-1.76],0.3196299430197725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP7,GTPase IMAP family member 7,22429,37,0.50 [0.16-1.56],0.2301778991220125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP8,GTPase IMAP family member 8,22139,37,2.13 [1.46-3.10],8.223003565212587e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIP,Gastric inhibitory polypeptide,22310,34,2.31 [1.26-4.21],0.0065180599588022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,22882,35,4.91 [2.26-10.68],6.042993428430652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC3,PDZ domain-containing protein GIPC3,22858,36,1.13 [0.83-1.56],0.439773009285716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPR,Gastric inhibitory polypeptide receptor,22293,36,0.86 [0.39-1.89],0.7116464985166171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIT1,ARF GTPase-activating protein GIT1,22293,36,1.10 [0.80-1.52],0.559314794616729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GJA8,Gap junction alpha-8 protein,22139,37,0.76 [0.41-1.38],0.3582665584918266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GKN1,Gastrokine-1,25320,40,1.52 [0.58-3.99],0.3903705067488922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLA,Alpha-galactosidase A,22382,36,2.93 [1.46-5.90],0.0025353396414542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLB1,Beta-galactosidase,26246,40,1.28 [0.67-2.44],0.4523348694154538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLI2,Zinc finger protein GLI2,22293,36,1.16 [0.47-2.85],0.7484173253225808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLO1,Lactoylglutathione lyase,25946,40,0.90 [0.54-1.49],0.6786957155964572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLOD4,Glyoxalase domain-containing protein 4,26351,40,0.77 [0.36-1.67],0.5140381188338002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLP1R,Glucagon-like peptide 1 receptor,22212,34,0.55 [0.18-1.64],0.2822408386174619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX,Glutaredoxin-1,26257,39,0.91 [0.56-1.48],0.7066750436358593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",22429,37,1.12 [0.83-1.52],0.4638300681452372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,25812,41,1.10 [0.62-1.95],0.7494450341925545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLYR1,Putative oxidoreductase GLYR1,22835,37,0.73 [0.40-1.34],0.3121489315809044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,22387,36,1.95 [1.32-2.89],0.000837285360444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMFG,Glia maturation factor gamma,22945,37,1.03 [0.68-1.55],0.8960964014278862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR,GMP reductase 1,26732,42,0.52 [0.32-0.84],0.0082265339589241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR2,GMP reductase 2,22429,37,0.97 [0.62-1.52],0.9027506850146928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNAS,Neuroendocrine secretory protein 55,22907,37,1.26 [0.95-1.65],0.1032281330818618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,25789,40,0.85 [0.56-1.29],0.4389991493206233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,22304,36,0.74 [0.34-1.60],0.445608001809761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNLY,Granulysin,26404,41,1.07 [0.65-1.78],0.7815060968797041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,22310,34,0.85 [0.52-1.39],0.5224029103206271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,22429,37,0.51 [0.22-1.17],0.110023683538673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLGA3,Golgin subfamily A member 3,22907,37,1.43 [1.00-2.03],0.0478803242343552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,26677,41,11.35 [5.04-25.58],4.6392497109287255e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,26402,41,1.03 [0.79-1.34],0.8375664500355353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GORASP2,Golgi reassembly-stacking protein 2,22858,36,1.11 [0.60-2.06],0.7314227370049995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOT1,"Aspartate aminotransferase, cytoplasmic",22926,36,0.72 [0.36-1.46],0.3634952821664848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BA,Platelet glycoprotein Ib alpha chain,26281,40,1.22 [0.55-2.70],0.629214969024062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BB,Platelet glycoprotein Ib beta chain,22213,35,1.04 [0.66-1.65],0.8512331914440809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,25610,40,1.30 [0.97-1.73],0.0783266028361677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP5,Platelet glycoprotein V,22429,37,1.42 [0.59-3.41],0.4391255772933394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP6,Platelet glycoprotein VI,26367,41,1.12 [0.83-1.50],0.4588517359004709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPA33,Cell surface A33 antigen,26305,39,0.62 [0.50-0.78],2.6475038876671315e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC1,Glypican-1,26655,42,1.58 [0.63-3.95],0.3262467790830342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC5,Glypican-5,26246,40,0.75 [0.47-1.18],0.2149423894803551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPD1,Glycerol-3-phosphate dehydrogenase,22835,37,1.53 [0.92-2.55],0.0976335336851178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPHA2,Glycoprotein hormone alpha-2,22858,36,0.51 [0.19-1.39],0.1881728856712037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPI,Glucose-6-phosphate isomerase,22963,37,1.20 [0.66-2.16],0.5537777053852467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,22858,36,1.30 [0.79-2.14],0.300054042177993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPKOW,G-patch domain and KOW motifs-containing protein,25812,41,1.58 [0.82-3.08],0.1744356054250333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,25705,36,3.90 [1.31-11.67],0.0147537504534897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR101,Probable G-protein coupled receptor 101,22212,34,0.70 [0.32-1.51],0.358434825376636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR158,Probable G-protein coupled receptor 158,22907,37,1.08 [0.42-2.74],0.8752724954030581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR15L,Protein GPR15L,22858,36,1.32 [0.80-2.15],0.2739647233173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,25946,40,3.31 [2.23-4.90],2.526175787078127e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,22835,37,1.27 [0.84-1.91],0.2587584828466183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRAP2,GRB2-related adapter protein 2,26416,40,1.01 [0.82-1.25],0.917579178858342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,22945,37,1.10 [0.68-1.78],0.687470879653191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",22907,37,0.59 [0.21-1.63],0.3070992854675741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",22212,34,0.66 [0.29-1.50],0.3241846046569108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRK5,G protein-coupled receptor kinase 5,25946,40,1.06 [0.63-1.78],0.817506529407496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,26271,41,5.15 [2.31-11.48],6.278669618036292e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRP,Gastrin-releasing peptide,22310,34,1.44 [0.77-2.69],0.2488075504690509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",26305,39,1.77 [1.24-2.53],0.0017178686330239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRSF1,G-rich sequence factor 1,22013,37,1.11 [0.78-1.57],0.5696828399053506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSAP,Gamma-secretase-activating protein,25789,40,1.27 [1.02-1.59],0.0360200407337633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,22867,36,0.42 [0.19-0.95],0.0374667233326022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSR,"Glutathione reductase, mitochondrial",22838,36,0.70 [0.17-2.93],0.6200030365003721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA1,Glutathione S-transferase A1,26382,40,1.16 [0.84-1.60],0.36284209579284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA3,Glutathione S-transferase A3,25789,40,1.37 [1.00-1.87],0.0494615857542058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTM4,Glutathione S-transferase Mu 4,22213,35,1.33 [0.97-1.84],0.0808523682655511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTP1,Glutathione S-transferase P,25644,41,0.75 [0.48-1.17],0.1993669852455196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTT2B,Glutathione S-transferase theta-2B,22882,35,1.03 [0.90-1.17],0.7020807183891704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,22529,37,0.67 [0.35-1.29],0.2310219561298794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTPBP2,GTP-binding protein 2,22304,36,1.10 [0.76-1.58],0.6177159787173478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,26280,41,4.26 [2.46-7.35],2.067120755475425e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCY2C,Heat-stable enterotoxin receptor,22529,37,0.60 [0.35-1.04],0.066981751824281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUK1,Guanylate kinase,22213,35,1.15 [0.56-2.33],0.7047229115458933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUSB,Beta-glucuronidase,26503,40,1.94 [1.26-2.97],0.0024721912216485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GYS1,"Glycogen [starch] synthase, muscle",25946,40,0.81 [0.59-1.10],0.1755510509759716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMA,Granzyme A,26732,42,2.36 [1.20-4.61],0.0123483233083488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMB,Granzyme B,26402,41,0.66 [0.40-1.09],0.10430451342801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMH,Granzyme H,25946,40,1.10 [0.78-1.54],0.5769770819187594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,H2AP,Huntingtin-interacting protein M,22139,37,0.86 [0.39-1.90],0.7116375415516247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",22213,35,0.88 [0.48-1.62],0.6809196739942815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",26588,42,0.79 [0.53-1.17],0.2461468072510457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAO1,Hydroxyacid oxidase 1,26655,42,1.09 [0.87-1.36],0.4519341808940766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",26404,41,0.96 [0.68-1.35],0.809463303099282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,26622,42,1.70 [1.39-2.08],2.2639991469603683e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,26404,41,4.47 [2.58-7.74],9.337374951015973e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBEGF,Proheparin-binding EGF-like growth factor,26588,42,1.15 [0.81-1.63],0.4456679607839654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBQ1,Hemoglobin subunit theta-1,26655,42,0.67 [0.42-1.08],0.1033877554948961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBZ,Hemoglobin subunit zeta,22945,37,0.70 [0.51-0.98],0.0354066687118243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCG22,Protein PBMUCL2,22213,35,0.55 [0.20-1.47],0.2316733512196614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCLS1,Hematopoietic lineage cell-specific protein,26732,42,0.78 [0.48-1.28],0.3301857672790696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC8,Histone deacetylase 8,22293,36,1.05 [0.65-1.70],0.8409314759205947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC9,Histone deacetylase 9,22212,34,0.79 [0.41-1.51],0.4737277968915533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDDC2,5'-deoxynucleotidase HDDC2,22858,36,0.69 [0.33-1.48],0.3444349000332928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGF,Hepatoma-derived growth factor,26626,42,1.01 [0.75-1.36],0.9606279426876372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,22882,35,1.18 [0.74-1.86],0.4904190052664671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEBP1,Heme-binding protein 1,25946,40,1.00 [0.59-1.70],0.996068794769651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,22429,37,4.28 [1.49-12.25],0.0068342521001973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPACAM2,HEPACAM family member 2,22882,35,0.67 [0.31-1.45],0.3098258900261504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,22945,37,2.12 [0.62-7.24],0.230768400594994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEXIM1,Protein HEXIM1,26402,41,1.08 [0.78-1.51],0.6292703876737383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,26732,42,3.12 [1.81-5.35],3.912893721507653e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGFAC,Hepatocyte growth factor activator,22746,37,3.26 [0.99-10.76],0.0523296794714608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,25789,40,0.79 [0.56-1.12],0.1893359106040028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,22882,35,1.44 [0.97-2.16],0.0714636069771562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIF1A,Hypoxia-inducible factor 1-alpha,22293,36,1.24 [0.87-1.77],0.2288248091921272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1,Huntingtin-interacting protein 1,22213,35,0.81 [0.51-1.30],0.3903241101159377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,22844,35,1.84 [1.20-2.81],0.0047887868159348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HJV,Hemojuvelin,22907,37,2.45 [1.76-3.40],1.009477972834639e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HK2,Hexokinase-2,25946,40,0.38 [0.14-1.03],0.0578538120516627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",22907,37,3.45 [1.27-9.41],0.0155526067898554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",26314,40,1.79 [0.84-3.81],0.1310951003116398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",26402,41,4.88 [2.38-10.00],1.45996030289866e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMBS,Porphobilinogen deaminase,26655,42,0.66 [0.34-1.29],0.2240580908869444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMCN2,Hemicentin-2,22385,37,1.99 [1.17-3.37],0.0107965963434535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",22310,34,0.81 [0.43-1.56],0.5347458909792103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",22213,35,0.57 [0.26-1.29],0.1789243547919721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMMR,Hyaluronan mediated motility receptor,22102,37,0.78 [0.35-1.78],0.5588788488624695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX1,Heme oxygenase 1,26119,40,0.71 [0.38-1.32],0.2760932801286411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX2,Heme oxygenase 2,25812,41,1.03 [0.57-1.87],0.9130518940615634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNF1A,Hepatocyte nuclear factor 1-alpha,22304,36,1.15 [0.78-1.68],0.4809717772773308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNMT,Histamine N-methyltransferase,26124,40,2.02 [1.16-3.52],0.0130809354222038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,25852,40,0.83 [0.58-1.20],0.3246768904382946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,22907,37,1.12 [0.64-1.97],0.6811488512979427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPCAL1,Hippocalcin-like protein 1,26732,42,0.90 [0.63-1.29],0.5673881625804371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPGDS,Hematopoietic prostaglandin D synthase,25789,40,0.47 [0.23-0.98],0.0430330690301722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPSE,Heparanase,22627,36,1.58 [1.14-2.20],0.0062867408667544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRAS,GTPase Hras,22497,37,0.66 [0.38-1.15],0.1387028786390865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,22310,34,1.13 [0.42-3.07],0.8034494628907514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRG,Histidine-rich glycoprotein,22845,36,2.02 [0.75-5.47],0.1648156375910887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS1BP3,HCLS1-binding protein 3,22310,34,0.97 [0.68-1.37],0.8630592065070397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,26305,39,1.74 [0.84-3.62],0.1386945790427655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,26655,42,1.55 [0.76-3.15],0.2298368123715312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,22293,36,1.56 [0.67-3.65],0.3035353098698926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSBP1,Heat shock factor-binding protein 1,22310,34,1.07 [0.76-1.51],0.7024305792318735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,26402,41,0.31 [0.16-0.61],0.0005861550434716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,22882,35,1.45 [0.89-2.37],0.1306463785522299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,22213,35,0.71 [0.35-1.41],0.321541374866196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,22310,34,1.23 [0.66-2.29],0.5091972524536332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSP90B1,Endoplasmin,25685,40,0.79 [0.46-1.37],0.4028255755146069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA1A,Heat shock 70 kDa protein 1A,26489,40,1.02 [0.71-1.47],0.9193560067991938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,22835,37,1.39 [0.81-2.40],0.2320988069529492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB1,Heat shock protein beta-1,25978,40,0.99 [0.66-1.49],0.9615670259327384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,26655,42,3.27 [1.90-5.64],1.9077209276038766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,26189,40,3.27 [1.58-6.77],0.0013604161043369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1A,5-hydroxytryptamine receptor 1A,22212,34,0.77 [0.43-1.38],0.3845195850400648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1B,5-hydroxytryptamine receptor 1B,22212,34,1.18 [0.57-2.43],0.6585509955237405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTRA2,"Serine protease HTRA2, mitochondrial",26490,42,1.13 [0.75-1.70],0.5627280168339737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYAL1,Hyaluronidase-1,26240,38,3.30 [1.13-9.63],0.0290001987833866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,26739,40,7.06 [2.27-21.97],0.0007361039803519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICA1,Islet cell autoantigen 1,25930,40,0.91 [0.64-1.29],0.5977480975756692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,26281,40,4.19 [1.83-9.56],0.0006774584157704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM2,Intercellular adhesion molecule 2,26739,40,2.71 [1.06-6.91],0.0373968164074842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,26739,40,4.16 [1.61-10.76],0.0032581655053015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM4,Intercellular adhesion molecule 4,26402,41,0.43 [0.26-0.72],0.0014396485908736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM5,Intercellular adhesion molecule 5,26416,40,1.23 [0.66-2.30],0.5188012172583003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICOSLG,ICOS ligand,26305,39,1.63 [0.38-7.00],0.5132493538327009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ID4,DNA-binding protein inhibitor ID-4,22529,37,0.87 [0.40-1.90],0.7313041655076846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,25812,41,1.04 [0.61-1.79],0.8851152826333197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDO1,"Indoleamine 2,3-dioxygenase 1",22310,34,1.07 [0.63-1.82],0.8039944759732824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDS,Iduronate 2-sulfatase,26732,42,0.49 [0.11-2.11],0.3373681042714095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,26655,42,4.52 [2.37-8.63],4.854749246339205e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,22333,35,2.60 [1.32-5.11],0.005783216827999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,22529,37,1.21 [0.67-2.20],0.527260075018956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,22529,37,1.26 [0.60-2.67],0.5448229657473576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNAR1,Interferon alpha/beta receptor 1,22858,36,1.19 [0.32-4.43],0.8006548284319703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNG,Interferon gamma,25930,40,1.18 [0.92-1.51],0.2054091050644906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,26539,40,2.46 [1.25-4.83],0.009201249154227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR2,Interferon gamma receptor 2,26246,40,2.07 [1.29-3.32],0.0025610972616217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL1,Interferon lambda-1,25812,41,1.05 [0.57-1.95],0.8698319204164875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL2,Interferon lambda-2,22212,34,1.00 [0.56-1.77],0.9932362933355198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNLR1,Interferon lambda receptor 1,26402,41,1.34 [0.67-2.67],0.4147519281635299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNW1,Interferon omega-1,22213,35,0.76 [0.48-1.21],0.2462954245749058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFT20,Intraflagellar transport protein 20 homolog,22304,36,0.77 [0.38-1.55],0.4643697838556008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGBP1,Immunoglobulin-binding protein 1,22907,37,1.00 [0.63-1.60],0.9903404819603088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,22212,34,0.48 [0.17-1.32],0.1548848089078239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,22926,36,0.60 [0.34-1.06],0.0798786582796614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,26305,39,1.97 [1.14-3.41],0.0152815249526272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,22213,35,0.32 [0.11-0.89],0.0286165805046339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,26404,41,6.78 [3.21-14.32],5.381231153908382e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP1,Insulin-like growth factor-binding protein 1,26695,40,0.92 [0.74-1.15],0.4689729528337352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP2,Insulin-like growth factor-binding protein 2,26686,39,1.20 [0.78-1.87],0.4089096230346124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,26487,40,0.40 [0.20-0.81],0.0107608950982038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,26076,41,3.22 [2.24-4.63],2.4487260042680126e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,26283,40,2.14 [1.07-4.29],0.0320233940805128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,26739,40,3.25 [2.26-4.67],2.1201090257666663e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,26416,40,3.02 [1.68-5.42],0.0002128300082301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFL4,Insulin growth factor-like family member 4,22293,36,0.80 [0.45-1.40],0.4273172003425546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGHMBP2,DNA-binding protein SMUBP-2,22213,35,0.69 [0.37-1.28],0.2390976758155594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,22935,36,2.32 [1.31-4.09],0.0037635126402079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLON5,IgLON family member 5,22139,37,0.86 [0.59-1.25],0.4353232217286864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF21,Immunoglobulin superfamily member 21,22310,34,0.57 [0.23-1.37],0.2070530992281069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,26305,39,3.29 [2.33-4.64],1.3792489789995684e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,26416,40,4.98 [2.54-9.77],2.967534350538733e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,22945,37,2.16 [1.60-2.93],6.255566171991969e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKBKG,NF-kappa-B essential modulator,26402,41,1.03 [0.75-1.41],0.8508483951481449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKZF2,Zinc finger protein Helios,25789,40,0.83 [0.55-1.24],0.3611408108134638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10,Interleukin-10,25930,40,1.38 [1.07-1.78],0.0131375644188129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RA,Interleukin-10 receptor subunit alpha,25930,40,1.04 [0.64-1.68],0.8713922907080309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,26539,40,4.03 [2.69-6.02],1.1185189823299066e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL11,Interleukin-11,25930,40,1.06 [0.70-1.62],0.7798310185904189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,26305,39,2.12 [1.52-2.95],9.980506667383522e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,26732,42,2.26 [1.39-3.67],0.0010377371924418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,25930,40,3.25 [1.59-6.66],0.0012710606630004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB2,Interleukin-12 receptor subunit beta-2,22293,36,1.61 [0.82-3.18],0.1683732841419268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13,Interleukin-13,25930,40,1.19 [0.73-1.96],0.4833937693907365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,26075,42,4.26 [1.41-12.92],0.0104117051039837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,22212,34,0.92 [0.29-2.89],0.8850116614926149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15,Interleukin-15,26402,41,1.93 [0.88-4.22],0.0984025408379552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,25930,40,3.13 [1.41-6.91],0.0048512416667896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL16,Pro-interleukin-16,26732,42,1.07 [0.57-2.04],0.8265162630496502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17A,Interleukin-17A,25889,40,1.31 [0.84-2.04],0.2309435995913471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,25930,40,1.95 [1.48-2.56],1.6703743671713425e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17D,Interleukin-17D,25930,40,1.30 [0.72-2.35],0.3872313200325112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17F,Interleukin-17F,25930,40,1.09 [0.76-1.54],0.6482163566194721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RA,Interleukin-17 receptor A,26404,41,1.05 [0.56-1.99],0.8718734082800319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RB,Interleukin-17 receptor B,26059,41,0.84 [0.51-1.38],0.4917470230063901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,26305,39,2.49 [1.62-3.82],3.1843664641144455e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,26487,40,3.81 [0.37-39.27],0.2611884148309855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,26732,42,13.14 [6.27-27.55],8.95512329585162e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18RAP,Interleukin-18 receptor accessory protein,26083,39,0.74 [0.60-0.92],0.0062388318122433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,25768,39,1.63 [1.25-2.13],0.0002973784577642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1A,Interleukin-1 alpha,25930,40,0.88 [0.50-1.55],0.6614931923877314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1B,Interleukin-1 beta,25798,40,1.09 [0.70-1.70],0.6897467515143503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,26356,41,1.88 [1.19-2.97],0.0067668121285447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,26354,39,26.78 [7.00-102.54],1.5872064153384762e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RAP,Interleukin-1 receptor accessory protein,26404,41,1.43 [0.79-2.60],0.2367257427123252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL1,Interleukin-1 receptor-like 1,26640,40,1.54 [0.83-2.86],0.1688730377617635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL2,Interleukin-1 receptor-like 2,25930,40,0.90 [0.44-1.85],0.7734438960080157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,26358,40,2.14 [1.58-2.90],8.292596571141242e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2,Interleukin-2,25930,40,1.24 [0.49-3.18],0.6507564125737464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20,Interleukin-20,25930,40,0.87 [0.45-1.68],0.6780475058773792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RA,Interleukin-20 receptor subunit alpha,25930,40,1.35 [0.87-2.10],0.178249343642184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RB,Interleukin-20 receptor subunit beta,22293,36,0.68 [0.30-1.58],0.373324169261396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL21R,Interleukin-21 receptor,22293,36,1.16 [0.71-1.90],0.5422695212790429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22,Interleukin-22,22835,37,1.56 [1.06-2.30],0.0236800210231453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,25930,40,0.56 [0.24-1.32],0.1861504269078935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL24,Interleukin-24,25930,40,1.49 [0.99-2.26],0.0585187354491624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL25,Interleukin-25,22060,37,1.24 [0.48-3.20],0.6500869873704083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,26236,40,2.93 [1.77-4.85],3.121960593220209e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RB,Interleukin-2 receptor subunit beta,25930,40,0.87 [0.38-2.00],0.7441549675168795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RG,Cytokine receptor common subunit gamma,22835,37,1.31 [0.67-2.58],0.4290779855730262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3,Interleukin-3,22139,37,1.06 [0.61-1.85],0.8305583263302652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31,Interleukin-31,22293,36,1.34 [0.85-2.12],0.2137257746326676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31RA,Interleukin-31 receptor subunit alpha,22214,35,1.85 [0.84-4.08],0.1283738041127193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL32,Interleukin-32,26402,41,0.88 [0.45-1.70],0.6949734445621119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL33,Interleukin-33,25930,40,1.40 [0.68-2.88],0.3611979502878689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL34,Interleukin-34,25763,41,0.85 [0.38-1.89],0.6903483551047547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36A,Interleukin-36 alpha,22293,36,1.24 [0.81-1.89],0.3261192192839001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36G,Interleukin-36 gamma,22215,36,0.92 [0.55-1.56],0.7630747996045623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3RA,Interleukin-3 receptor subunit alpha,25930,40,0.91 [0.38-2.15],0.8232389805938019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4,Interleukin-4,25930,40,1.23 [0.84-1.79],0.2818100384580679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,26402,41,2.40 [1.25-4.60],0.0082038227448052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5,Interleukin-5,25930,40,1.08 [0.90-1.30],0.4032323006905428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5RA,Interleukin-5 receptor subunit alpha,26402,41,1.37 [0.88-2.14],0.1616428553390088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,26305,39,1.41 [1.07-1.85],0.0147848403002084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6R,Interleukin-6 receptor subunit alpha,26228,40,2.56 [1.12-5.84],0.0257598585861573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,26416,40,2.34 [0.83-6.66],0.1095106599223978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7,Interleukin-7,26402,41,0.91 [0.61-1.38],0.6641229923158696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7R,Interleukin-7 receptor subunit alpha,26404,41,0.52 [0.31-0.85],0.0090536625841501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL9,Interleukin-9,22529,37,0.68 [0.34-1.37],0.2789449099640761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,25774,41,0.82 [0.50-1.35],0.4350715992058792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,22835,37,2.52 [1.79-3.55],1.3573491400857996e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPA1,Inositol monophosphatase 1,26246,40,0.74 [0.47-1.17],0.2008857445603614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPACT,Protein IMPACT,22882,35,0.98 [0.56-1.71],0.9470028674475328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,22212,34,0.78 [0.45-1.34],0.3663452755731662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ING1,Inhibitor of growth protein 1,25769,41,0.94 [0.51-1.75],0.8444380056154109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,22429,37,2.62 [1.52-4.52],0.0005341083100821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,26404,41,4.92 [2.18-11.13],0.0001271704494419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP1,Inositol polyphosphate 1-phosphatase,26305,39,0.68 [0.39-1.18],0.1678110981093128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",22310,34,1.22 [0.73-2.05],0.4415974994727575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",22907,37,0.62 [0.25-1.53],0.2997392191399713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",26305,39,1.08 [0.80-1.45],0.6083557150433213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL3,Insulin-like 3,22882,35,0.68 [0.48-0.97],0.0341476245813467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL4,Early placenta insulin-like peptide,22835,37,1.49 [0.98-2.24],0.0590928407029401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL5,Insulin-like peptide INSL5,22858,36,1.19 [0.87-1.62],0.2671043007309646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,22293,36,35.79 [7.00-183.01],1.7333207044965704e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,26202,40,1.05 [0.77-1.44],0.7623996690265011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,26305,39,1.19 [0.70-2.01],0.5187177193568187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",25946,40,1.10 [0.82-1.46],0.5366863595402659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK1,Interleukin-1 receptor-associated kinase 1,25930,40,0.99 [0.67-1.48],0.972251916890734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK4,Interleukin-1 receptor-associated kinase 4,26402,41,0.93 [0.72-1.21],0.597290851863854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,25430,40,0.67 [0.32-1.40],0.2882369009772582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM1,Isthmin-1,26402,41,0.97 [0.48-1.98],0.9415260256394228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM2,Isthmin-2,22926,36,0.77 [0.35-1.73],0.5323403095620711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IST1,IST1 homolog,22692,35,1.04 [0.76-1.42],0.8037419036033936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA11,Integrin alpha-11,26402,41,0.55 [0.25-1.25],0.1532779041013764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA2,Integrin alpha-2,22429,37,0.58 [0.24-1.43],0.2380806237791708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,26404,41,6.26 [2.28-17.21],0.0003728205625591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA6,Integrin alpha-6,26402,41,0.95 [0.57-1.56],0.8266340038196951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAL,Integrin alpha-L,22293,36,2.78 [1.27-6.11],0.0108634749324722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAM,Integrin alpha-M,26404,41,3.23 [1.49-7.03],0.0030321981028465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAV,Integrin alpha-V,26655,42,0.39 [0.09-1.80],0.2287031819790678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAX,Integrin alpha-X,22529,37,1.38 [0.83-2.28],0.2123454156946367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1,Integrin beta-1,26353,40,1.91 [0.56-6.51],0.3008678039163187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP1,Integrin beta-1-binding protein 1,25789,40,1.43 [0.74-2.79],0.288793542314224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP2,Integrin beta-1-binding protein 2,25946,40,0.92 [0.72-1.18],0.5191225101203731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,26246,38,4.27 [2.36-7.73],1.5774991593172292e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB5,Integrin beta-5,26490,42,1.28 [0.71-2.29],0.4064856871350584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB6,Integrin beta-6,25930,40,3.07 [1.23-7.65],0.0158707082571187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,26655,42,3.21 [1.98-5.20],2.1765662363395263e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,22926,36,3.42 [1.97-5.96],1.3453826786060335e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,22968,36,1.04 [0.20-5.40],0.9668500588814242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,26487,40,2.82 [1.37-5.79],0.0048406702270568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,22968,36,1.89 [0.63-5.69],0.2565774882941426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,22835,37,1.29 [0.67-2.49],0.4456243533693155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITM2A,Integral membrane protein 2A,26402,41,0.83 [0.53-1.30],0.4171100883204847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPA,Inosine triphosphate pyrophosphatase,22213,35,1.20 [0.79-1.82],0.3914703915620967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",22310,34,1.28 [0.88-1.86],0.1985396248732594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",22212,34,0.82 [0.42-1.62],0.5744352943398287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",25812,41,0.76 [0.40-1.43],0.3959281448028926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IZUMO1,Izumo sperm-egg fusion protein 1,22139,37,1.22 [0.70-2.11],0.4809056071532952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,26677,41,2.89 [1.23-6.81],0.0149285288999504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM3,Junctional adhesion molecule C,22429,37,1.70 [1.07-2.71],0.0259136861278882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JCHAIN,Immunoglobulin J chain,25930,40,1.21 [0.76-1.91],0.4164966037925891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,22139,37,0.91 [0.52-1.59],0.7354455953805162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JPT2,Jupiter microtubule associated homolog 2,22858,36,1.17 [0.82-1.66],0.3801585462696972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JUN,Transcription factor AP-1,25930,40,0.72 [0.36-1.44],0.353126861301533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,26305,39,1.20 [0.63-2.27],0.5834853125325493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZN,Kazrin,22858,36,1.23 [0.91-1.67],0.1718916467302811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,22212,34,1.38 [0.83-2.30],0.2081823803458145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,22304,36,1.10 [0.72-1.68],0.6457398354972986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNIP4,Kv channel-interacting protein 4,25812,41,0.77 [0.39-1.52],0.4558493653334757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCTD5,BTB/POZ domain-containing protein KCTD5,22432,35,1.36 [0.72-2.58],0.3443765482929982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDM3A,Lysine-specific demethylase 3A,22293,36,0.69 [0.41-1.18],0.1755630735377865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDR,Vascular endothelial growth factor receptor 2,26490,42,1.27 [0.40-3.96],0.6862353370200753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KEL,Kell blood group glycoprotein,25812,41,1.17 [0.53-2.56],0.7007434734396285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHDC3L,KH domain-containing protein 3,22139,37,1.21 [0.83-1.77],0.3116318240444536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHK,Ketohexokinase,22310,34,1.30 [0.75-2.25],0.3431962565029823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA0319,Dyslexia-associated protein KIAA0319,22882,35,1.41 [0.54-3.67],0.4776934774678406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549,UPF0606 protein KIAA1549,22529,37,0.97 [0.60-1.58],0.903222501498491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549L,UPF0606 protein KIAA1549L,22529,37,0.88 [0.29-2.63],0.8164947308580913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA2013,Uncharacterized protein KIAA2013,22835,37,0.97 [0.54-1.77],0.9322164806913732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF1C,Kinesin-like protein KIF1C,22213,35,1.10 [0.49-2.45],0.817371003589866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF20B,Kinesin-like protein KIF20B,22212,34,1.18 [0.80-1.75],0.4067302693236135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF22,Kinesin-like protein KIF22,22213,35,1.29 [0.97-1.70],0.0768610963499252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIFBP,KIF-binding protein,26305,39,0.97 [0.69-1.37],0.8768035817041616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,22835,37,1.42 [0.98-2.04],0.0641868116860227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,25789,40,1.31 [0.91-1.90],0.1484194717783255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,22858,36,1.00 [0.83-1.20],0.9680949549084824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,25789,40,0.94 [0.75-1.18],0.6042610143690881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,22139,37,1.05 [0.74-1.49],0.7968212091592941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL1,Kin of IRRE-like protein 1,22212,34,0.84 [0.44-1.61],0.608695844673584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL2,Kin of IRRE-like protein 2,25812,41,0.83 [0.40-1.71],0.6088731966703735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIT,Mast/stem cell growth factor receptor Kit,26454,40,0.52 [0.20-1.34],0.1747194727626202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KITLG,Kit ligand,26416,40,0.56 [0.29-1.08],0.0837236490087435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLB,Beta-klotho,25812,41,0.74 [0.50-1.08],0.1203475877410983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLF4,Krueppel-like factor 4,22212,34,0.92 [0.40-2.09],0.8327178232551508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLHL41,Kelch-like protein 41,22907,37,0.73 [0.40-1.34],0.3135994480832074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK1,Kallikrein-1,26157,42,1.03 [0.84-1.28],0.7590546941346592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK10,Kallikrein-10,26407,42,1.47 [0.76-2.83],0.2503729356328784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,26236,42,3.25 [2.10-5.03],1.342104120413254e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK12,Kallikrein-12,25789,40,1.22 [0.97-1.54],0.0900593779620972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK13,Kallikrein-13,25829,39,1.83 [1.01-3.32],0.0474476635845081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK14,Kallikrein-14,26655,42,0.84 [0.46-1.54],0.5806052876590505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK15,Kallikrein-15,22798,37,0.63 [0.33-1.18],0.1462431947133678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK3,Prostate-specific antigen,22926,36,0.64 [0.44-0.92],0.0174524978772411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,26655,42,1.85 [1.38-2.49],4.706931218845404e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK6,Kallikrein-6,26452,42,2.33 [1.01-5.40],0.0474620621141096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK7,Kallikrein-7,21846,35,0.63 [0.25-1.55],0.3126527426936912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK8,Kallikrein-8,25538,42,1.77 [0.85-3.68],0.1291617929693584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLKB1,Plasma kallikrein,22522,35,2.76 [0.86-8.89],0.0894705543283876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,26732,42,11.43 [6.42-20.33],1.1316683632684775e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,22212,34,0.54 [0.24-1.20],0.1289505250190264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,26732,42,2.99 [1.73-5.20],9.627507710894772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,22293,36,2.15 [1.59-2.92],8.154078389081715e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,22882,35,2.58 [1.66-4.02],2.7297094345753936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT14,"Keratin, type I cytoskeletal 14",24995,39,0.90 [0.37-2.18],0.8202663613479255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT17,"Keratin, type I cytoskeletal 17",22213,35,1.21 [0.54-2.69],0.6473799510796394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",26305,39,1.53 [1.17-2.00],0.0017503626398389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",26368,41,2.67 [1.99-3.58],5.5706148241100886e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT5,"Keratin, type II cytoskeletal 5",25812,41,0.57 [0.32-1.02],0.0598495375350154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT6C,"Keratin, type II cytoskeletal 6C",22213,35,0.81 [0.31-2.12],0.6739959574452516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",22212,34,1.47 [1.21-1.79],0.0001089540697927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,26363,40,0.85 [0.52-1.37],0.5046862705835755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYNU,Kynureninase,26732,42,1.31 [0.74-2.32],0.3555960050248364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L1CAM,Neural cell adhesion molecule L1,26490,42,2.07 [0.82-5.27],0.1252021506965528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,22945,37,1.22 [0.90-1.67],0.2059429580303995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACRT,Extracellular glycoprotein lacritin,22797,37,0.34 [0.12-0.99],0.047441193408131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACTB2,Endoribonuclease LACTB2,26416,40,0.96 [0.64-1.42],0.8269622135594198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,26305,39,2.50 [1.76-3.54],2.767863231148073e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,26400,39,2.84 [1.93-4.19],1.4032844266052444e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,26246,40,0.94 [0.72-1.23],0.6605334693925672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA1,Laminin subunit alpha-1,22213,35,1.25 [0.78-1.99],0.3560512781629691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA4,Laminin subunit alpha-4,26539,40,2.25 [1.19-4.26],0.0127925134210768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,22310,34,5.03 [1.75-14.45],0.0027237969599544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP1,Lysosome-associated membrane glycoprotein 1,22299,36,1.87 [1.24-2.81],0.0027905970437981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP2,Lysosome-associated membrane glycoprotein 2,25629,40,3.87 [0.99-15.16],0.0525071634123965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,26684,42,2.22 [1.37-3.61],0.0012877005249152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMTOR5,Ragulator complex protein LAMTOR5,22835,37,0.51 [0.21-1.27],0.1476654512270709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAP3,Cytosol aminopeptidase,25930,40,0.87 [0.46-1.63],0.6552280265294186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LARP1,La-related protein 1,22835,37,0.96 [0.58-1.61],0.8894157696217924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT,Linker for activation of T-cells family member 1,26732,42,1.08 [0.76-1.54],0.6606639723340777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT2,Linker for activation of T-cells family member 2,26305,39,1.02 [0.82-1.28],0.8304793920675146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LATS1,Serine/threonine-protein kinase LATS1,22293,36,1.17 [0.84-1.65],0.3560041311915541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,26203,40,4.13 [2.37-7.21],5.998160288450253e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBP,Lipopolysaccharide-binding protein,26487,40,1.27 [0.80-1.99],0.3101193518512045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBR,Delta(14)-sterol reductase LBR,26677,41,1.19 [0.85-1.66],0.3086601065985733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCAT,Phosphatidylcholine-sterol acyltransferase,22963,37,6.63 [1.52-28.96],0.0118568237012893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,22907,37,1.70 [1.24-2.32],0.0009658417123911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,25569,39,2.72 [1.63-4.54],0.0001235986855298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCP1,Plastin-2,22926,36,1.31 [0.71-2.43],0.3931569784358226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLR,Low-density lipoprotein receptor,26486,39,1.24 [0.72-2.13],0.4310838306053384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,22907,37,1.16 [0.86-1.57],0.3175204328137854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LECT2,Leukocyte cell-derived chemotaxin-2,22945,37,0.98 [0.60-1.59],0.9313885144235488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEFTY2,Left-right determination factor 2,26621,42,1.51 [0.93-2.46],0.0942824229286909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEG1,Protein LEG1 homolog,21640,36,1.23 [0.81-1.86],0.3371020694113904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LELP1,Late cornified envelope-like proline-rich protein 1,22212,34,0.98 [0.64-1.49],0.9126011203395422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEO1,RNA polymerase-associated protein LEO1,22907,37,1.60 [0.74-3.43],0.2301562155836374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEP,Leptin,26416,40,1.45 [0.93-2.26],0.101698714821483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEPR,Leptin receptor,26416,40,1.90 [0.86-4.22],0.1122593308755117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LETM1,Mitochondrial proton/calcium exchanger protein,22907,37,1.59 [0.98-2.56],0.0596088410744856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS1,Galectin-1,26416,40,1.69 [0.77-3.71],0.1907759719668099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3,Galectin-3,26478,38,1.78 [0.70-4.56],0.2256826345484381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,22968,36,2.92 [1.64-5.19],0.0002625067287367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,26400,39,5.05 [3.47-7.35],2.4211748585539467e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS7_LGALS7B,Galectin-7,26368,42,1.05 [0.54-2.03],0.8864339545785112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS8,Galectin-8,26677,41,0.90 [0.58-1.40],0.6511872972215965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,26401,40,5.51 [2.69-11.28],3.0820071481702773e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGMN,Legumain,26539,40,2.90 [1.48-5.66],0.0018407709587859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHB,Lutropin subunit beta,25789,40,0.99 [0.71-1.36],0.9330619791921534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,26455,40,0.61 [0.39-0.95],0.0277370861084138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIF,Leukemia inhibitory factor,25812,41,1.08 [0.69-1.68],0.7360337324501257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,26402,41,7.21 [3.90-13.33],2.8117944100986117e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,26404,41,2.44 [1.07-5.56],0.0330167145755302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,22926,36,1.00 [0.80-1.25],0.9824544010669696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,22213,35,0.68 [0.31-1.46],0.3202056950142228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,26384,40,4.22 [2.47-7.22],1.4386334399832168e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,22945,37,1.09 [0.71-1.67],0.6881389477082975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,26739,40,4.01 [1.44-11.11],0.0076443189679439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,26587,39,2.82 [1.15-6.89],0.0228538943144048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,25930,40,2.13 [1.16-3.89],0.0144879533090824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,26739,40,1.45 [0.92-2.29],0.1069308134032749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIPF,Gastric triacylglycerol lipase,22310,34,1.73 [1.17-2.55],0.0057308648460256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB1,Lamin-B1,22812,36,0.75 [0.43-1.31],0.3079520058315338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB2,Lamin-B2,22882,35,2.13 [0.80-5.69],0.1295931458570333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,22907,37,1.54 [0.87-2.70],0.1351157376646166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD2,Leiomodin-2,22212,34,0.70 [0.36-1.34],0.281381183153863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LONP1,"Lon protease homolog, mitochondrial",22310,34,1.25 [0.92-1.70],0.1501782332506312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPA,Apolipoprotein(a),22412,36,0.91 [0.76-1.08],0.2928270336277494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,26305,39,1.03 [0.56-1.90],0.9195921991361669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPL,Lipoprotein lipase,26416,40,0.47 [0.31-0.70],0.0002156765869356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,25579,39,3.54 [2.46-5.08],8.228681326426519e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPP,Lipoma-preferred partner,22213,35,1.10 [0.69-1.75],0.6804297475016403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,22213,35,1.31 [0.87-1.96],0.1945020093448538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,22304,36,0.51 [0.20-1.31],0.1608910373002415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRG1,Leucine-rich alpha-2-glycoprotein,22968,36,3.09 [1.03-9.32],0.0449198953968471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,26588,42,2.66 [1.28-5.52],0.0087035771108049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,22213,36,1.77 [0.77-4.04],0.178857235550696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,26305,39,0.54 [0.18-1.58],0.2583132377477431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,26416,40,3.83 [1.99-7.35],5.677667088624196e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2,Low-density lipoprotein receptor-related protein 2,22304,36,0.94 [0.39-2.24],0.8827539630933058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2BP,LRP2-binding protein,22304,36,0.85 [0.54-1.36],0.508174083892477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,26677,41,0.98 [0.61-1.58],0.9490853613303484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,26305,39,1.86 [0.98-3.55],0.0595062610249258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,22858,36,1.74 [0.83-3.64],0.1434922974627221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC38,Leucine-rich repeat-containing protein 38,22304,36,1.30 [0.75-2.26],0.3515120129236618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC59,Leucine-rich repeat-containing protein 59,22945,37,1.10 [0.65-1.87],0.7244071109744903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,22835,37,1.24 [0.71-2.18],0.4485427104252703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRN1,Leucine-rich repeat neuronal protein 1,25930,40,0.65 [0.47-0.92],0.0135349714123238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,22304,36,0.58 [0.24-1.44],0.2429633718129946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,22907,37,0.34 [0.09-1.33],0.12126419970592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,25789,40,0.93 [0.53-1.61],0.7908900454062252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,22529,37,0.80 [0.49-1.31],0.3827063919171619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSP1,Lymphocyte-specific protein 1,26402,41,0.79 [0.38-1.64],0.5297947355664461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA,Lymphotoxin-alpha,26402,41,1.06 [0.51-2.19],0.8798704051847692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA4H,Leukotriene A-4 hydrolase,26655,42,0.38 [0.22-0.66],0.0006784346506327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTB,Lymphotoxin-beta,22835,37,0.71 [0.24-2.08],0.5318851059685603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,26739,40,4.76 [2.36-9.61],1.2979037473984282e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,25789,40,1.50 [1.00-2.23],0.0479282662934654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,26253,39,4.52 [2.31-8.85],1.0532336387987146e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTO1,Protein LTO1 homolog,25930,40,0.70 [0.32-1.52],0.3689760126299304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LUZP2,Leucine zipper protein 2,22835,37,1.14 [0.57-2.25],0.7155693126414573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LXN,Latexin,26114,40,0.63 [0.39-1.00],0.052065733997238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY6D,Lymphocyte antigen 6D,26269,40,1.83 [0.98-3.43],0.058481678197024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY75,Lymphocyte antigen 75,26402,41,1.32 [0.63-2.75],0.4640780333522194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,26147,41,5.42 [2.35-12.52],7.600625431061443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,26246,40,3.18 [2.00-5.04],9.329466159519412e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYAR,Cell growth-regulating nucleolar protein,25789,40,0.82 [0.43-1.59],0.5641118418454351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYN,Tyrosine-protein kinase Lyn,26305,39,0.93 [0.67-1.29],0.6532343617332332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD1,Ly6/PLAUR domain-containing protein 1,25812,41,0.83 [0.48-1.43],0.4918278605873705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD3,Ly6/PLAUR domain-containing protein 3,26295,42,3.42 [1.66-7.04],0.0008424809578258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD8,Ly6/PLAUR domain-containing protein 8,25789,40,1.55 [1.03-2.34],0.0352322954000175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPLA2,Acyl-protein thioesterase 2,22212,34,0.67 [0.42-1.06],0.0846079197831585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,22304,36,0.81 [0.55-1.17],0.2620751850964631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,22968,36,3.14 [0.65-15.03],0.1527779617267771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYZL2,Lysozyme-like protein 2,22139,37,0.70 [0.30-1.67],0.4246507502468756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LZTFL1,Leucine zipper transcription factor-like protein 1,22429,37,1.08 [0.73-1.61],0.6998677277194988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,M6PR,Cation-dependent mannose-6-phosphate receptor,22310,34,0.66 [0.25-1.79],0.4186177799211278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,26166,40,1.39 [0.93-2.07],0.1077218297594866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAEA,E3 ubiquitin-protein transferase MAEA,25789,40,0.85 [0.40-1.81],0.6792326530078538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAG,Myelin-associated glycoprotein,22304,36,0.91 [0.45-1.83],0.7918613814995001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGEA3,Melanoma-associated antigen 3,22529,37,0.76 [0.59-0.99],0.0426719631277648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGED1,Melanoma-associated antigen D1,25789,40,0.93 [0.52-1.67],0.8057998891465813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC2,MAM domain-containing protein 2,22945,37,2.62 [1.18-5.80],0.0173876154070866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC4,Apical endosomal glycoprotein,22835,37,1.82 [1.13-2.94],0.0134048211745863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",22310,34,0.81 [0.22-2.95],0.7489892097910988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN2B2,Epididymis-specific alpha-mannosidase,22945,37,1.32 [0.77-2.28],0.3129006840039909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",22139,37,1.27 [0.70-2.29],0.4281731641636348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,26539,40,1.07 [0.85-1.36],0.5656769922640379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,26490,42,4.88 [2.25-10.57],5.818024276315303e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC4,MANSC domain-containing protein 4,22213,35,1.51 [0.97-2.35],0.0656879766406242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,22212,34,0.70 [0.24-2.01],0.5070372377266559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,22213,35,0.64 [0.29-1.42],0.2721082773369073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,22882,35,2.05 [1.21-3.47],0.0078194877418199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,22858,36,1.21 [0.76-1.91],0.4203504699464898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,26402,41,0.99 [0.76-1.30],0.954991500968093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,25789,40,0.99 [0.75-1.31],0.9379553930920336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,26203,40,0.96 [0.75-1.23],0.7497373811358261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK13,Mitogen-activated protein kinase 13,22139,37,1.35 [0.76-2.40],0.310504069605395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK9,Mitogen-activated protein kinase 9,26402,41,1.04 [0.54-1.98],0.908693449185552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPKAPK2,MAP kinase-activated protein kinase 2,22529,37,0.96 [0.64-1.45],0.8554634804644206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,22139,37,0.99 [0.80-1.23],0.940292285253887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPT,Microtubule-associated protein tau,25812,41,1.16 [0.66-2.05],0.601340443751224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARCO,Macrophage receptor MARCO,26416,40,2.30 [0.75-7.08],0.1458640742239669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",22382,36,1.17 [0.83-1.66],0.3629150066336151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MASP1,Mannan-binding lectin serine protease 1,26203,40,3.81 [1.23-11.76],0.0202158105815894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN2,Matrilin-2,26448,39,2.39 [0.97-5.92],0.0590268534837572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN3,Matrilin-3,26202,40,0.40 [0.17-0.90],0.0279892088546102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAVS,Mitochondrial antiviral-signaling protein,25789,40,1.00 [0.74-1.34],0.9963298421259472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAX,Protein max,25812,41,1.05 [0.82-1.35],0.7027141799687904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MB,Myoglobin,26739,40,1.14 [0.75-1.75],0.5430067642784973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MBL2,Mannose-binding protein C,22636,36,1.19 [0.89-1.61],0.2438797108066961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCAM,Cell surface glycoprotein MUC18,26487,40,1.18 [0.51-2.70],0.6977401408636341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",22907,37,0.65 [0.29-1.48],0.309167048675849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEMP1,Mast cell-expressed membrane protein 1,22293,36,1.50 [1.11-2.02],0.0084524477558027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCFD2,Multiple coagulation factor deficiency protein 2,26308,40,1.48 [0.84-2.60],0.1781376360744417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCTS1,Malignant T-cell-amplified sequence 1,22858,36,2.14 [0.93-4.93],0.0741989085927714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,26246,40,1.33 [0.90-1.96],0.1578331212465943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDH1,"Malate dehydrogenase, cytoplasmic",22835,37,0.85 [0.39-1.82],0.6694409369028655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,26402,42,1.72 [1.25-2.36],0.0008288045319292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDM1,Nuclear protein MDM1,22304,36,0.69 [0.25-1.87],0.4636956789856515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",22310,34,1.14 [0.84-1.55],0.3847507682764004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED18,Mediator of RNA polymerase II transcription subunit 18,25789,40,1.01 [0.71-1.44],0.9584102467903632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED21,Mediator of RNA polymerase II transcription subunit 21,22213,35,0.54 [0.21-1.38],0.1992473814091113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,26400,39,1.65 [0.81-3.35],0.1658867335260788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,22213,35,0.66 [0.20-2.17],0.4916270680966802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,26640,40,1.78 [0.79-4.04],0.1654613545255274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MELTF,Melanotransferrin,22945,37,0.86 [0.28-2.63],0.7966418856691149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,22429,37,0.40 [0.20-0.77],0.0060270813456797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1A,Meprin A subunit alpha,22858,36,1.43 [0.98-2.10],0.0660362310690516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1B,Meprin A subunit beta,26416,40,0.95 [0.75-1.20],0.6438128750949617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEPE,Matrix extracellular phosphoglycoprotein,26400,39,0.37 [0.14-0.93],0.0353452757318756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MERTK,Tyrosine-protein kinase Mer,26732,42,1.73 [0.59-5.09],0.3208741160136231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MESD,LRP chaperone MESD,26404,41,1.01 [0.82-1.25],0.9224186209765008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MET,Hepatocyte growth factor receptor,26490,38,0.52 [0.27-1.01],0.0542201169203319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1,Methionine aminopeptidase 1,25812,41,0.51 [0.18-1.44],0.2058688745554369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",26402,41,1.08 [0.80-1.46],0.6058714200516838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP2,Methionine aminopeptidase 2,26621,42,1.00 [0.62-1.60],0.9898699518509192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3,Microfibril-associated glycoprotein 3,25946,40,1.18 [0.68-2.05],0.5512294157775327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3L,Microfibrillar-associated protein 3-like,22304,36,0.38 [0.16-0.91],0.0291775122477434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,22429,37,5.26 [2.07-13.38],0.0004958503346848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP5,Microfibrillar-associated protein 5,26739,40,1.70 [0.88-3.29],0.1115263822164973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,26404,41,4.15 [2.75-6.26],1.3276609377119167e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGLL,Monoglyceride lipase,26498,40,1.07 [0.78-1.47],0.6718579998416129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,26402,41,1.04 [0.83-1.32],0.7290457139515367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIA,Melanoma-derived growth regulatory protein,26490,42,0.62 [0.29-1.30],0.2014078666362526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICALL2,MICAL-like protein 2,22304,36,1.04 [0.66-1.62],0.8709243974053225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,26402,41,1.18 [0.91-1.52],0.2050283117861045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIF,Macrophage migration inhibitory factor,26360,41,0.92 [0.62-1.36],0.6637001186915528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,25930,40,2.18 [1.34-3.53],0.0016564446099971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,22835,37,1.09 [0.82-1.44],0.5424874486040702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINK1,Misshapen-like kinase 1,22882,35,1.15 [0.82-1.61],0.4108589217337354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MITD1,MIT domain-containing protein 1,26246,40,0.97 [0.73-1.29],0.8397889773592171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MKI67,Proliferation marker protein Ki-67,22293,36,0.73 [0.28-1.87],0.509845609613705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLLT1,Protein ENL,22139,37,0.84 [0.49-1.44],0.52602101301757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLN,Promotilin,26402,41,1.57 [1.15-2.15],0.0049993405791294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,26305,39,1.45 [1.04-2.03],0.0295598413525383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP1,Interstitial collagenase,25465,40,1.43 [1.03-1.99],0.0350912604848987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,26375,39,2.00 [1.36-2.96],0.0004920956928761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,26461,42,2.91 [1.88-4.51],1.889151719573524e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP13,Collagenase 3,25812,41,1.56 [0.64-3.83],0.3279462679434765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP15,Matrix metalloproteinase-15,22945,37,0.57 [0.21-1.54],0.2694663583406598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP3,Stromelysin-1,26404,41,1.07 [0.61-1.87],0.8237870961192888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,25904,40,3.23 [1.83-5.70],5.015272480337816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP8,Neutrophil collagenase,26638,41,1.22 [0.85-1.74],0.2799557548539129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP9,Matrix metalloproteinase-9,26367,41,1.29 [0.82-2.03],0.2731016534862076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",22213,35,1.05 [0.57-1.93],0.8693178236417456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MN1,Transcriptional activator MN1,22304,36,0.45 [0.20-0.99],0.0458863344169339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNAT1,CDK-activating kinase assembly factor MAT1,22529,37,0.71 [0.33-1.52],0.3773122962637955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNDA,Myeloid cell nuclear differentiation antigen,26382,40,0.95 [0.70-1.28],0.7327616190468615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOCS2,Molybdopterin synthase catalytic subunit,22429,37,1.36 [0.89-2.10],0.1593039621590882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOG,Myelin-oligodendrocyte glycoprotein,26655,42,1.15 [0.51-2.58],0.7311723549911622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORC3,MORC family CW-type zinc finger protein 3,22882,35,0.96 [0.33-2.80],0.939054527777992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L1,Mortality factor 4-like protein 1,22529,37,1.29 [0.69-2.42],0.4299883076626235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L2,Mortality factor 4-like protein 2,22139,37,1.30 [0.64-2.64],0.4698911479033656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORN4,MORN repeat-containing protein 4,22139,37,0.95 [0.64-1.41],0.7937194850097623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPHOSPH8,M-phase phosphoprotein 8,25946,40,0.98 [0.68-1.41],0.9157067812752412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPI,Mannose-6-phosphate isomerase,26305,39,0.99 [0.72-1.36],0.9573663979878164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,26498,40,1.32 [0.87-1.99],0.1950359786443699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPO,Myeloperoxidase,26404,41,1.26 [0.70-2.25],0.4407603164810063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPRIP,Myosin phosphatase Rho-interacting protein,22798,37,1.08 [0.54-2.17],0.8324388420020592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,22963,37,9.70 [4.26-22.12],6.489862661589336e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRI1,Methylthioribose-1-phosphate isomerase,22304,36,0.79 [0.49-1.27],0.328893384542529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL24,"39S ribosomal protein L24, mitochondrial",22213,35,0.52 [0.18-1.47],0.2162079285224513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL28,"39S ribosomal protein L28, mitochondrial",22907,37,0.89 [0.31-2.54],0.8259655045392023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL46,"39S ribosomal protein L46, mitochondrial",25812,41,1.37 [0.54-3.46],0.5024438837636791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL52,"39S ribosomal protein L52, mitochondrial",22102,37,3.15 [1.51-6.54],0.0021172116224173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",22907,37,1.17 [0.81-1.68],0.4081134946174438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPS16,"28S ribosomal protein S16, mitochondrial",22293,36,0.90 [0.31-2.62],0.8511276817595614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,26269,39,1.85 [1.21-2.84],0.0046019103996471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLNL,Mesothelin-like protein,22304,36,0.77 [0.29-2.07],0.6059606316183492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSMB,Beta-microseminoprotein,26337,37,1.35 [0.95-1.93],0.0935810303454401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,26677,41,3.92 [2.38-6.44],7.624692348994198e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,26490,42,0.96 [0.67-1.37],0.8098603033058684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MST1,Hepatocyte growth factor-like protein,22626,36,1.33 [0.69-2.58],0.3982080904591206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSTN,Growth/differentiation factor 8,25946,40,0.66 [0.39-1.11],0.1180945223180034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTDH,Protein LYRIC,22293,36,1.16 [0.85-1.58],0.3454846747349472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",22882,35,0.85 [0.25-2.93],0.7967078891836638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,22529,37,1.22 [0.94-1.57],0.1350060035302864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",22858,36,1.13 [0.83-1.55],0.4321843961519398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTPN,Myotrophin,25946,40,0.47 [0.17-1.30],0.1469403148973274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTR,Methionine synthase,22213,35,0.50 [0.24-1.04],0.0632255937068553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS1,Protein MTSS 1,22858,36,1.30 [0.98-1.72],0.066437749337509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS2,Protein MTSS 2,22835,37,1.16 [0.86-1.57],0.3224599557026169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTUS1,Microtubule-associated tumor suppressor 1,22529,37,0.85 [0.48-1.51],0.5756549341436559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,25812,41,7.16 [4.95-10.35],1.5995250650694096e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC16,Mucin-16,26305,39,0.96 [0.82-1.11],0.5514684193633264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC2,Mucin-2,22926,36,1.35 [0.96-1.89],0.0868424013399368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUCL3,Mucin-like protein 3,22139,37,1.18 [0.64-2.19],0.5981976956256174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,25930,40,1.57 [1.17-2.09],0.0022566757470357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MXRA8,Matrix remodeling-associated protein 8,22429,37,0.50 [0.31-0.80],0.0038044874893579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",22945,37,1.66 [1.18-2.32],0.0033366977140453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC2,"Myosin-binding protein C, fast-type",22310,34,1.08 [0.74-1.57],0.7035966508863154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,22907,37,1.26 [0.84-1.89],0.2720728969565038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYDGF,Myeloid-derived growth factor,22945,37,1.23 [0.92-1.65],0.1604080369912553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH4,Myosin-4,22213,35,0.41 [0.15-1.07],0.0683104796451846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH7B,Myosin-7B,22139,37,0.67 [0.28-1.59],0.3612172821598771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH9,Myosin-9,22926,36,1.34 [1.02-1.76],0.0332296175361078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",22213,35,1.22 [0.73-2.02],0.4465982649890698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,22310,34,1.70 [1.16-2.51],0.0070756643075442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL4,Myosin light chain 4,22310,34,0.95 [0.53-1.68],0.8557314313761849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL6B,Myosin light chain 6B,22304,36,0.72 [0.46-1.13],0.1592500192064708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",22304,36,0.79 [0.42-1.49],0.4730438363620062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO6,Unconventional myosin-VI,22907,37,1.26 [0.63-2.53],0.5180050547336309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO9B,Unconventional myosin-IXb,25930,40,0.94 [0.61-1.45],0.7927907751353823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOC,Myocilin,26404,41,0.69 [0.38-1.25],0.2206188545209806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM1,Myomesin-1,22212,34,1.04 [0.51-2.12],0.9172950549958148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM2,Myomesin-2,22213,35,1.30 [0.75-2.26],0.3452081408263699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM3,Myomesin-3,22429,37,1.34 [0.99-1.82],0.0613965385156564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,26489,39,2.04 [1.25-3.33],0.0042544716703749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZT1,Mitotic-spindle organizing protein 1,25789,40,0.95 [0.56-1.61],0.8390308217487575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA10,N-alpha-acetyltransferase 10,22213,35,0.81 [0.47-1.40],0.4483240847567113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA80,N-alpha-acetyltransferase 80,22304,36,1.15 [0.90-1.47],0.2640183878848585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,26114,40,0.54 [0.32-0.90],0.0178528100672792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NACC1,Nucleus accumbens-associated protein 1,22835,37,1.18 [0.71-1.96],0.5177729425164811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NADK,NAD kinase,26416,40,0.83 [0.47-1.46],0.5115905417256784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGA,Alpha-N-acetylgalactosaminidase,22260,35,1.00 [0.57-1.76],0.9918800401304896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGK,N-acetyl-D-glucosamine kinase,22268,34,0.63 [0.35-1.13],0.1231259751755302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,22429,37,4.69 [1.17-18.83],0.029451260790437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAMPT,Nicotinamide phosphoribosyltransferase,25789,40,0.87 [0.48-1.56],0.6343092743704182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAP1L4,Nucleosome assembly protein 1-like 4,22821,36,0.91 [0.43-1.91],0.8001896753897925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAPRT,Nicotinate phosphoribosyltransferase,22882,35,0.61 [0.22-1.65],0.3278664702109855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",22907,37,1.32 [0.67-2.60],0.4152942450636251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,26490,42,5.39 [2.44-11.89],3.0154382281386088e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBN,Nibrin,25930,40,0.83 [0.44-1.54],0.5501392424462693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM1,Neural cell adhesion molecule 1,26487,40,0.56 [0.24-1.34],0.1937906646838033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM2,Neural cell adhesion molecule 2,26404,41,0.40 [0.14-1.14],0.0858298966825891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,26677,41,0.55 [0.40-0.76],0.0002673403746825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCF2,Neutrophil cytosol factor 2,26352,40,0.70 [0.47-1.04],0.0745171134204347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCK2,Cytoplasmic protein NCK2,26539,40,1.05 [0.83-1.35],0.6705563431731658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCLN,Nicalin,25930,40,0.81 [0.41-1.60],0.5478412170501179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,26366,41,3.53 [1.72-7.25],0.0005937139972682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,22858,36,3.36 [1.59-7.11],0.0015452513916193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,26655,42,3.54 [1.36-9.20],0.0095182397355488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDRG1,Protein NDRG1,25812,41,0.76 [0.45-1.30],0.3216127232939327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,22835,37,0.99 [0.57-1.74],0.9733543033801674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,22247,36,1.77 [0.86-3.65],0.1221597282394201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,22858,36,1.25 [0.93-1.70],0.1425963833948311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",25789,40,1.06 [0.76-1.49],0.7251560886554183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEB,Nebulin,22213,35,1.09 [0.46-2.55],0.850461057938365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECAP2,Adaptin ear-binding coat-associated protein 2,22213,35,1.06 [0.67-1.68],0.799269162687652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN1,Nectin-1,22293,36,0.61 [0.20-1.86],0.3864367092968849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,26384,40,6.53 [3.45-12.35],8.141861970096198e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,26490,42,2.83 [1.71-4.66],4.734283316360162e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,22293,36,1.00 [0.52-1.94],0.9977274789649244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD9,Enhancer of filamentation 1,22293,36,0.51 [0.16-1.63],0.2547133385400297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,25729,40,1.32 [1.05-1.65],0.0161022732910908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEK7,Serine/threonine-protein kinase Nek7,22529,37,1.00 [0.66-1.51],0.9909049916178664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,26490,42,0.31 [0.17-0.56],0.0001556310941688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL2,Protein kinase C-binding protein NELL2,26539,40,1.61 [0.60-4.32],0.3464690351421473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NENF,Neudesin,22835,37,0.98 [0.73-1.31],0.8791847257174726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEO1,Neogenin,22907,37,2.13 [0.79-5.74],0.1355926568171798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEXN,Nexilin,22963,37,1.05 [0.69-1.61],0.8059176203545515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,26732,42,27.39 [12.93-58.04],5.663620191892571e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFAT5,Nuclear factor of activated T-cells 5,22293,36,1.12 [0.79-1.59],0.51468133149535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",26402,41,1.07 [0.82-1.41],0.6074952884973388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",25930,40,1.72 [1.17-2.53],0.0055666765057614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFE2,Transcription factor NF-E2 45 kDa subunit,22310,34,1.08 [0.71-1.64],0.7146760344526593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFIC,Nuclear factor 1 C-type,22907,37,0.96 [0.46-2.00],0.9144591528690532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,22213,35,1.18 [0.79-1.75],0.4225947460496835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,22529,37,1.04 [0.58-1.85],0.8920437097963745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKBIE,NF-kappa-B inhibitor epsilon,25789,40,1.12 [0.65-1.92],0.6839318890312678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",22858,36,1.16 [0.88-1.53],0.2906176945338982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFX1,Transcriptional repressor NF-X1,22213,35,1.19 [0.75-1.89],0.4609286592368792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFYA,Nuclear transcription factor Y subunit alpha,22213,35,0.68 [0.26-1.78],0.4367434520194186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGF,Beta-nerve growth factor,26246,40,1.33 [0.16-11.32],0.7919536239153752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGFR,Tumor necrosis factor receptor superfamily member 16,22945,37,1.92 [1.02-3.60],0.0428064577359972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,22882,35,2.27 [0.93-5.56],0.0719941031697541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,21913,35,6.47 [2.39-17.49],0.0002333875550107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID1,Nidogen-1,26412,40,1.83 [0.90-3.70],0.0935101470183185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID2,Nidogen-2,26404,41,1.17 [0.82-1.66],0.3808361906188042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NINJ1,Ninjurin-1,25789,40,1.17 [0.73-1.86],0.5132068094824044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT1,Deaminated glutathione amidase,22310,34,0.69 [0.33-1.45],0.3282347291626553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT2,Omega-amidase NIT2,22857,37,1.32 [0.88-2.00],0.1804588095548512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN1,Neuroligin-1,22304,36,1.32 [0.92-1.87],0.1277424705675966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN2,Neuroligin-2,22212,34,0.59 [0.23-1.49],0.2627358102090569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME1,Nucleoside diphosphate kinase A,22293,36,1.31 [0.30-5.72],0.7221887880628826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME3,Nucleoside diphosphate kinase 3,26448,39,1.20 [0.38-3.80],0.761954551500166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMI,N-myc-interactor,22739,36,0.87 [0.57-1.31],0.4946399076033867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,26246,40,0.80 [0.51-1.25],0.3335725599033878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMRK2,Nicotinamide riboside kinase 2,22139,37,0.77 [0.29-2.06],0.6036513600666618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,22907,37,0.89 [0.54-1.47],0.653796977280627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,26404,41,5.12 [3.09-8.48],2.2350874317218648e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOP56,Nucleolar protein 56,22213,35,0.94 [0.69-1.28],0.6966877059386881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",25812,41,1.37 [0.86-2.19],0.1851623255613469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS2,"Nitric oxide synthase, inducible",22213,35,0.72 [0.29-1.77],0.475573767853093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",25812,41,1.85 [1.35-2.53],0.0001112482058321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,26739,40,13.31 [2.59-68.38],0.0019327356476598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH2,Neurogenic locus notch homolog protein 2,22926,36,2.71 [0.78-9.41],0.1162357618765176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH3,Neurogenic locus notch homolog protein 3,26739,40,0.96 [0.43-2.12],0.92028074990153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPC2,NPC intracellular cholesterol transporter 2,22544,36,4.16 [2.50-6.94],4.28447479701895e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,26416,40,2.53 [1.44-4.45],0.0013138779430362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS1,Nephrin,22293,36,0.71 [0.26-1.94],0.5006078227922288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS2,Podocin,22293,36,0.99 [0.72-1.35],0.9321818588350952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPL,N-acetylneuraminate lyase,22945,37,2.02 [1.11-3.68],0.020980803617307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,25946,40,1.44 [1.14-1.83],0.002266420795879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPC,C-type natriuretic peptide,26402,41,1.50 [0.97-2.34],0.0692994021640537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPR1,Atrial natriuretic peptide receptor 1,22213,35,0.33 [0.10-1.09],0.0691543326367851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTN,Neuroplastin,25789,40,1.16 [0.87-1.54],0.3088139986596185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX1,Neuronal pentraxin-1,26404,41,1.08 [0.56-2.08],0.8116470607756099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX2,Neuronal pentraxin-2,22926,36,0.45 [0.19-1.12],0.0851901991329871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTXR,Neuronal pentraxin receptor,26416,40,0.63 [0.43-0.92],0.016546929280195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,26655,42,4.31 [2.65-7.01],4.2617637444971036e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,26416,40,7.68 [3.60-16.35],1.259098054878579e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRGN,Neurogranin,22963,37,1.11 [0.81-1.52],0.5138806053079286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRN1,Neuritin,22907,37,1.04 [0.42-2.57],0.938730447666053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,26539,40,2.26 [0.86-5.91],0.0974177467069852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP2,Neuropilin-2,26404,41,0.62 [0.23-1.70],0.3521367129693977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRTN,Neurturin,25930,40,0.81 [0.44-1.47],0.4860041254587943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRXN3,Neurexin-3,22304,36,0.64 [0.23-1.81],0.4037405642976787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NSFL1C,NSFL1 cofactor p47,26677,41,0.76 [0.50-1.15],0.1887792473894494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",22945,37,0.94 [0.64-1.39],0.7645603067479301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,22882,35,2.20 [1.37-3.54],0.0011359630899709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,26354,41,0.80 [0.59-1.08],0.1450713913615405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5E,5'-nucleotidase,26490,42,1.62 [1.07-2.47],0.022931259166344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF3,Neurotrophin-3,26402,41,2.03 [1.05-3.92],0.0341980821704456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF4,Neurotrophin-4,25789,40,0.87 [0.49-1.56],0.6361554568199794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK2,BDNF/NT-3 growth factors receptor,26416,40,0.71 [0.23-2.24],0.5640683214702233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK3,NT-3 growth factor receptor,26677,41,0.51 [0.29-0.90],0.0196667029484918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,26416,40,1.65 [1.30-2.09],3.058547540616592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUB1,NEDD8 ultimate buster 1,26402,41,1.04 [0.76-1.42],0.8217329950905377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,22835,37,0.96 [0.69-1.34],0.8070028418095969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,26619,42,2.43 [1.35-4.37],0.0030459473963226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDC,Nuclear migration protein nudC,26732,42,1.14 [0.74-1.76],0.5592456592356789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,22310,34,0.78 [0.41-1.46],0.4348664045506127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,22213,35,0.64 [0.28-1.47],0.2925573292581579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT16,U8 snoRNA-decapping enzyme,22824,36,1.18 [0.85-1.64],0.3148015628973763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],26305,39,0.51 [0.29-0.88],0.016615894250636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT5,ADP-sugar pyrophosphatase,26404,41,1.14 [0.68-1.91],0.6167972585783876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUMB,Protein numb homolog,22293,36,1.21 [0.83-1.77],0.31757467401156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUP50,Nuclear pore complex protein Nup50,22213,35,0.96 [0.32-2.86],0.944510625642419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPE4,NXPE family member 4,22213,35,0.34 [0.09-1.27],0.1095681761336108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH1,Neurexophilin-1,25812,41,0.51 [0.24-1.08],0.0795368270469152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH3,Neurexophilin-3,22293,36,0.82 [0.28-2.38],0.7187837169079079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OBP2B,Odorant-binding protein 2b,26153,40,0.70 [0.45-1.08],0.1082782949944329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,22907,37,2.55 [1.32-4.94],0.005402435038923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ODAM,Odontogenic ameloblast-associated protein,25763,41,0.95 [0.55-1.65],0.8548002212267998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OFD1,Oral-facial-digital syndrome 1 protein,22529,37,0.83 [0.48-1.45],0.5165726516701293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGA,Protein O-GlcNAcase,22858,36,1.32 [0.87-2.01],0.1914392691743149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGFR,Opioid growth factor receptor,26305,39,0.77 [0.32-1.85],0.5580932568116537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,26404,41,1.96 [1.07-3.59],0.0291888001387844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,22529,37,0.79 [0.44-1.41],0.4233740811191852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,21598,33,1.48 [1.12-1.97],0.0059421598916927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLR1,Oxidized low-density lipoprotein receptor 1,26156,40,1.24 [0.82-1.89],0.3089274756381543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,26539,40,0.69 [0.52-0.93],0.0130533117159792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMG,Oligodendrocyte-myelin glycoprotein,26305,39,0.71 [0.48-1.06],0.0921217451101629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMP,Olfactory marker protein,22212,34,0.88 [0.43-1.81],0.7374667474520948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPHN1,Oligophrenin-1,22882,35,1.20 [0.89-1.60],0.2264837629509589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPLAH,5-oxoprolinase,22310,34,1.18 [0.74-1.88],0.483371779999755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPTC,Opticin,26305,39,0.52 [0.25-1.05],0.0691783518058826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ORM1,Alpha-1-acid glycoprotein 1,22889,36,3.31 [0.78-14.14],0.1054370488550182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSBPL2,Oxysterol-binding protein-related protein 2,22882,35,0.95 [0.44-2.05],0.9041165054599808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,26448,39,3.77 [1.58-9.04],0.00289152343844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSM,Oncostatin-M,26266,41,1.43 [0.98-2.07],0.0631141204943038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSMR,Oncostatin-M-specific receptor subunit beta,26539,40,2.74 [0.66-11.34],0.1633732529016275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSTN,Osteocrin,22304,36,0.67 [0.25-1.83],0.4330418535793521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTOA,Otoancorin,22212,34,1.42 [0.96-2.10],0.0829238117992231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD6B,Deubiquitinase OTUD6B,22858,36,1.07 [0.64-1.78],0.8033068795471272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD7B,OTU domain-containing protein 7B,22907,37,1.39 [0.89-2.18],0.1495745023545482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",22310,34,1.12 [0.74-1.68],0.5986600224399468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXT,Oxytocin-neurophysin 1,26677,41,1.48 [1.20-1.81],0.0001799366556121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,P4HB,Protein disulfide-isomerase,26282,42,1.95 [1.02-3.74],0.0449064355292664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PACS2,Phosphofurin acidic cluster sorting protein 2,22213,35,1.11 [0.69-1.80],0.6614345464169471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI2,Protein-arginine deiminase type-2,25930,40,1.20 [0.79-1.83],0.3897466192040458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI4,Protein-arginine deiminase type-4,25763,41,0.69 [0.45-1.07],0.0942343275403868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAEP,Glycodelin,26246,40,1.02 [0.81-1.30],0.8469059024498361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,22907,37,1.00 [0.77-1.31],0.9865498770950536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",22529,37,1.04 [0.59-1.86],0.8827634167837244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,25946,40,1.72 [1.15-2.58],0.0087832839751451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,22310,34,0.54 [0.22-1.29],0.1651565470487249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,22095,37,1.58 [0.97-2.57],0.0633051878456108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAK4,Serine/threonine-protein kinase PAK 4,25812,41,1.14 [0.76-1.72],0.5176757692564631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALLD,Palladin,22293,36,0.82 [0.32-2.12],0.6843628164845507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,22739,36,3.13 [1.25-7.81],0.0146063462705985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,22882,35,3.98 [2.27-6.97],1.3358548180952247e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM3,Paralemmin-3,22213,35,0.81 [0.47-1.39],0.4489466281963733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,26605,39,0.82 [0.28-2.39],0.7162507964142477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAMR1,Inactive serine protease PAMR1,26404,41,3.09 [1.12-8.58],0.0300413566588167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAPPA,Pappalysin-1,25930,40,0.58 [0.32-1.05],0.0732529105061085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARD3,Partitioning defective 3 homolog,22529,37,1.12 [0.77-1.63],0.5405454760257105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARK7,Parkinson disease protein 7,26404,41,0.85 [0.52-1.40],0.5276613846960805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARP1,Poly [ADP-ribose] polymerase 1,26402,41,1.08 [0.70-1.66],0.729937115452384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAXX,Protein PAXX,22429,37,1.30 [0.71-2.36],0.3929130902810244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,22139,37,0.63 [0.23-1.76],0.3822337261145576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBLD,Phenazine biosynthesis-like domain-containing protein,25812,41,0.95 [0.56-1.61],0.8541441795738431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,22858,36,1.33 [0.51-3.51],0.5595800670612021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCARE,Photoreceptor cilium actin regulator,22212,34,1.05 [0.73-1.50],0.7980236088584131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,22380,37,1.21 [0.66-2.21],0.530636136783404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBP2,Poly(rC)-binding protein 2,22907,37,1.10 [0.74-1.65],0.638508277880207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH1,Protocadherin-1,26648,42,2.06 [0.76-5.60],0.1545494768828944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH12,Protocadherin-12,22907,37,1.30 [0.41-4.15],0.6601548004544525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,26416,40,3.94 [2.02-7.68],5.690904166039988e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH7,Protocadherin-7,22858,36,1.20 [0.51-2.82],0.6824216839095262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH9,Protocadherin-9,22858,36,4.05 [1.59-10.28],0.0032929988246246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDHB15,Protocadherin beta-15,22835,37,1.47 [0.75-2.88],0.2557295445558503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCNA,Proliferating cell nuclear antigen,22139,37,0.89 [0.50-1.57],0.6795000996110303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,22835,37,0.83 [0.45-1.55],0.5638435997693008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,26739,40,4.18 [2.21-7.89],1.0532908852361629e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,22858,36,1.10 [0.73-1.66],0.6393248356797356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,22945,37,1.13 [0.83-1.52],0.4449781254734678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,26614,42,2.16 [1.26-3.72],0.005295580179131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,26305,39,3.66 [1.98-6.79],3.637183166567653e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD5,Programmed cell death protein 5,26677,41,0.96 [0.61-1.50],0.8586026852109603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD6,Programmed cell death protein 6,26416,40,1.70 [1.01-2.88],0.0478349391109013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCL2,Phosducin-like protein 2,22139,37,1.35 [0.82-2.23],0.2417032749253478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",22139,37,1.20 [0.79-1.81],0.3905463669515501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",22213,35,0.41 [0.16-1.07],0.067744026211502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",22429,37,1.22 [0.90-1.66],0.2033522708061907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFA,Platelet-derived growth factor subunit A,26739,40,1.52 [1.04-2.22],0.0305143782785799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFB,Platelet-derived growth factor subunit B,26539,40,1.56 [1.12-2.17],0.0087442854763326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFC,Platelet-derived growth factor C,25789,40,2.08 [0.97-4.44],0.059725787525881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,26416,40,2.45 [0.97-6.17],0.0580792241653268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRB,Platelet-derived growth factor receptor beta,26739,40,1.18 [0.53-2.63],0.6797506638801192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA2,Protein disulfide-isomerase A2,22139,37,1.06 [0.47-2.38],0.8820592025150391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA3,Protein disulfide-isomerase A3,22429,37,1.87 [0.83-4.20],0.1294338866457902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA4,Protein disulfide-isomerase A4,22926,36,1.18 [0.75-1.86],0.4775820654314863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA5,Protein disulfide-isomerase A5,22139,37,1.43 [0.95-2.15],0.0837684365315667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM5,PDZ and LIM domain protein 5,22907,37,1.05 [0.80-1.37],0.7292582812810926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM7,PDZ and LIM domain protein 7,26539,40,1.03 [0.83-1.27],0.8074059426167599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",25789,40,1.19 [0.72-1.98],0.4944627659188404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDRG1,p53 and DNA damage-regulated protein 1,22304,36,0.56 [0.24-1.27],0.1623206945799875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,22139,37,0.85 [0.38-1.92],0.6967174257663922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZD2,PDZ domain-containing protein 2,22213,35,0.92 [0.53-1.60],0.7633847383985473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,22293,36,2.08 [1.26-3.44],0.0042101595208128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEAR1,Platelet endothelial aggregation receptor 1,26739,40,1.97 [0.61-6.42],0.2596324009504192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEBP1,Phosphatidylethanolamine-binding protein 1,26404,41,0.86 [0.54-1.36],0.5188596447398295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECAM1,Platelet endothelial cell adhesion molecule,26404,41,1.81 [0.79-4.17],0.1617612342248709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,22310,34,0.74 [0.23-2.38],0.6105520707069658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,22429,37,3.57 [1.87-6.81],0.0001125711666706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEPD,Xaa-Pro dipeptidase,22963,37,0.64 [0.19-2.16],0.4723134125259687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PER3,Period circadian protein homolog 3,22293,36,1.35 [1.06-1.73],0.0163635670353335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PF4,Platelet factor 4,22795,36,1.41 [1.04-1.91],0.0261150504903939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN2,Prefoldin subunit 2,25812,41,0.83 [0.51-1.35],0.4502380770999682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN4,Prefoldin subunit 4,22139,37,1.18 [0.69-2.01],0.553042685844298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN6,Prefoldin subunit 6,22304,36,1.28 [0.83-1.96],0.2580982969018285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",26269,39,0.72 [0.49-1.06],0.0919201582548442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGA4,Pepsin A-4,22963,37,3.04 [2.09-4.41],6.046542612641521e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",22945,37,1.13 [0.64-2.01],0.6646771630282875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,26732,42,3.33 [1.96-5.65],8.825837997025261e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,26587,39,2.68 [1.62-4.44],0.0001285928626524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,22666,36,5.21 [1.77-15.34],0.0027592580447953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP4,Peptidoglycan recognition protein 4,22213,35,1.08 [0.62-1.85],0.7937677134773282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGM2,Phosphoglucomutase-2,22304,36,1.13 [0.71-1.78],0.6057290838333834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGR,Progesterone receptor,22293,36,0.81 [0.53-1.23],0.3274008319298493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHACTR2,Phosphatase and actin regulator 2,22907,37,1.15 [0.89-1.49],0.2770926483375269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB1,Pleckstrin homology-like domain family B member 1,22858,36,1.82 [1.06-3.11],0.030161473556968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB2,Pleckstrin homology-like domain family B member 2,22139,37,1.08 [0.79-1.47],0.6285681269877237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,26246,40,2.38 [0.98-5.80],0.0566399501931442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,22429,37,1.44 [0.71-2.92],0.3184820891872365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI16,Peptidase inhibitor 16,22963,37,1.09 [0.29-4.10],0.8991072764899695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,26036,38,1.90 [1.32-2.74],0.0005444398098959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",22907,37,1.07 [0.74-1.55],0.7086011900146316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,26072,40,3.15 [1.81-5.46],4.565237014764343e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,26402,41,0.81 [0.51-1.29],0.3810758865546885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,26404,41,4.12 [2.30-7.36],1.8074607043045327e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,22293,36,0.96 [0.55-1.65],0.8708634638202749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,26404,41,3.91 [2.28-6.73],7.803314539542503e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,26416,40,3.26 [1.85-5.75],4.55973764997816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,22429,37,0.71 [0.46-1.10],0.1291668714427796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PITHD1,PITH domain-containing protein 1,22095,37,1.01 [0.67-1.53],0.9612903895884488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,22945,37,10.57 [3.58-31.16],1.926832683623349e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD2,Polycystin-2,22213,35,1.40 [0.89-2.20],0.1435794300587926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKLR,Pyruvate kinase PKLR,26448,40,0.79 [0.51-1.24],0.3106948728026451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKN3,Serine/threonine-protein kinase N3,22529,37,1.13 [0.76-1.68],0.5314609514856323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G10,Group 10 secretory phospholipase A2,26246,40,1.40 [0.89-2.21],0.1487748457307925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,26490,42,3.92 [1.63-9.39],0.0022160606405596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G1B,Phospholipase A2,26690,40,1.23 [0.63-2.39],0.5444079982284867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G2A,"Phospholipase A2, membrane associated",26356,39,1.24 [0.90-1.72],0.1870203575384821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G4A,Cytosolic phospholipase A2,26539,40,1.09 [0.81-1.48],0.5541120028952031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G7,Platelet-activating factor acetylhydrolase,26404,41,0.76 [0.51-1.15],0.1948961978851636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAT,Tissue-type plasminogen activator,26640,40,1.00 [0.59-1.69],0.9941066088787284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAU,Urokinase-type plasminogen activator,26404,41,1.06 [0.42-2.66],0.9010069473336104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,26217,39,11.99 [5.76-24.94],3.032790353387716e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLB1,"Phospholipase B1, membrane-associated",22882,35,0.66 [0.39-1.10],0.1121775088677905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",22293,36,1.08 [0.54-2.18],0.8230057395327922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",22882,35,1.17 [0.86-1.59],0.3061892312823435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,22882,35,1.53 [1.02-2.30],0.0379151828386565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLG,Plasminogen,22368,36,3.15 [1.18-8.45],0.0223779180340734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN1,Perilipin-1,25812,41,1.72 [0.96-3.08],0.0661955370208469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN3,Perilipin-3,26416,40,1.54 [0.87-2.75],0.1414525838676359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLPBP,Pyridoxal phosphate homeostasis protein,26416,40,0.89 [0.60-1.32],0.5530827200780826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLSCR3,Phospholipid scramblase 3,22844,35,1.56 [0.95-2.59],0.0817643390847603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLTP,Phospholipid transfer protein,26643,39,0.44 [0.23-0.87],0.0183836154977962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC1,Plexin domain-containing protein 1,25789,40,0.78 [0.30-2.05],0.6107897262568258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC2,Plexin domain-containing protein 2,22882,35,2.86 [1.22-6.72],0.0155746900026568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNA4,Plexin-A4,26402,41,1.28 [0.92-1.78],0.1418727395224896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,26611,39,2.79 [1.81-4.28],2.8517195297102885e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB3,Plexin-B3,26321,40,1.27 [0.76-2.13],0.3583090742008981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,26308,39,1.06 [0.91-1.25],0.446245231751587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMCH,Pro-MCH,22213,35,0.82 [0.47-1.42],0.4790719743384946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMM2,Phosphomannomutase 2,22213,35,1.13 [0.70-1.82],0.6123281901365539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMS1,PMS1 protein homolog 1,22304,36,0.89 [0.44-1.77],0.732485681116842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMVK,Phosphomevalonate kinase,25771,41,0.88 [0.70-1.11],0.2856602711451262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIP,Pancreatic triacylglycerol lipase,22963,37,1.83 [1.21-2.77],0.0041995821562407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,22882,35,1.74 [1.19-2.53],0.0041902542352585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP2,Pancreatic lipase-related protein 2,26400,39,1.00 [0.90-1.10],0.957805677630468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA1,Paraneoplastic antigen Ma1,22310,34,0.86 [0.49-1.49],0.5833635777622388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA2,Paraneoplastic antigen Ma2,22212,34,0.83 [0.34-1.99],0.6682679206102671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",25930,40,0.87 [0.67-1.13],0.3128223564108381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL,Podocalyxin,26305,39,0.70 [0.29-1.70],0.4329032715844372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL2,Podocalyxin-like protein 2,26490,42,1.80 [0.75-4.33],0.1894726540410735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,22293,36,1.71 [1.13-2.58],0.01136731735446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,22293,36,1.26 [0.44-3.57],0.6680514897995106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",26305,39,1.17 [0.57-2.39],0.67383662020216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POMC,Pro-opiomelanocortin,22310,34,1.03 [0.68-1.56],0.8757444399156553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON1,Serum paraoxonase/arylesterase 1,22963,37,0.45 [0.26-0.80],0.0059989377661186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON2,Serum paraoxonase/arylesterase 2,25946,40,0.98 [0.44-2.19],0.9697124097309732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,26539,40,0.63 [0.49-0.82],0.0005967497051317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POSTN,Periostin,22926,36,0.67 [0.29-1.54],0.3470635477428824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPBP,Platelet basic protein,22789,36,1.65 [1.15-2.35],0.0061487933338014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,26677,41,0.86 [0.49-1.51],0.5989531319176513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,26405,39,1.06 [0.80-1.41],0.6705909591602444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,22529,37,1.04 [0.67-1.63],0.852550302718669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",22926,36,1.41 [0.98-2.03],0.0679381978883041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPL,Periplakin,22293,36,1.30 [0.51-3.29],0.5801693532445227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1A,Protein phosphatase 1A,25789,40,0.83 [0.53-1.29],0.4049351633542344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1B,Protein phosphatase 1B,22293,36,1.00 [0.60-1.67],0.9956244906676964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1F,Protein phosphatase 1F,22945,37,1.06 [0.62-1.81],0.8327942270135379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPME1,Protein phosphatase methylesterase 1,26305,39,0.71 [0.45-1.13],0.1453907291942681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,22835,37,1.05 [0.75-1.48],0.7751430871019448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,26490,42,1.06 [0.81-1.38],0.6788650738979742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,22529,37,1.36 [1.00-1.85],0.0490955060337793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,22907,37,1.24 [0.87-1.76],0.2357417243006626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,22907,37,1.84 [1.02-3.32],0.0438407336729834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R2,Protein phosphatase inhibitor 2,26416,40,1.01 [0.73-1.41],0.9360865616053002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R9B,Neurabin-2,26732,42,1.02 [0.77-1.35],0.8923119717925474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,22858,36,1.09 [0.86-1.39],0.4831009465176328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP3R1,Calcineurin subunit B type 1,26246,40,0.84 [0.43-1.64],0.6072900381426896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPT1,Palmitoyl-protein thioesterase 1,22304,36,1.01 [0.67-1.52],0.9594640386736284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,26359,42,1.75 [1.35-2.28],2.983326794161198e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PQBP1,Polyglutamine-binding protein 1,25789,40,0.70 [0.38-1.28],0.2432622835387871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAME,Melanoma antigen preferentially expressed in tumors,22139,37,2.06 [0.84-5.07],0.1147982803175831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,22926,36,33.49 [13.09-85.72],2.41178738886867e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRC1,Protein regulator of cytokinesis 1,22835,37,0.61 [0.21-1.75],0.3603184365071695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,26553,40,8.72 [5.61-13.58],8.358111456955319e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX1,Peroxiredoxin-1,25700,39,0.80 [0.57-1.12],0.1922935119543447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX2,Peroxiredoxin-2,22588,35,0.45 [0.25-0.81],0.0071020866200798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",25930,40,0.82 [0.55-1.20],0.3041592232116562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX5,"Peroxiredoxin-5, mitochondrial",26732,42,0.69 [0.47-1.00],0.0487999314611194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX6,Peroxiredoxin-6,26655,42,0.48 [0.29-0.77],0.0024578087192265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PREB,Prolactin regulatory element-binding protein,25930,40,1.68 [0.80-3.53],0.1702711027061164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,26400,39,7.91 [2.17-28.86],0.0017270485245267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG2,Bone marrow proteoglycan,22926,36,1.61 [0.88-2.92],0.1191443848932291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG3,Proteoglycan 3,22926,36,0.86 [0.46-1.61],0.6330443311835601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,25930,40,1.16 [0.70-1.91],0.5619577090093781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,22304,36,0.92 [0.30-2.78],0.8821404499878794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,26416,40,1.11 [0.80-1.54],0.523352213336435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,22837,35,1.24 [0.83-1.85],0.3002710686238573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKCQ,Protein kinase C theta type,25930,40,1.46 [0.90-2.35],0.1236458431627899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKD2,Serine/threonine-protein kinase D2,22213,35,1.02 [0.52-2.00],0.9595805555034076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKG1,cGMP-dependent protein kinase 1,22429,37,1.06 [0.84-1.34],0.6285857758046989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,25789,40,1.31 [0.90-1.89],0.1544298012955082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRL,Prolactin,26677,41,0.80 [0.54-1.17],0.2496244776244515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRND,Prion-like protein doppel,22882,35,0.79 [0.42-1.49],0.465470851978929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROC,Vitamin K-dependent protein C,26454,40,2.19 [0.74-6.43],0.1556038369310658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROCR,Endothelial protein C receptor,22213,35,0.74 [0.23-2.33],0.6057704554445333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROK1,Prokineticin-1,26402,41,1.26 [0.77-2.05],0.3577835602155651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROS1,Vitamin K-dependent protein S,22968,36,1.79 [0.57-5.57],0.3161890854005328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR4,Proline-rich protein 4,22276,37,1.14 [0.76-1.72],0.5236826166350276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR5,Proline-rich protein 5,22293,36,0.93 [0.45-1.90],0.8321840833660785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRRT3,Proline-rich transmembrane protein 3,22310,34,1.71 [0.71-4.14],0.2314617334383438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS2,Trypsin-2,26487,40,1.63 [1.03-2.58],0.0354458180973606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,22293,36,1.81 [0.98-3.34],0.0566731057956802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS27,Serine protease 27,26317,40,1.95 [0.99-3.81],0.0520061412111846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS53,Serine protease 53,22882,35,0.45 [0.19-1.10],0.0811090653599655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,26320,40,6.13 [3.61-10.42],2.0617601275324508e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,25812,41,0.96 [0.76-1.22],0.7542775849177241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTG,Protogenin,26655,42,2.40 [1.09-5.27],0.0288564895396406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTN3,Myeloblastin,25754,39,1.73 [1.17-2.58],0.0063872181021447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRUNE2,Protein prune homolog 2,22529,37,1.52 [0.58-4.02],0.3940297375020721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,22713,36,2.93 [1.43-6.00],0.003370129177228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAPL1,Proactivator polypeptide-like 1,22858,36,0.85 [0.44-1.66],0.6344754616864747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSCA,Prostate stem cell antigen,22858,36,1.10 [0.96-1.26],0.1807362809620067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,26246,40,1.52 [1.10-2.10],0.0109851500477114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSIP1,PC4 and SFRS1-interacting protein,26402,41,0.98 [0.64-1.49],0.9197163328987668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMA1,Proteasome subunit alpha type-1,25789,40,1.06 [0.63-1.79],0.8152697358141539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMC3,26S proteasome regulatory subunit 6A,22139,37,0.78 [0.27-2.23],0.6460306064799495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,22907,37,0.66 [0.33-1.31],0.2387146991269837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,22304,36,0.72 [0.33-1.54],0.3927299516127074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,26305,39,0.50 [0.27-0.91],0.0232108463021228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME1,Proteasome activator complex subunit 1,26214,40,0.68 [0.32-1.45],0.317496951334741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME2,Proteasome activator complex subunit 2,26135,39,0.77 [0.35-1.70],0.5150819408256277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG3,Proteasome assembly chaperone 3,26402,41,0.69 [0.39-1.22],0.204769971483691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG4,Proteasome assembly chaperone 4,22293,36,0.84 [0.48-1.48],0.5442969885893101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSPN,Persephin,26402,41,1.09 [0.81-1.48],0.5604215029686646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSRC1,Proline/serine-rich coiled-coil protein 1,25789,40,1.14 [0.79-1.65],0.4962287396800929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,21591,35,1.06 [0.79-1.42],0.7182460023406612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",25812,41,0.72 [0.28-1.84],0.4947940644560289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,26200,40,2.95 [1.56-5.56],0.0008340795626841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGES2,Prostaglandin E synthase 2,22119,35,1.56 [0.98-2.50],0.0634504993558978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGR1,Prostaglandin reductase 1,22945,37,1.52 [1.07-2.15],0.0192896150794169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH,Parathyroid hormone,22304,36,0.76 [0.51-1.13],0.1762784276653445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,26402,41,1.54 [0.99-2.42],0.057796931015682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTK7,Inactive tyrosine-protein kinase 7,25812,41,2.35 [1.18-4.67],0.014856653498564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTN,Pleiotrophin,25946,40,0.76 [0.44-1.31],0.3254672151365031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,22293,36,1.26 [0.74-2.15],0.4000361247871441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,26246,40,1.02 [0.72-1.44],0.9191616359531636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,26498,40,0.96 [0.71-1.30],0.788355724107366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,22246,36,1.99 [1.20-3.29],0.0075833250547721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,22945,37,3.79 [2.02-7.11],3.298705088331515e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,22926,36,5.71 [1.97-16.53],0.0013273104159247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,26739,40,0.75 [0.28-2.00],0.5666496519023008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,22858,36,1.58 [0.87-2.87],0.1359953274246551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,22858,36,1.63 [0.50-5.33],0.4202447565889043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,26353,40,1.36 [0.44-4.21],0.5955061457888391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,26154,40,2.26 [1.12-4.56],0.0225885346676431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,22882,35,1.10 [0.47-2.58],0.8325750630825671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,26739,40,0.64 [0.22-1.87],0.4191781158799643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,22945,37,0.56 [0.20-1.59],0.2761933991125763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,22429,37,0.93 [0.56-1.53],0.766476715891042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,25693,41,1.45 [0.93-2.27],0.1028208120273105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTTG1,Securin,22529,37,0.71 [0.30-1.66],0.4280894164154855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTX3,Pentraxin-related protein PTX3,26402,41,1.52 [0.78-2.96],0.2135930041801602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVALB,Parvalbumin alpha,26553,42,0.86 [0.69-1.06],0.155974478127437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,26677,41,3.42 [2.05-5.71],2.519291551466988e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXDNL,Peroxidasin-like protein,22835,37,0.67 [0.32-1.40],0.2886676284211985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXN,Paxillin,25812,41,1.22 [0.74-2.00],0.4322476819566706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYDC1,Pyrin domain-containing protein 1,22310,34,0.57 [0.22-1.48],0.2462567730252139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,22213,35,2.15 [1.64-2.81],2.7609387409143883e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PZP,Pregnancy zone protein,22968,36,0.68 [0.31-1.46],0.3200746546400178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QDPR,Dihydropteridine reductase,26288,40,1.07 [0.57-2.03],0.8295164349929932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,26409,39,8.93 [4.02-19.86],7.910438123002603e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QSOX1,Sulfhydryl oxidase 1,22495,35,1.71 [1.19-2.45],0.0033978165624537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB10,Ras-related protein Rab-10,22945,37,1.15 [0.71-1.86],0.5758825606929134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB11FIP3,Rab11 family-interacting protein 3,22945,37,1.19 [0.90-1.57],0.2134271724523144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB27B,Ras-related protein Rab-27B,22945,37,1.33 [0.89-1.99],0.1637948425590022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB2B,Ras-related protein Rab-2B,22835,37,1.03 [0.64-1.67],0.8944661760971343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB33A,Ras-related protein Rab-33A,22213,35,1.17 [0.76-1.81],0.4766435550727517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB37,Ras-related protein Rab-37,25930,40,0.85 [0.59-1.20],0.3496806830883662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB39B,Ras-related protein Rab-39B,22213,35,1.06 [0.77-1.46],0.7213901010873836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,22212,34,0.76 [0.39-1.51],0.4386564712987486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB44,Ras-related protein Rab-44,22835,37,0.96 [0.50-1.85],0.903348277277246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,26402,41,0.32 [0.18-0.58],0.0001667799424936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6B,Ras-related protein Rab-6B,25812,41,0.90 [0.48-1.69],0.7477911367013805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEP1,Rab GTPase-binding effector protein 1,22429,37,1.17 [0.81-1.70],0.4094356126336128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEPK,Rab9 effector protein with kelch motifs,25789,40,0.71 [0.41-1.20],0.1993361280923282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABGAP1L,Rab GTPase-activating protein 1-like,25930,40,0.62 [0.38-1.03],0.0639223437720026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAC3,Ras-related C3 botulinum toxin substrate 3,22304,36,1.07 [0.66-1.73],0.7792160539038495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD23B,UV excision repair protein RAD23 homolog B,25789,40,0.95 [0.53-1.71],0.8587810612492353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD51,DNA repair protein RAD51 homolog 1,22529,37,1.16 [0.71-1.90],0.5565778031429851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALB,Ras-related protein Ral-B,22293,36,0.90 [0.29-2.77],0.8576794566561502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALY,RNA-binding protein Raly,22835,37,0.88 [0.44-1.75],0.704915562821313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP1,Ran-specific GTPase-activating protein,22310,34,0.69 [0.37-1.29],0.2439193334691271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP2,E3 SUMO-protein ligase RanBP2,22212,34,0.83 [0.30-2.29],0.7157874345604707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANGAP1,Ran GTPase-activating protein 1,25789,40,1.23 [0.71-2.13],0.4518861149537589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAP1A,Ras-related protein Rap-1A,22293,36,1.37 [0.96-1.95],0.0805020805235092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,22529,37,1.13 [0.69-1.85],0.6266929020558345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES1,Retinoic acid receptor responder protein 1,25789,40,1.58 [0.96-2.60],0.0708083518504458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,26539,40,2.04 [1.45-2.86],4.4988359600273777e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASA1,Ras GTPase-activating protein 1,25812,41,1.07 [0.46-2.49],0.8765326827136718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,22139,37,1.40 [0.71-2.76],0.3324528611654593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASSF2,Ras association domain-containing protein 2,25789,40,0.90 [0.53-1.54],0.7092407438232433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,22907,37,2.65 [1.79-3.93],1.264955480689003e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBKS,Ribokinase,25824,40,0.64 [0.39-1.07],0.087623205013527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM17,Splicing factor 45,22907,37,1.30 [0.89-1.88],0.1701332390597305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM19,Probable RNA-binding protein 19,22213,35,0.68 [0.31-1.50],0.3410477269409294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM25,RNA-binding protein 25,22139,37,1.50 [0.79-2.85],0.2142861951922407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP1,Retinol-binding protein 1,22304,36,0.88 [0.53-1.47],0.6188954010989589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,26305,39,1.79 [1.28-2.50],0.0006110456393066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,26305,39,2.10 [1.37-3.22],0.0006375299752245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP7,Retinoid-binding protein 7,22858,36,1.55 [1.08-2.22],0.0175579677356785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS,RNA-binding protein with multiple splicing,22293,36,0.97 [0.58-1.61],0.8920623576788774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS2,RNA-binding protein with multiple splicing 2,22310,34,1.17 [0.87-1.58],0.2906109843971159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCC1,Regulator of chromosome condensation,22835,37,0.85 [0.41-1.76],0.662249458799151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCOR1,REST corepressor 1,25946,40,0.99 [0.49-1.98],0.9690181346570764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,22310,34,0.73 [0.15-3.60],0.6946106135272934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REEP4,Receptor expression-enhancing protein 4,22907,37,1.31 [0.88-1.94],0.1885765973852926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,26249,40,3.16 [2.25-4.43],2.8680362158124557e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,26739,40,2.29 [1.66-3.17],5.415792938913122e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,26739,40,2.23 [1.59-3.14],3.507911968938413e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3G,Regenerating islet-derived protein 3-gamma,22835,37,1.39 [0.69-2.84],0.3594172344531495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,26448,39,5.43 [3.47-8.47],1.045822373774956e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELB,Transcription factor RelB,22293,36,0.95 [0.50-1.80],0.8745685832040574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,26404,41,2.41 [1.00-5.79],0.0493808869139335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,26416,40,2.25 [1.78-2.84],1.0780654194852235e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REPS1,RalBP1-associated Eps domain-containing protein 1,22293,36,1.17 [0.55-2.48],0.6791010307337998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REST,RE1-silencing transcription factor,22139,37,0.87 [0.35-2.17],0.7597966767350669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,26305,39,1.58 [0.76-3.27],0.2210940910830355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,26340,38,2.34 [1.46-3.75],0.0003816541918747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REXO2,"Oligoribonuclease, mitochondrial",22213,35,1.02 [0.49-2.10],0.9661140308637745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RFC4,Replication factor C subunit 4,22835,37,2.19 [0.88-5.48],0.0928526156921059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGCC,Regulator of cell cycle RGCC,22907,37,0.95 [0.64-1.42],0.8047685005797071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,22529,37,1.33 [0.93-1.89],0.1177521789343137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMA,Repulsive guidance molecule A,26677,41,0.72 [0.31-1.71],0.4596405556821392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMB,RGM domain family member B,26677,41,0.86 [0.30-2.45],0.7757983272064818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS10,Regulator of G-protein signaling 10,22907,37,1.04 [0.64-1.69],0.87790844883942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS8,Regulator of G-protein signaling 8,25930,40,1.22 [0.84-1.76],0.2974226398736245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RHOC,Rho-related GTP-binding protein RhoC,26088,40,1.00 [0.79-1.27],0.9969759180331838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RICTOR,Rapamycin-insensitive companion of mTOR,22293,36,0.81 [0.42-1.56],0.5260767264231478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,22429,37,1.33 [0.75-2.36],0.3294955491862958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILP,Rab-interacting lysosomal protein,26588,42,0.82 [0.53-1.26],0.3537442011461275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILPL2,RILP-like protein 2,22945,37,1.13 [0.84-1.53],0.424674403768948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,22213,35,0.95 [0.57-1.59],0.8478660205147082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN1,Prorelaxin H1,22907,37,1.13 [0.67-1.90],0.6407831551552369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN2,Prorelaxin H2,22391,37,0.97 [0.65-1.45],0.8707038413716348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,22963,37,6.02 [3.52-10.29],5.034669339311461e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,22310,34,1.90 [1.21-2.99],0.0055280060910204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE3,Eosinophil cationic protein,26283,40,0.94 [0.72-1.22],0.6199071224476486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,22229,33,4.08 [2.34-7.12],7.141242708719686e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,22807,36,0.32 [0.08-1.27],0.1064551739484911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASEH2A,Ribonuclease H2 subunit A,22907,37,0.97 [0.51-1.87],0.9361902254729678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,26597,40,5.47 [3.06-9.78],9.831739510314346e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,22310,34,6.25 [3.08-12.68],3.901057569789697e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF168,E3 ubiquitin-protein ligase RNF168,22293,36,0.57 [0.21-1.49],0.2489492274076629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF31,E3 ubiquitin-protein ligase RNF31,22293,36,0.79 [0.29-2.14],0.6414251563532263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF4,E3 ubiquitin-protein ligase RNF4,22529,37,0.91 [0.55-1.53],0.7330073800773396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF41,E3 ubiquitin-protein ligase NRDP1,25789,40,0.87 [0.57-1.32],0.5188393264193769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF43,E3 ubiquitin-protein ligase RNF43,22529,37,1.16 [0.73-1.84],0.5393888102233759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF5,E3 ubiquitin-protein ligase RNF5,22310,34,0.86 [0.55-1.34],0.5099853671916665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,26448,39,4.92 [1.99-12.16],0.0005473016726653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO2,Roundabout homolog 2,26677,41,0.72 [0.41-1.26],0.2465064427214192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO4,Roundabout homolog 4,22310,34,0.46 [0.07-3.17],0.4322915700904194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,26416,40,1.15 [0.49-2.68],0.7530196891717917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RP2,Protein XRP2,26305,39,0.74 [0.39-1.41],0.3641950309747015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPA2,Replication protein A 32 kDa subunit,22293,36,0.85 [0.28-2.59],0.7685506754723302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPE,Ribulose-phosphate 3-epimerase,22529,37,0.88 [0.56-1.38],0.5885395073698483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,22304,36,0.67 [0.28-1.64],0.3827855443766177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPL14,60S ribosomal protein L14,22310,34,0.95 [0.43-2.08],0.8887702208315812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPS10,40S ribosomal protein S10,22213,35,0.82 [0.35-1.94],0.6529686562241204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRAS,Ras-related protein R-Ras,22304,36,1.07 [0.86-1.34],0.5520597903008466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,25789,40,1.29 [0.83-2.02],0.2547074287341136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,25789,40,1.03 [0.69-1.54],0.8726482277568641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRP15,RRP15-like protein,22212,34,1.19 [0.84-1.67],0.3261208023209125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO1,R-spondin-1,26246,40,1.26 [0.62-2.58],0.520863949451104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,26655,42,0.98 [0.36-2.64],0.9641659523147006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTBDN,Retbindin,26305,39,1.15 [0.43-3.06],0.7813046185769522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTKN2,Rhotekin-2,22213,35,1.18 [0.71-1.93],0.5240255058777186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",22907,37,1.08 [0.80-1.45],0.6191679762125719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,26655,42,3.70 [2.78-4.92],3.859138760513613e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RUVBL1,RuvB-like 1,25789,40,1.02 [0.77-1.36],0.8906002531453503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RWDD1,RWD domain-containing protein 1,26677,41,0.89 [0.59-1.34],0.5753086217617058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RYR1,Ryanodine receptor 1,22213,35,1.27 [0.53-3.07],0.5924090461096774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A11,Protein S100-A11,26208,40,0.94 [0.51-1.73],0.8441426477677544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A12,Protein S100-A12,26056,39,0.82 [0.56-1.22],0.3361053948702822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A13,Protein S100-A13,22293,36,1.39 [0.65-3.00],0.3964672907732925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A14,Protein S100-A14,22907,37,0.40 [0.19-0.87],0.0200849131177273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A16,Protein S100-A16,25763,41,0.69 [0.41-1.15],0.1510186121770476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A3,Protein S100-A3,22835,37,1.33 [0.81-2.18],0.2596744022409006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A4,Protein S100-A4,26490,42,1.06 [0.67-1.70],0.7986490392368595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100G,Protein S100-G,22907,37,0.53 [0.26-1.08],0.081413653484071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100P,Protein S100-P,25946,40,1.47 [0.99-2.17],0.0542816899082074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAA4,Serum amyloid A-4 protein,22968,36,0.96 [0.43-2.14],0.9259458611481112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAFB2,Scaffold attachment factor B2,22907,37,0.54 [0.15-1.88],0.3310429802220004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAG,S-arrestin,22212,34,0.68 [0.36-1.29],0.2377359463935446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,26402,41,1.05 [0.73-1.50],0.7922886645335683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAP18,Histone deacetylase complex subunit SAP18,22529,37,1.12 [0.74-1.69],0.5856705424862196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SARG,Specifically androgen-regulated gene protein,22869,37,1.25 [0.95-1.66],0.1131359189088941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,22213,35,0.85 [0.33-2.18],0.7342137684057146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT1,Diamine acetyltransferase 1,22213,35,0.52 [0.22-1.27],0.1513784081876182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT2,Thialysine N-epsilon-acetyltransferase,22529,37,1.29 [0.90-1.83],0.1608255762152161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SATB1,DNA-binding protein SATB1,22907,37,1.65 [0.71-3.81],0.2417978319315912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SBSN,Suprabasin,22884,36,0.41 [0.16-1.05],0.0633199330716924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCAMP3,Secretory carrier-associated membrane protein 3,26305,39,1.11 [0.80-1.53],0.5384219693587238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,26677,41,3.05 [1.37-6.83],0.006510984783606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB1,Scavenger receptor class B member 1,25812,41,1.33 [0.90-1.98],0.1525442865861221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,25737,40,3.89 [2.43-6.24],1.747003025880137e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,26739,40,2.18 [1.22-3.89],0.0084500149628104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,26677,41,3.29 [1.33-8.14],0.009997659229883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,26552,42,9.41 [4.75-18.64],1.2671619047524728e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG3,Secretogranin-3,26448,39,0.78 [0.34-1.80],0.5620857446154806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB1A1,Uteroglobin,26466,40,1.02 [0.62-1.66],0.9509127491617646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB2A2,Mammaglobin-A,22213,35,0.73 [0.44-1.22],0.2315537662976534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A1,Secretoglobin family 3A member 1,22429,37,1.79 [0.51-6.27],0.3605227288760833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A2,Secretoglobin family 3A member 2,26498,40,1.46 [1.13-1.88],0.0034273437073975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,25930,40,2.38 [1.39-4.08],0.0015645392689776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCIN,Adseverin,22212,34,0.75 [0.44-1.26],0.2800002296393291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCLY,Selenocysteine lyase,26588,42,1.34 [0.77-2.34],0.2988449794851365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2A,Sodium channel protein type 2 subunit alpha,22212,34,0.57 [0.23-1.45],0.2398147754109874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2B,Sodium channel subunit beta-2,22304,36,0.57 [0.17-1.91],0.3621083490877717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3A,Sodium channel protein type 3 subunit alpha,22304,36,0.57 [0.19-1.68],0.3068763737348842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3B,Sodium channel subunit beta-3,22212,34,0.47 [0.18-1.22],0.1199024896580089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN4B,Sodium channel subunit beta-4,22310,34,1.22 [0.58-2.57],0.5925608328949625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCP2,Non-specific lipid-transfer protein,25789,40,0.85 [0.57-1.26],0.4116189030717831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,22231,34,1.81 [1.07-3.08],0.0283010214050641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRG1,Scrapie-responsive protein 1,22945,37,2.06 [1.03-4.13],0.0418370033695284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRIB,Protein scribble homolog,22310,34,0.96 [0.66-1.39],0.830126708681478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRN1,Secernin-1,26402,41,0.62 [0.36-1.06],0.0815560015883569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCT,Secretin,22304,36,1.06 [0.52-2.15],0.8689136564267002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,26416,40,1.96 [1.10-3.48],0.0215505806745611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC4,Syndecan-4,26416,40,0.81 [0.46-1.43],0.4672951158776824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDCCAG8,Serologically defined colon cancer antigen 8,22835,37,1.15 [0.88-1.51],0.2932931677154573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDHB,Succinate dehydrogenase,22858,36,1.13 [0.72-1.76],0.6078888070437951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDK2,Protein sidekick-2,22429,37,0.86 [0.35-2.13],0.7513645169577876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEC31A,Protein transport protein Sec31A,22310,34,0.84 [0.55-1.29],0.4316797442350166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEL1L,Protein sel-1 homolog 1,22310,34,2.04 [1.45-2.89],4.851734712274157e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,26739,40,2.95 [1.72-5.07],9.110593702947268e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELENOP,Selenoprotein P,22968,36,1.87 [0.50-7.04],0.3530697235461186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELL,L-selectin,22968,36,0.36 [0.09-1.41],0.1416314351135839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELP,P-selectin,26487,40,1.39 [0.89-2.15],0.1450268162538676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELPLG,P-selectin glycoprotein ligand 1,26402,41,3.13 [1.81-5.41],4.509239459405445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,26416,40,4.93 [1.85-13.14],0.0014123648540254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3G,Semaphorin-3G,22429,37,2.52 [1.33-4.77],0.0046487644638042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4C,Semaphorin-4C,26305,39,0.62 [0.20-1.97],0.4222558177433219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4D,Semaphorin-4D,26677,41,1.56 [0.62-3.93],0.3445869854808463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA6C,Semaphorin-6C,22293,36,1.02 [0.31-3.39],0.9708235625455284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,26640,40,4.80 [2.82-8.17],7.253818921550158e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN3,Neuronal-specific septin-3,22907,37,1.42 [1.02-1.99],0.0404458875553228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN7,Septin-7,22529,37,0.83 [0.42-1.65],0.5974513083449854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,22832,35,2.15 [0.94-4.90],0.0699676468407671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN9,Septin-9,26305,39,0.50 [0.17-1.51],0.2189675324529019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA1,Alpha-1-antitrypsin,22555,34,16.67 [1.46-189.85],0.0233708965711324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA11,Serpin A11,26739,40,2.50 [1.30-4.83],0.0061679344782716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA12,Serpin A12,25673,38,1.24 [1.02-1.51],0.0347591181457968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA3,Alpha-1-antichymotrypsin,22897,36,2.89 [0.67-12.44],0.1530989675696489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA4,Kallistatin,22561,36,6.14 [2.09-18.05],0.0009729578650804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA5,Plasma serine protease inhibitor,22644,36,1.98 [1.18-3.32],0.010071815198595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA6,Corticosteroid-binding globulin,22968,36,13.76 [2.87-66.03],0.0010527259164539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA7,Thyroxine-binding globulin,22968,36,2.40 [0.45-12.86],0.3068331605029054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA9,Serpin A9,26185,39,1.38 [0.97-1.95],0.0696045823855985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB1,Leukocyte elastase inhibitor,26323,41,0.94 [0.70-1.27],0.680050634888737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB5,Serpin B5,25946,40,0.75 [0.43-1.31],0.3164272407921086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB6,Serpin B6,26588,40,0.96 [0.62-1.50],0.8615186388942794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB8,Serpin B8,26732,42,0.95 [0.59-1.52],0.8160013749340789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB9,Serpin B9,26246,40,0.69 [0.29-1.63],0.4011986188553597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINC1,Antithrombin-III,22923,36,5.06 [0.61-41.72],0.1317283468032582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPIND1,Heparin cofactor 2,22923,36,3.55 [1.23-10.22],0.0188343928690179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE1,Plasminogen activator inhibitor 1,26739,40,1.60 [1.03-2.50],0.0378836048939602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE2,Glia-derived nexin,22945,37,1.24 [0.80-1.91],0.3308838093894464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,22631,34,7.70 [3.80-15.63],1.5626722401067294e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF2,Alpha-2-antiplasmin,22551,34,9.65 [1.10-84.56],0.0406501848563566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPING1,Plasma protease C1 inhibitor,22923,36,6.27 [1.34-29.35],0.0198414711148098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINH1,Serpin H1,22529,37,1.23 [0.98-1.55],0.0781502833756394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI1,Neuroserpin,22382,36,0.31 [0.09-1.04],0.057732539910033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI2,Serpin I2,22858,36,1.43 [0.88-2.32],0.1530419625888571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,25812,41,0.85 [0.56-1.30],0.4582574932643244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,26163,40,0.46 [0.28-0.74],0.0014359141223946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6,Seizure protein 6 homolog,22304,36,0.52 [0.18-1.52],0.2315323528240904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L,Seizure 6-like protein,26490,42,2.26 [0.90-5.68],0.0842621915224218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L2,Seizure 6-like protein 2,26305,39,1.14 [0.36-3.60],0.8220182122190847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SF3B4,Splicing factor 3B subunit 4,26305,39,0.79 [0.53-1.16],0.2293233902410671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP1,Secreted frizzled-related protein 1,26153,40,1.49 [0.95-2.35],0.080112907456588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP4,Secreted frizzled-related protein 4,22429,37,1.25 [0.58-2.67],0.570274615848731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA1,Pulmonary surfactant-associated protein A1,25789,40,1.20 [0.82-1.77],0.353244536121552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA2,Pulmonary surfactant-associated protein A2,25789,40,1.06 [0.63-1.79],0.8184187812065071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPD,Pulmonary surfactant-associated protein D,26416,40,1.56 [1.03-2.37],0.0351248293392437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SGSH,N-sulphoglucosamine sulphohydrolase,22580,37,1.89 [1.23-2.90],0.0035559107797092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2B3,SH2B adapter protein 3,25789,40,0.96 [0.73-1.27],0.762252668822126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2D1A,SH2 domain-containing protein 1A,26402,41,1.16 [0.77-1.76],0.4815172368190987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,22212,34,1.12 [0.71-1.76],0.6176507555180288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BP1,SH3 domain-binding protein 1,22858,36,1.11 [0.62-2.00],0.7206648315797728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GL3,Endophilin-A3,22386,36,1.09 [0.76-1.58],0.6343166289712858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GLB2,Endophilin-B2,22882,35,0.98 [0.62-1.56],0.9356113237933747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHBG,Sex hormone-binding globulin,22963,37,0.32 [0.18-0.58],0.000184857761294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHC1,SHC-transforming protein 1,22139,37,0.88 [0.66-1.18],0.4025934376064773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHD,SH2 domain-containing adapter protein D,22179,34,1.33 [1.01-1.76],0.0402037755948911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHH,Sonic hedgehog protein,22293,36,1.39 [0.72-2.67],0.3292975369389344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,22926,36,4.28 [2.36-7.76],1.5863053158401833e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",26498,40,1.06 [0.77-1.46],0.7292238633742216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHPK,Sedoheptulokinase,22529,37,0.70 [0.27-1.84],0.4736958866043255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIAE,Sialate O-acetylesterase,26444,42,1.77 [1.08-2.91],0.0235803588972788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,26539,40,3.85 [2.49-5.95],1.413120926019117e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,26402,41,5.47 [3.38-8.85],4.3736399237064926e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,25812,41,0.73 [0.45-1.20],0.2145062273613693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,26404,41,1.65 [1.16-2.34],0.0053702157977286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,26655,42,4.18 [2.51-6.96],3.9422029470889954e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,26416,40,8.18 [3.87-17.30],3.792880644866832e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,22310,34,2.27 [1.13-4.53],0.0205874803455333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,26622,42,4.83 [2.04-11.46],0.0003521267094473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIL1,Nucleotide exchange factor SIL1,22310,34,1.08 [0.41-2.79],0.8795026083911475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,26471,38,1.63 [0.93-2.86],0.0871096478919503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,26350,39,4.22 [2.51-7.10],6.131358392980302e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,22293,36,0.89 [0.58-1.36],0.5971600945389522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,26305,39,0.86 [0.62-1.18],0.3480249479846284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",25812,41,0.68 [0.37-1.26],0.2204966344298237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,25930,40,2.11 [1.27-3.48],0.0036349274636677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP1,Src kinase-associated phosphoprotein 1,26203,40,1.39 [0.97-2.01],0.0744423630430961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP2,Src kinase-associated phosphoprotein 2,26539,40,1.13 [0.87-1.45],0.3636387981956447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKIV2L,Helicase SKI2W,22213,35,1.31 [0.68-2.53],0.4247897878755322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLA2,Src-like-adapter 2,22907,37,1.14 [0.86-1.50],0.3586091219495173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,25930,40,1.70 [1.03-2.80],0.0363895697228957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,25789,40,2.50 [1.43-4.37],0.0013084489092185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,26402,41,1.92 [1.27-2.90],0.0019003081200774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,25789,40,3.72 [2.27-6.07],1.633552559703481e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC12A2,Solute carrier family 12 member 2,22213,35,0.39 [0.10-1.46],0.1625118573268187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC13A1,Solute carrier family 13 member 1,22835,37,1.02 [0.57-1.82],0.9436073807571256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC16A1,Monocarboxylate transporter 1,25812,41,1.25 [0.88-1.77],0.2165560306766511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC1A4,Neutral amino acid transporter A,22304,36,1.00 [0.57-1.74],0.9880278456110309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC27A4,Long-chain fatty acid transport protein 4,25812,41,1.00 [0.68-1.48],0.9840048320811496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC28A1,Sodium/nucleoside cotransporter 1,22139,37,0.88 [0.47-1.62],0.6704177394318876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,22139,37,1.00 [0.50-1.99],0.9994454681247236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A14,Zinc transporter ZIP14,25812,41,1.41 [0.62-3.21],0.4134945851803442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A5,Zinc transporter ZIP5,26402,41,1.20 [0.71-2.02],0.4896992492967394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC44A4,Choline transporter-like protein 4,22304,36,1.04 [0.66-1.63],0.871687758070135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC4A1,Band 3 anion transport protein,22926,36,0.81 [0.42-1.55],0.5177392141189405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC51B,Organic solute transporter subunit beta,22213,35,0.74 [0.45-1.23],0.2422053730301362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,22429,37,1.17 [0.84-1.62],0.3610296429902261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,22858,36,1.37 [0.90-2.09],0.1407360960698949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",22139,37,0.88 [0.48-1.63],0.6869424023881974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIT2,Slit homolog 2 protein,25812,41,0.98 [0.56-1.71],0.948886964699907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK1,SLIT and NTRK-like protein 1,22293,36,0.52 [0.33-0.81],0.0042023670436919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK2,SLIT and NTRK-like protein 2,26655,42,1.62 [0.81-3.24],0.1698398451537048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK6,SLIT and NTRK-like protein 6,25946,40,1.09 [0.51-2.34],0.8306910263105438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLK,STE20-like serine/threonine-protein kinase,22529,37,0.74 [0.41-1.33],0.3158042146112203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLMAP,Sarcolemmal membrane-associated protein,22858,36,1.46 [1.06-2.01],0.0189969504912181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,22762,36,1.44 [0.77-2.68],0.2536107034091136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD1,Mothers against decapentaplegic homolog 1,25789,40,1.14 [0.84-1.56],0.3918718587392336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD2,Mothers against decapentaplegic homolog 2,22835,37,1.13 [0.76-1.69],0.5496227316235203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD3,Mothers against decapentaplegic homolog 3,22835,37,1.12 [0.62-2.03],0.6989295093858954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD5,Mothers against decapentaplegic homolog 5,26305,39,0.46 [0.12-1.75],0.2526613337157217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMARCA2,Probable global transcription activator SNF2L2,25812,41,1.01 [0.71-1.43],0.9774080419453156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMC3,Structural maintenance of chromosomes protein 3,22139,37,1.22 [0.80-1.85],0.3591960350965811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,22858,36,0.98 [0.58-1.64],0.9280189783256274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,26655,42,3.51 [2.29-5.39],9.723320270524936e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,26539,40,1.97 [0.99-3.89],0.0524038040632546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD1,Sphingomyelin phosphodiesterase,26554,39,1.76 [1.06-2.92],0.027975294573977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD3,Sphingomyelin phosphodiesterase 3,22293,36,0.63 [0.28-1.43],0.2703674194987134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,26489,40,0.80 [0.53-1.22],0.3036464589203877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,22835,37,0.90 [0.56-1.46],0.6720564214868152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMS,Spermine synthase,22212,34,1.30 [0.93-1.81],0.1287261745301944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMTN,Smoothelin,22829,35,1.32 [1.00-1.76],0.0541197972243296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP23,Synaptosomal-associated protein 23,26416,40,1.10 [0.79-1.53],0.5655002918603664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP25,Synaptosomal-associated protein 25,22212,34,1.62 [0.88-2.98],0.1239068302158667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP29,Synaptosomal-associated protein 29,26490,42,1.13 [0.85-1.51],0.3865625983339593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAPIN,SNARE-associated protein Snapin,22907,37,0.72 [0.42-1.23],0.2293963726681994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCA,Alpha-synuclein,22429,37,0.98 [0.75-1.27],0.8666304329170631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,26246,40,1.55 [1.01-2.37],0.0443380107628219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",22310,34,1.12 [0.41-3.09],0.8223906779288728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',22882,35,1.06 [0.57-1.96],0.8566967947877244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNU13,NHP2-like protein 1,22213,35,0.75 [0.41-1.38],0.3554904816059085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX15,Sorting nexin-15,22429,37,0.73 [0.41-1.30],0.2844447772882954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX18,Sorting nexin-18,22858,36,0.78 [0.39-1.57],0.4866748050159942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX2,Sorting nexin-2,22835,37,1.21 [0.88-1.68],0.2402151231961093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX5,Sorting nexin-5,22310,34,0.63 [0.21-1.86],0.403790372783805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX9,Sorting nexin-9,26416,40,1.04 [0.71-1.52],0.8551114225036761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD1,Superoxide dismutase [Cu-Zn],25840,38,0.92 [0.51-1.66],0.7902899887498438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",26404,41,0.87 [0.44-1.70],0.678268052379541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD3,Extracellular superoxide dismutase,22963,37,0.80 [0.41-1.57],0.5143599166465659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORBS1,Sorbin and SH3 domain-containing protein 1,22907,37,1.93 [1.20-3.13],0.007248400165317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,25789,40,4.19 [2.31-7.58],2.206354167836123e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORD,Sorbitol dehydrogenase,26539,41,0.92 [0.63-1.36],0.6939206890300821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORT1,Sortilin,26384,40,2.53 [1.37-4.69],0.0031323098818543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOST,Sclerostin,26384,40,1.84 [0.88-3.84],0.1046111805603879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,22304,36,0.76 [0.34-1.68],0.492065806874997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX2,Transcription factor SOX-2,22870,37,0.70 [0.36-1.36],0.2972438948111865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX9,Transcription factor SOX-9,22304,36,1.67 [0.49-5.66],0.4076616058492321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,22907,37,0.93 [0.32-2.74],0.8964489347996335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPAG1,Sperm-associated antigen 1,22907,37,1.24 [0.81-1.88],0.3230547233489205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARC,SPARC,26490,42,1.37 [0.91-2.06],0.1299578997696789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARCL1,SPARC-like protein 1,26408,40,0.67 [0.23-1.93],0.4544129294302137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPART,Spartin,22429,37,1.17 [0.80-1.71],0.420795804789056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPESP1,Sperm equatorial segment protein 1,22945,37,0.86 [0.32-2.31],0.763301050697272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,26404,41,3.42 [2.31-5.06],7.22219277335258e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK2,Serine protease inhibitor Kazal-type 2,22429,37,1.52 [0.69-3.31],0.295544176235563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,26402,41,3.59 [2.75-4.68],3.8846048868147815e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK5,Serine protease inhibitor Kazal-type 5,26404,41,0.56 [0.24-1.30],0.1769179933243831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK6,Serine protease inhibitor Kazal-type 6,26655,42,1.07 [0.64-1.77],0.7964393056451131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK8,Serine protease inhibitor Kazal-type 8,22213,35,1.46 [0.79-2.70],0.2236188127365037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,26312,41,4.17 [2.00-8.67],0.0001337382189291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,26539,40,3.59 [2.00-6.42],1.721169039177763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT3,Kunitz-type protease inhibitor 3,22858,36,1.03 [0.84-1.25],0.7924703656842828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPOCK1,Testican-1,26246,40,0.66 [0.39-1.10],0.1076980340221131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,26448,39,3.79 [2.10-6.81],8.871026815264656e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,26290,40,2.69 [1.26-5.75],0.0104212930528963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPP1,Osteopontin,26686,39,1.56 [0.85-2.86],0.147547542248185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",22293,36,1.30 [0.69-2.47],0.4148374048341794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRING1,SREBP regulating gene protein,22139,37,0.79 [0.42-1.48],0.4632566968341707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR1B,Cornifin-B,22529,37,0.95 [0.65-1.38],0.7901164435867611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR3,Small proline-rich protein 3,22882,35,1.42 [0.90-2.26],0.134858294971336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRY2,Protein sprouty homolog 2,25930,40,0.90 [0.67-1.21],0.4998104803656022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",22212,34,1.36 [0.52-3.58],0.535260179798428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTLC1,Serine palmitoyltransferase 1,22882,35,1.06 [0.50-2.23],0.8771801160380658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRC,Proto-oncogene tyrosine-protein kinase Src,26451,42,1.00 [0.81-1.24],0.9903147003323346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRP14,Signal recognition particle 14 kDa protein,26305,39,0.92 [0.58-1.47],0.7306935737375353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPK2,SRSF protein kinase 2,26402,41,1.05 [0.78-1.40],0.7637745159567599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPX,Sushi repeat-containing protein SRPX,22945,37,1.66 [0.69-3.98],0.2531104631948647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSB,Lupus La protein,25812,41,0.87 [0.53-1.41],0.5712235779298627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",22293,36,0.55 [0.18-1.64],0.282891383233437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,26384,40,0.38 [0.27-0.53],1.6344350083705268e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,26487,40,1.77 [0.94-3.34],0.0770700931671607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSH3,Protein phosphatase Slingshot homolog 3,22139,37,0.73 [0.27-1.97],0.5332367326489311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,22858,36,1.27 [0.76-2.13],0.3670909409933631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST13,Hsc70-interacting protein,22429,37,0.93 [0.54-1.59],0.7928496292440431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",26305,39,1.49 [0.87-2.56],0.1506498338767528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",26739,40,5.50 [2.48-12.18],2.630277609683069e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",22293,36,1.14 [0.60-2.15],0.6982474161187173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAB2,Stabilin-2,22926,36,3.19 [1.23-8.30],0.0173484355782666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAM,Signal transducing adapter molecule 1,22835,37,1.93 [1.00-3.73],0.0505181341730769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAMBP,STAM-binding protein,26203,40,0.80 [0.52-1.24],0.3224406125326901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT2,Signal transducer and activator of transcription 2,22293,36,1.18 [0.81-1.72],0.3971683142910422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT5B,Signal transducer and activator of transcription 5B,26305,39,0.92 [0.75-1.13],0.4074634715433844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,22139,37,1.18 [0.77-1.81],0.4590895928204748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,26677,41,1.87 [1.12-3.13],0.0161056979047258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC2,Stanniocalcin-2,26367,41,2.03 [0.67-6.12],0.2108717860277053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STEAP4,Metalloreductase STEAP4,22212,34,0.99 [0.61-1.60],0.9515548974035688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STIP1,Stress-induced-phosphoprotein 1,26360,41,0.86 [0.58-1.29],0.4777921848388102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK11,Serine/threonine-protein kinase STK11,25946,40,0.88 [0.60-1.27],0.4870016124145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK24,Serine/threonine-protein kinase 24,25812,41,0.96 [0.62-1.48],0.8559627079328793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK4,Serine/threonine-protein kinase 4,26416,40,1.01 [0.75-1.36],0.9381113469185836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STOML2,"Stomatin-like protein 2, mitochondrial",22139,37,0.79 [0.53-1.17],0.2444643841425813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX16,Syntaxin-16,25789,40,1.23 [0.79-1.91],0.3559781711764931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX1B,Syntaxin-1B,22304,36,0.90 [0.37-2.17],0.8162628020066408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX3,Syntaxin-3,22882,35,0.71 [0.26-1.91],0.4975887465214493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX4,Syntaxin-4,26305,39,1.18 [0.80-1.74],0.3925535626786612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX5,Syntaxin-5,22293,36,1.64 [0.90-2.98],0.1074578497319197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX6,Syntaxin-6,25789,40,1.18 [0.80-1.75],0.4081154867003038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX7,Syntaxin-7,22293,36,1.54 [0.80-2.98],0.1947734946020015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX8,Syntaxin-8,26402,41,1.34 [0.81-2.21],0.2529341748002617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP1,Syntaxin-binding protein 1,22907,37,1.08 [0.73-1.61],0.6952045685028968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP3,Syntaxin-binding protein 3,25789,40,0.89 [0.47-1.71],0.7351321598105252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGP1,SURP and G-patch domain-containing protein 1,22858,36,1.17 [0.60-2.28],0.6511573049015066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGT1,Protein SGT1 homolog,25789,40,0.89 [0.63-1.25],0.4941588453464111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT1A1,Sulfotransferase 1A1,26677,41,0.90 [0.74-1.10],0.316204115924567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT2A1,Bile salt sulfotransferase,26402,41,1.50 [1.08-2.09],0.0170136276911374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF1,Formylglycine-generating enzyme,22293,36,1.09 [0.72-1.65],0.6887268191927154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,26677,41,1.40 [0.83-2.39],0.2085027258087272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUOX,"Sulfite oxidase, mitochondrial",22907,37,1.47 [0.94-2.28],0.0891857708731301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD1,Sushi domain-containing protein 1,25946,40,1.14 [0.62-2.08],0.6703645445545177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD2,Sushi domain-containing protein 2,26404,41,1.82 [0.82-4.06],0.1433315101309453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD4,Sushi domain-containing protein 4,22835,37,1.03 [0.48-2.20],0.9384912960957714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD5,Sushi domain-containing protein 5,22309,36,0.62 [0.24-1.59],0.3210394154357566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SV2A,Synaptic vesicle glycoprotein 2A,22304,36,1.40 [0.90-2.17],0.133796299131741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SWAP70,Switch-associated protein 70,22858,36,0.99 [0.43-2.28],0.9759965987725506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYAP1,Synapse-associated protein 1,22429,37,0.91 [0.55-1.51],0.7065738545250678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,22212,34,1.29 [0.84-2.00],0.2441373341074298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYT1,Synaptotagmin-1,22882,35,0.92 [0.36-2.30],0.8521245930069812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYTL4,Synaptotagmin-like protein 4,22945,37,1.32 [0.94-1.87],0.1102556299240281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,22529,37,1.06 [0.79-1.41],0.7160568299720325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACC3,Transforming acidic coiled-coil-containing protein 3,26305,39,0.91 [0.72-1.16],0.4494762700796957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,23481,39,6.25 [2.72-14.34],1.5686016274048798e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TADA3,Transcriptional adapter 3,22835,37,1.15 [0.58-2.28],0.6817863446813908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,26305,39,1.44 [0.68-3.07],0.3391527946689231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAGLN3,Transgelin-3,22139,37,1.03 [0.58-1.83],0.9089531595883472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TALDO1,Transaldolase,22849,36,1.31 [0.70-2.46],0.402814929700646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TANK,TRAF family member-associated NF-kappa-B activator,25930,40,1.06 [0.71-1.58],0.7688205636391687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAP1,Antigen peptide transporter 1,22529,37,0.72 [0.37-1.43],0.349323378736262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARBP2,RISC-loading complex subunit TARBP2,25812,41,1.07 [0.76-1.50],0.697156971060497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",22304,36,1.03 [0.66-1.60],0.8942991445797869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",22835,37,1.41 [0.66-3.00],0.374187136520963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAX1BP1,Tax1-binding protein 1,22882,35,1.49 [0.97-2.30],0.0710121181896657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D17,TBC1 domain family member 17,25812,41,0.86 [0.44-1.68],0.6629228716929885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D23,TBC1 domain family member 23,26305,39,0.96 [0.71-1.30],0.7707131599934962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D5,TBC1 domain family member 5,26402,41,0.99 [0.70-1.40],0.9679188235784936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCA,Tubulin-specific chaperone A,22429,37,0.97 [0.68-1.37],0.8527844214357647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCB,Tubulin-folding cofactor B,26246,40,0.92 [0.70-1.21],0.5404042625754373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCC,Tubulin-specific chaperone C,26246,40,0.95 [0.68-1.34],0.7746109648855863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,25789,40,0.91 [0.66-1.25],0.5476901736866242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBR1,T-box brain protein 1,22304,36,0.90 [0.41-2.00],0.8006376927295149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1A,T-cell leukemia/lymphoma protein 1A,26194,40,0.67 [0.51-0.88],0.0033050850591603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1B,T-cell leukemia/lymphoma protein 1B,25946,40,0.82 [0.52-1.29],0.3885309196105604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN1,Transcobalamin-1,22517,34,1.95 [0.99-3.84],0.052233572176969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,26686,39,2.32 [1.14-4.70],0.0199595097374661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCOF1,Treacle protein,22945,37,1.71 [0.92-3.17],0.091409118365893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCP11,T-complex protein 11 homolog,22529,37,0.85 [0.48-1.49],0.5638083723794698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCTN3,Tectonic-3,22945,37,2.37 [0.85-6.58],0.0977342837363415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDGF1,Teratocarcinoma-derived growth factor 1,25812,41,1.21 [1.01-1.45],0.0434218052299255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDO2,"Tryptophan 2,3-dioxygenase",22304,36,0.79 [0.33-1.90],0.5969732339207445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,22835,37,0.72 [0.41-1.27],0.2529236234044456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDRKH,Tudor and KH domain-containing protein,25812,41,1.02 [0.75-1.38],0.91522273799842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEF,Thyrotroph embryonic factor,22213,35,0.52 [0.22-1.23],0.13634453770425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,26490,42,6.02 [1.93-18.81],0.0020032423034962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TERF1,Telomeric repeat-binding factor 1,22293,36,0.89 [0.31-2.60],0.836044904329371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TET2,Methylcytosine dioxygenase TET2,22497,37,0.59 [0.33-1.03],0.0625920298773068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX101,Testis-expressed protein 101,22304,36,0.53 [0.29-0.97],0.0404979166611285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX33,Testis-expressed protein 33,22529,37,1.04 [0.48-2.24],0.9263661969841388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TF,Serotransferrin,22968,36,1.85 [0.44-7.88],0.4028474863542618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFAP2A,Transcription factor AP-2-alpha,22212,34,0.73 [0.37-1.43],0.3528676408214866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,26281,41,2.17 [1.69-2.78],1.127624063750113e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,26498,40,3.62 [2.61-5.01],1.3313659609916664e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,26377,40,2.26 [1.66-3.08],2.105654295047208e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI,Tissue factor pathway inhibitor,26314,40,0.67 [0.27-1.67],0.3863769913126742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,26397,42,1.83 [1.28-2.63],0.001017632699818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFRC,Transferrin receptor protein 1,26499,40,1.95 [1.05-3.60],0.0338243035807474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TG,Thyroglobulin,22835,37,1.11 [0.84-1.48],0.4631220797744338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,26402,41,2.32 [1.49-3.61],0.0001861608557724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,26684,42,2.77 [1.57-4.90],0.0004424027198304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB2,Transforming growth factor beta-2 proprotein,22835,37,1.11 [0.69-1.77],0.6689910420424705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,26228,40,0.42 [0.15-1.18],0.0982727834188623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR1,TGF-beta receptor type-1,22293,36,1.36 [0.41-4.58],0.6177159885076651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,26490,42,3.17 [1.96-5.12],2.668386546492039e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR3,Transforming growth factor beta receptor type 3,26739,40,0.76 [0.32-1.81],0.5358103958148888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,26368,40,0.85 [0.58-1.24],0.391228675548027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,22963,37,2.24 [0.67-7.49],0.1883583617347554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,22095,37,0.94 [0.63-1.41],0.7758210606360104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,26416,40,3.28 [1.37-7.82],0.0074818865837158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,26404,41,3.92 [2.39-6.43],6.377897400812326e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS4,Thrombospondin-4,26412,40,1.24 [0.69-2.21],0.4690578333069921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THOP1,Thimet oligopeptidase,26306,40,0.87 [0.37-2.06],0.7476047453750578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THPO,Thrombopoietin,25946,40,0.89 [0.44-1.79],0.7438224051754151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THRAP3,Thyroid hormone receptor-associated protein 3,22213,35,0.76 [0.51-1.15],0.1977215918932649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THSD1,Thrombospondin type-1 domain-containing protein 1,22126,35,0.51 [0.18-1.42],0.196650418069383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THTPA,Thiamine-triphosphatase,22785,36,0.90 [0.64-1.29],0.5743478294924271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,26677,41,1.28 [0.48-3.41],0.6197364710955233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIA1,Nucleolysin TIA-1 isoform p40,25667,39,0.94 [0.75-1.18],0.6024435674387998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIE1,Tyrosine-protein kinase receptor Tie-1,26739,40,1.18 [0.55-2.54],0.6680573832708135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",25769,41,0.88 [0.48-1.63],0.6944160217464075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,22529,37,1.81 [0.91-3.62],0.0933026406555145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,26487,40,0.74 [0.39-1.41],0.3601569261421374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,22945,37,1.37 [0.72-2.61],0.3400874142125425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,22882,35,1.10 [0.77-1.57],0.5901159392537834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,26103,40,5.09 [2.59-10.00],2.3202555085646377e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP2,Metalloproteinase inhibitor 2,22945,37,1.38 [0.78-2.43],0.2633132064806431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP3,Metalloproteinase inhibitor 3,26539,40,1.22 [1.00-1.49],0.0517355823839839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP4,Metalloproteinase inhibitor 4,26404,41,0.98 [0.49-1.95],0.9458185546181302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,26337,40,5.22 [1.64-16.58],0.0051418808356881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJAP1,Tight junction-associated protein 1,26490,42,1.03 [0.75-1.42],0.8373962350296803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJP3,Tight junction protein ZO-3,22212,34,0.85 [0.35-2.04],0.7158246485279416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TK1,"Thymidine kinase, cytosolic",22529,37,1.16 [0.60-2.24],0.6622395842516313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,22293,36,5.42 [2.57-11.46],9.348015815560027e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR2,Toll-like receptor 2,22529,37,1.74 [0.50-6.00],0.3825376371525841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR3,Toll-like receptor 3,26732,42,1.42 [0.89-2.26],0.1408218629658471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR4,Toll-like receptor 4,22293,36,3.47 [1.45-8.32],0.0053178681447013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,22304,36,1.50 [0.95-2.37],0.0788798310208686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED1,Transmembrane emp24 domain-containing protein 1,22529,37,1.08 [0.62-1.89],0.7745432613866412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED10,Transmembrane emp24 domain-containing protein 10,22213,35,0.51 [0.16-1.64],0.2548045378904895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED4,Transmembrane emp24 domain-containing protein 4,22213,35,0.59 [0.28-1.24],0.1638428955513083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED8,Protein TMED8,22858,36,1.16 [0.86-1.56],0.3299850055973371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM106A,Transmembrane protein 106A,22835,37,1.16 [0.79-1.70],0.4515019583699465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM132A,Transmembrane protein 132A,22310,34,0.97 [0.58-1.60],0.8937600982041863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM25,Transmembrane protein 25,22907,37,0.76 [0.38-1.54],0.449421996263304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMOD4,Tropomodulin-4,22139,37,1.69 [0.85-3.37],0.1337856212255287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11B,Transmembrane protease serine 11B,22212,34,0.82 [0.48-1.40],0.4747673881440024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,22832,35,2.61 [1.31-5.20],0.0063737270972973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,26305,39,1.89 [1.35-2.64],0.0001812354641602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS5,Transmembrane protease serine 5,26110,40,0.91 [0.45-1.84],0.7911577667299416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMSB10,Thymosin beta-10,26404,41,1.19 [0.83-1.71],0.3411902845285682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNC,Tenascin,26487,40,1.57 [0.90-2.76],0.1126973408575423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,25899,40,1.99 [1.39-2.85],0.0001673124832323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,22858,36,1.24 [0.72-2.15],0.4417072408232244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,25930,40,1.09 [0.51-2.31],0.8224127493916638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,22429,37,1.08 [0.70-1.66],0.7363219855599032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,26246,40,3.57 [2.65-4.83],9.244579076706056e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,26246,40,1.53 [1.25-1.89],5.7770266413094206e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,26454,39,1.51 [0.81-2.82],0.1955351305992383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,26732,42,4.39 [2.82-6.84],6.226098751919609e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,26400,39,4.46 [2.61-7.61],4.317536203167296e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,26490,42,4.53 [2.70-7.61],1.0987030090305854e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,26448,39,3.06 [1.98-4.75],5.538926663031315e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,25930,40,1.25 [0.65-2.39],0.5056224863473715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,26448,39,7.73 [4.21-14.21],4.4064448347430704e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,22429,37,2.95 [1.42-6.11],0.0036078458361456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,26655,42,2.57 [1.47-4.51],0.0009858834655447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,26404,41,5.97 [3.35-10.66],1.4619150781451383e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,26404,41,2.29 [1.72-3.05],1.2848384592714172e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,26677,41,2.58 [1.02-6.53],0.0447128393710763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,26684,42,3.24 [1.93-5.45],9.16038658141288e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,26246,40,1.88 [1.28-2.75],0.0012141036884904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,26677,41,1.79 [1.03-3.12],0.0390736275950241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,26246,40,2.67 [1.75-4.07],4.587805533544013e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,26732,42,0.69 [0.42-1.13],0.1421468896599397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,26402,41,0.52 [0.33-0.81],0.0039908677707301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,26732,42,0.37 [0.15-0.92],0.031549365742019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,26539,40,3.65 [1.47-9.08],0.0052829997951271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,26686,40,1.12 [0.40-3.11],0.8250057924698333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,26246,40,1.33 [0.84-2.12],0.2227739849995121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,22926,36,2.85 [1.36-5.98],0.0055927090092049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNIP1,TNFAIP3-interacting protein 1,22882,35,1.21 [0.86-1.71],0.2791669064383079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNN,Tenascin-N,22926,36,2.19 [1.08-4.43],0.0301789682120485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNNI3,"Troponin I, cardiac muscle",25946,40,1.07 [0.74-1.55],0.7028582921867973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNPO1,Transportin-1,22529,37,0.90 [0.36-2.29],0.832188165286754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNR,Tenascin-R,26246,40,0.85 [0.44-1.64],0.6374575606438919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNXB,Tenascin-X,26404,41,0.71 [0.42-1.18],0.1825096885040856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,22945,37,1.38 [0.98-1.93],0.0620451737888602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1,DNA topoisomerase 1,22858,36,1.29 [0.98-1.70],0.0659444761652022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1MT,"DNA topoisomerase I, mitochondrial",22139,37,0.59 [0.25-1.38],0.2214961835121644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP2B,DNA topoisomerase 2-beta,22293,36,1.29 [0.89-1.85],0.174335184812835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOR1AIP1,Torsin-1A-interacting protein 1,22310,34,0.91 [0.50-1.68],0.7678521286626343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53,Cellular tumor antigen p53,25789,40,1.13 [0.60-2.12],0.7124006123243232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53BP1,TP53-binding protein 1,22293,36,1.22 [0.84-1.77],0.3048038196499665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53I3,Quinone oxidoreductase PIG3,21943,35,1.47 [0.85-2.53],0.1663146683077325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,25946,40,0.36 [0.09-1.39],0.1393250085856243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP73,Tumor protein p73,22304,36,1.08 [0.43-2.75],0.8663413760740987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPBGL,Trophoblast glycoprotein-like,22304,36,0.34 [0.11-1.00],0.0507995059692093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPD52L2,Tumor protein D54,22429,37,1.08 [0.82-1.43],0.5837343087421187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPK1,Thiamin pyrophosphokinase 1,22945,37,0.79 [0.46-1.35],0.3843829112058241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPM3,Tropomyosin alpha-3 chain,22213,35,0.84 [0.38-1.84],0.6605223548398516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPMT,Thiopurine S-methyltransferase,25789,40,0.72 [0.48-1.06],0.0982806769133895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,26231,39,1.93 [1.26-2.94],0.0023931359600343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP2,Tubulin polymerization-promoting protein family member 2,22529,37,0.99 [0.65-1.51],0.9727159371205416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP3,Tubulin polymerization-promoting protein family member 3,25812,41,0.56 [0.24-1.32],0.1832770746030034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPR,Nucleoprotein TPR,22213,35,1.11 [0.63-1.96],0.7246159174140641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPRKB,EKC/KEOPS complex subunit TPRKB,22139,37,0.80 [0.45-1.43],0.4524912790637019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSAB1,Tryptase alpha/beta-1,26687,42,1.09 [0.64-1.84],0.7571456790179305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSD1,Tryptase delta,22907,37,1.54 [0.83-2.87],0.1729285525750395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSG1,Tryptase gamma,22293,36,1.00 [0.34-2.97],0.999092309396853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPT1,Translationally-controlled tumor protein,25930,40,1.31 [1.00-1.70],0.0468828099262392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF2,TNF receptor-associated factor 2,26402,41,0.87 [0.59-1.29],0.4945212444020145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",22293,36,1.32 [0.66-2.64],0.4317819765102441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,22213,35,0.61 [0.24-1.53],0.2919457973381983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,22529,37,1.10 [0.77-1.57],0.6008516727386441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREH,Trehalase,22926,36,1.59 [1.02-2.50],0.0423246015586689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,26400,39,2.98 [1.95-4.56],5.10511598576907e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML1,Trem-like transcript 1 protein,22963,37,1.13 [0.68-1.87],0.637369847593196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML2,Trem-like transcript 2 protein,26404,41,1.41 [0.62-3.18],0.4084214100153889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,26655,42,1.32 [0.89-1.95],0.1706704464296709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,26402,41,0.90 [0.65-1.25],0.5412525201804327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM24,Transcription intermediary factor 1-alpha,22483,37,1.20 [0.79-1.81],0.39417794912447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,22858,36,1.17 [0.88-1.57],0.2756152718767066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM26,Tripartite motif-containing protein 26,22139,37,0.93 [0.52-1.66],0.7995910485454923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM40,E3 ubiquitin ligase TRIM40,22304,36,1.23 [0.82-1.84],0.3221471865270335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM5,Tripartite motif-containing protein 5,26402,41,1.01 [0.74-1.39],0.9461540927763148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,22835,37,1.18 [0.84-1.66],0.3431094181881237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,22213,35,0.83 [0.49-1.40],0.4754011635907523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC1,Hamartin,22293,36,0.70 [0.38-1.27],0.2375486341727405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC22D1,TSC22 domain family protein 1,22907,37,1.22 [0.81-1.84],0.333648192180664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSHB,Thyrotropin subunit beta,26416,40,0.77 [0.53-1.14],0.1902166539961104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSLP,Thymic stromal lymphopoietin,25946,40,0.97 [0.58-1.61],0.8983886994609335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSNAX,Translin-associated protein X,22213,35,0.76 [0.35-1.63],0.4792129266526688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN1,Tetraspanin-1,25946,40,0.81 [0.41-1.62],0.5540162607572665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN15,Tetraspanin-15,22213,35,1.08 [0.54-2.16],0.8247560249740545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN7,Tetraspanin-7,22212,34,0.62 [0.35-1.08],0.0927781519882911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN8,Tetraspanin-8,22858,36,1.03 [0.73-1.43],0.8796788885846801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPYL1,Testis-specific Y-encoded-like protein 1,22293,36,1.08 [0.51-2.28],0.8465089898013397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TST,Thiosulfate sulfurtransferase,25774,41,1.03 [0.73-1.46],0.8483255503883094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTF2,Transcription termination factor 2,22304,36,0.88 [0.47-1.65],0.6818186830872065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTN,Titin,22213,35,0.84 [0.50-1.43],0.5187208418957145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTR,Transthyretin,22714,36,0.74 [0.22-2.49],0.6273148124449739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TUBB3,Tubulin beta-3 chain,22212,34,0.91 [0.29-2.84],0.8686329414556682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TWF2,Twinfilin-2,22926,36,1.13 [0.80-1.60],0.4837126081879228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXK,Tyrosine-protein kinase TXK,22529,37,0.99 [0.63-1.56],0.9675231816572788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXLNA,Alpha-taxilin,26246,40,1.17 [0.85-1.62],0.3422082601014431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXN,Thioredoxin,22595,35,0.74 [0.34-1.60],0.4482954040006445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC15,Thioredoxin domain-containing protein 15,26490,42,2.51 [1.02-6.21],0.0462585557198816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC5,Thioredoxin domain-containing protein 5,26677,41,1.17 [0.81-1.69],0.4102167069283974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC9,Thioredoxin domain-containing protein 9,22882,35,1.18 [0.72-1.95],0.5069506464865352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNL1,Thioredoxin-like protein 1,22169,34,0.70 [0.43-1.12],0.1382318869425214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",26404,41,1.23 [0.72-2.10],0.4503233935404646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYMP,Thymidine phosphorylase,26256,40,1.04 [0.69-1.56],0.8448184030651236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,26416,40,1.13 [0.43-2.98],0.8108220524015658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",22293,36,2.23 [1.26-3.92],0.0055658905703268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBAC1,Ubiquitin-associated domain-containing protein 1,26305,39,0.35 [0.15-0.84],0.0185914669336618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,22835,37,0.66 [0.22-1.98],0.4620377019448121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,22945,37,1.37 [0.85-2.19],0.1924703844799871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,22293,36,1.22 [0.77-1.93],0.3871831142893995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBQLN3,Ubiquilin-3,22213,35,1.20 [0.74-1.92],0.4624943441647779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBXN1,UBX domain-containing protein 1,22429,37,1.05 [0.69-1.60],0.824767646533796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,22858,36,1.08 [0.86-1.34],0.5105988590822175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UGDH,UDP-glucose 6-dehydrogenase,22213,35,0.96 [0.68-1.34],0.7921668659479524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,22213,35,0.60 [0.19-1.90],0.3835586268489122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,26246,40,2.26 [1.19-4.29],0.0129548715038685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,26645,39,0.37 [0.25-0.57],3.4751654492525303e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC5D,Netrin receptor UNC5D,22293,36,0.68 [0.19-2.48],0.563014175551552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC79,Protein unc-79 homolog,22139,37,1.26 [0.76-2.09],0.3630730803208095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNG,Uracil-DNA glycosylase,22835,37,1.20 [0.53-2.72],0.66551349457533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPB1,Beta-ureidopropionase,22945,37,1.43 [1.06-1.94],0.0191476770277512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3A,Uroplakin-3a,22212,34,1.11 [0.55-2.25],0.7681725469555236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3BL1,Uroplakin-3b-like protein 1,22492,37,1.34 [0.87-2.06],0.1883225226384594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROD,Uroporphyrinogen decarboxylase,22429,37,1.05 [0.70-1.59],0.8101760879460314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROS,Uroporphyrinogen-III synthase,22304,36,0.79 [0.47-1.33],0.3681585008439497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USO1,General vesicular transport factor p115,26305,39,0.86 [0.62-1.17],0.3306338353179065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,22835,37,1.13 [0.76-1.70],0.5429134614831786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,22882,35,1.24 [0.58-2.63],0.578520548367388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,22213,35,0.98 [0.69-1.39],0.9118513050969108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,25946,40,0.98 [0.73-1.32],0.9017336654717236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UXS1,UDP-glucuronic acid decarboxylase 1,25789,40,1.06 [0.65-1.72],0.808260589699369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP5,Vesicle-associated membrane protein 5,25946,40,0.78 [0.41-1.49],0.4533831864748824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP8,Vesicle-associated membrane protein 8,22293,36,1.09 [0.78-1.53],0.6111948638532188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,26402,41,1.05 [0.77-1.42],0.7736394118729615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASN,Vasorin,25983,39,1.47 [0.55-3.93],0.4462819329742286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASP,Vasodilator-stimulated phosphoprotein,22963,37,1.07 [0.72-1.57],0.7469492443929844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,26305,39,0.70 [0.36-1.36],0.2922080936750797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAV3,Guanine nucleotide exchange factor VAV3,22212,34,1.10 [0.81-1.51],0.5314701918403391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,26454,40,5.80 [2.74-12.24],4.124689567212409e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAN,Versican core protein,26677,41,1.09 [0.42-2.87],0.8547165164129348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCPKMT,Protein-lysine methyltransferase METTL21D,22139,37,1.11 [0.80-1.55],0.5314743259523691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,26645,42,1.97 [1.33-2.92],0.0006747781489443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,22293,36,4.50 [1.95-10.39],0.000427011217657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFC,Vascular endothelial growth factor C,26490,42,1.71 [1.08-2.71],0.0222371406076411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,26690,42,2.89 [1.47-5.66],0.0019842255822805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VGF,Neurosecretory protein VGF,22907,37,2.10 [0.89-4.94],0.0908133147355348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIM,Vimentin,25946,40,1.12 [0.85-1.47],0.4202485183214605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,22310,34,0.70 [0.37-1.31],0.2617272885898412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIT,Vitrin,22945,37,1.04 [0.44-2.41],0.9361720321590646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VMO1,Vitelline membrane outer layer protein 1 homolog,26305,39,1.49 [0.94-2.36],0.0909294093782875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN1,Pantetheinase,22963,37,1.23 [0.79-1.93],0.363275885875101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN2,Vascular non-inflammatory molecule 2,26305,39,1.42 [0.75-2.71],0.2815482773003034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,22529,37,0.97 [0.62-1.52],0.899829023262597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS37A,Vacuolar protein sorting-associated protein 37A,26305,39,1.07 [0.76-1.52],0.6983446086600424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS4B,Vacuolar protein sorting-associated protein 4B,22835,37,1.05 [0.78-1.43],0.7369798296355001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,26305,39,0.96 [0.68-1.36],0.813908567726897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,22835,37,1.50 [0.73-3.09],0.2689980271239179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,22213,35,1.05 [0.39-2.80],0.9300066192797444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,22835,37,3.34 [2.43-4.60],1.196718540919429e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,26367,41,4.33 [2.85-6.57],6.183526675555786e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,26382,40,1.44 [1.02-2.02],0.035902439028193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSNL1,Visinin-like protein 1,22882,35,0.91 [0.39-2.10],0.8171165097708288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM1,V-set and transmembrane domain-containing protein 1,25812,41,1.35 [0.79-2.31],0.2788619505613643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,22529,37,0.50 [0.18-1.42],0.1930446439029463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,25946,40,1.20 [0.76-1.89],0.4451906681899147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,26677,41,0.88 [0.61-1.26],0.491701551053778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,25789,40,2.24 [1.06-4.73],0.0343242471784155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,22429,37,1.44 [0.91-2.29],0.1228614238981583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA1,von Willebrand factor A domain-containing protein 1,26621,42,1.30 [0.69-2.44],0.4214363531578451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA5A,von Willebrand factor A domain-containing protein 5A,22139,37,0.77 [0.46-1.28],0.3147309488612041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,26159,40,2.33 [1.17-4.64],0.0162497192303039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,22907,37,1.10 [0.59-2.02],0.7677034382180161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWF,von Willebrand factor,26739,40,1.47 [1.03-2.11],0.0333063427132277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",26404,41,1.25 [0.57-2.71],0.5746628139509629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WAS,Wiskott-Aldrich syndrome protein,25930,40,1.22 [0.83-1.77],0.3108089111536809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,25946,40,0.90 [0.67-1.21],0.4761516073930965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,25812,41,0.96 [0.70-1.32],0.7916601488461543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASHC3,WASH complex subunit 3,22882,35,1.27 [0.89-1.82],0.190858776258227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASL,Neural Wiskott-Aldrich syndrome protein,22293,36,0.69 [0.36-1.30],0.2494130510141252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WDR46,WD repeat-containing protein 46,22835,37,1.42 [0.75-2.67],0.2782985371564764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC1,WAP four-disulfide core domain protein 1,22379,36,1.39 [0.93-2.07],0.1049422680965636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC12,WAP four-disulfide core domain protein 12,26606,42,1.21 [0.79-1.87],0.3838859716168623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,25053,41,0.71 [0.27-1.83],0.4742277200770919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",26163,40,0.38 [0.19-0.76],0.0058976325008668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",26448,39,1.38 [0.58-3.29],0.4607827114102982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WIF1,Wnt inhibitory factor 1,26655,42,0.69 [0.47-1.02],0.0624532505515263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,25930,40,3.05 [1.66-5.60],0.0003303029959394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,26246,40,0.84 [0.49-1.46],0.5445741126309755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XCL1,Lymphotactin,26655,42,1.84 [1.31-2.58],0.0004447612111603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,26601,40,2.11 [1.07-4.16],0.0303315235793296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XIAP,E3 ubiquitin-protein ligase XIAP,22293,36,1.26 [0.77-2.08],0.3596177745415547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XPNPEP2,Xaa-Pro aminopeptidase 2,26490,42,0.86 [0.67-1.10],0.218688465099033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XRCC4,DNA repair protein XRCC4,25812,41,0.88 [0.42-1.88],0.7476831604874137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,22882,35,5.20 [2.35-11.50],4.642027448869788e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",22858,36,1.05 [0.85-1.31],0.6439120941794638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YES1,Tyrosine-protein kinase Yes,26305,39,1.07 [0.84-1.38],0.5782226615626342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YJU2,Splicing factor YJU2,22835,37,1.20 [0.54-2.67],0.6608166835928297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YOD1,Ubiquitin thioesterase OTU1,22213,35,0.77 [0.45-1.31],0.340063792170921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YTHDF3,YTH domain-containing family protein 3,25930,40,0.91 [0.66-1.25],0.5600907778084396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YWHAQ,14-3-3 protein theta,22429,37,1.00 [0.68-1.47],0.986099758027482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YY1,Transcriptional repressor protein YY1,22293,36,1.51 [0.54-4.21],0.4267596746798611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBP1,Z-DNA-binding protein 1,22293,36,0.85 [0.36-2.02],0.7208889442071751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,25789,40,1.10 [0.76-1.58],0.6265501153963462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,25946,40,0.90 [0.44-1.82],0.7605016262479825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,22213,35,1.06 [0.64-1.76],0.8096897628381811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZFYVE19,Abscission/NoCut checkpoint regulator,22858,36,1.13 [0.81-1.57],0.484113629769376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZHX2,Zinc fingers and homeoboxes protein 2,22882,35,0.95 [0.36-2.53],0.9235082851879006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF174,Zinc finger protein 174,22293,36,1.60 [0.92-2.78],0.0950658984165362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF75D,Zinc finger protein 75D,22529,37,0.67 [0.35-1.29],0.2353270953303586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF830,Zinc finger protein 830,22835,37,0.69 [0.42-1.15],0.1518019167883042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,22858,36,2.12 [1.47-3.05],6.357500589644968e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,22835,37,1.53 [0.94-2.49],0.0845016009621723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP3,Zona pellucida sperm-binding protein 3,22310,34,0.94 [0.83-1.07],0.3656787169438686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP4,Zona pellucida sperm-binding protein 4,22139,37,1.27 [0.58-2.78],0.5510586577010654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZPR1,Zinc finger protein ZPR1,22212,34,1.15 [0.92-1.44],0.218711614157159
